,index,key,score,total_mentions
0,630,infarction mi,74.28571428571419,300.0
1,2351,mortality morbidity,71.93333333333221,166.0
2,1101,young adults,62.39999999999975,624.0
3,2885,cerebral perfusion,53.81860465116303,203.0
4,2562,patients receiving,52.90277777777806,586.0
5,3406,analysis results,52.33548387096804,208.0
6,3411,duplex ultrasound,38.26490066225179,270.0
7,1327,trend toward,35.11363636363669,309.0
8,139,functional status,31.850000000000268,196.0
9,2924,excluded patients,28.99999999999983,145.0
10,3153,fractional flow,28.522388059701573,273.0
11,387,records patients,28.19090909090853,443.0
12,2405,malignant lesions,26.74374999999988,389.0
13,1461,treatment strategy,26.670935960591205,253.0
14,1662,late gadolinium,23.818750000000072,309.0
15,1730,aortic aneurysms,23.504477611940665,254.0
16,865,performed cases,22.499999999999623,225.0
17,296,single institution,22.14576271186428,278.0
18,1657,largely unknown,21.716546762590085,351.0
19,1117,signs symptoms,18.90465631929042,290.0
20,839,transthoracic echocardiography,17.034146341463362,582.0
21,656,regions including,16.97499999999991,194.0
22,1436,provide important,16.79240506329125,201.0
23,1349,cognitive deficits,16.693457943925363,229.0
24,3162,vessel diameter,16.53432835820892,191.0
25,2707,patients early,16.486363636363595,351.0
26,3466,least years,16.37777777777782,201.0
27,2817,weeks later,15.899999999999844,159.0
28,2192,renal artery,15.331972789115506,382.0
29,2363,patients chronic,14.309923664122026,721.0
30,2763,rv function,14.235195530726203,307.0
31,1089,ventricular rv,14.14644351464433,345.0
32,2687,women aged,14.09703872437358,319.0
33,3484,adverse cardiovascular,13.698245614035104,192.0
34,1250,patients presented,13.131390134529099,681.0
35,3387,analyses used,12.99999999999994,182.0
36,3198,acl reconstruction,12.926121372031657,355.0
37,1516,tomography angiography,12.71860902255641,953.0
38,1953,chest wall,12.600000000000053,243.0
39,2375,microcomputed tomography,12.211111111111135,157.0
40,1853,membrane potential,12.070454545454593,226.0
41,2344,ischemic stroke,12.01643835616431,1462.0
42,1630,analyzed patients,11.90322580645164,369.0
43,313,patients control,11.617054263565896,381.0
44,693,stent grafts,11.437037037037017,193.0
45,2022,retrospective chart,11.344051446945372,280.0
46,1626,injury tbi,11.31056910569096,188.0
47,2740,strain gls,11.066666666666633,166.0
48,3527,fiber layer,11.004901960784208,449.0
49,1915,studies confirmed,10.837288135593202,139.0
50,1583,nerve head,10.818181818181818,170.0
51,3638,rotator cuff,10.792452830188667,715.0
52,91,widely available,10.742105263157857,157.0
53,1633,subjects aged,10.645161290322559,150.0
54,1901,weeks range,10.548717948717911,121.0
55,3468,reserve ffr,10.470422535211227,177.0
56,1389,gadolinium enhancement,10.292079207920821,315.0
57,2443,confocal microscopy,10.101420454545494,1147.0
58,316,vascular access,9.964322469982852,282.0
59,1204,prefrontal cortex,9.869888922245632,1847.0
60,2358,cell morphology,9.692579505300365,211.0
61,69,using multivariate,9.663157894736853,153.0
62,2099,patients male,9.622222222222128,433.0
63,2593,temporal lobe,9.535883654758125,914.0
64,2314,de novo,9.260869565217378,497.0
65,293,consisted patients,9.05015479876158,232.0
66,1404,independent predictors,9.036012418075181,891.0
67,1366,females mean,8.761137440758247,237.0
68,2793,aortic repair,8.657439446366778,278.0
69,1545,characterized using,8.652173913043548,199.0
70,951,coronary intervention,8.609307737056396,961.0
71,2718,within first,8.487471526195902,230.0
72,94,endothelial cell,8.486319845857423,286.0
73,2354,femoral artery,8.41300813008126,398.0
74,3323,brain network,8.389937106918236,290.0
75,1201,functional outcomes,8.349179046129755,499.0
76,2015,period months,8.14487632508832,461.0
77,2713,dilated cardiomyopathy,7.986577181208079,238.0
78,1059,secondary outcomes,7.759477124182974,336.0
79,2377,volume total,7.750000000000023,155.0
80,1847,frontal parietal,7.644673539518914,227.0
81,3371,using mr,7.478048780487838,146.0
82,3515,response rate,7.477659574468084,213.0
83,1866,calculated using,7.366686710763674,738.0
84,148,lipoprotein cholesterol,7.311764705882382,226.0
85,1529,aortic arch,7.303862660944199,762.0
86,3109,groups based,7.270557717250315,308.0
87,2482,endothelial cells,7.228947368421031,603.0
88,2186,cardiovascular diseases,7.228125000000047,257.0
89,478,dorsolateral prefrontal,7.123484013230443,497.0
90,307,endovascular repair,7.11103896103894,233.0
91,2292,occurred patients,7.040424204616346,773.0
92,2509,studies demonstrated,7.011019283746564,509.0
93,2499,aim determine,6.851937594363406,674.0
94,1785,majority cases,6.5722222222222255,169.0
95,3550,used quantify,6.351145038168002,260.0
96,2801,endovascular treatment,6.3477064220183035,629.0
97,3374,without history,6.344272445820439,218.0
98,2025,january december,6.280849435622736,938.0
99,2991,patients reported,6.278787878787858,296.0
100,2654,institutes health,6.242447418738034,308.0
101,2730,patients postoperative,6.241059602649024,152.0
102,1636,studies included,6.238767650834399,300.0
103,2430,young patients,5.9740498034075715,213.0
104,1684,found groups,5.926923076923069,201.0
105,3563,myocardial ischemia,5.853012048192775,347.0
106,2762,femoral head,5.809373235460212,578.0
107,2574,wild type,5.774301675977641,304.0
108,2454,analogue scale,5.737254901960795,209.0
109,1738,ii iii,5.736448598130824,372.0
110,2913,surgical treatment,5.69648894668398,1043.0
111,2486,older years,5.612006861063457,287.0
112,2176,percutaneous coronary,5.606837606837532,984.0
113,2289,optimal treatment,5.604221635883905,180.0
114,1808,showed reduced,5.538943248532255,232.0
115,299,surgical resection,5.494817964390108,899.0
116,571,stent placement,5.484116899618813,332.0
117,1745,range range,5.482022471910091,287.0
118,727,value npv,5.442047531992676,244.0
119,1882,years underwent,5.36566757493191,547.0
120,1788,patients stage,5.33477672530446,256.0
121,2631,end points,5.318504190844613,365.0
122,2721,patients treatment,5.2656716417910365,168.0
123,2252,pleural effusion,5.244970414201166,277.0
124,926,score associated,5.239726027397266,153.0
125,3255,patients used,5.233333333333335,157.0
126,402,commonly associated,5.203603603603577,152.0
127,812,data regarding,5.162589928057552,312.0
128,1670,endovascular aortic,5.1550802139037515,241.0
129,1904,recent studies,5.100000000000001,639.0
130,2874,many studies,5.094949494949503,194.0
131,1556,groups vs,5.03089430894307,182.0
132,2235,pubmed embase,5.010714285714296,183.0
133,3063,independent component,4.982142857142852,186.0
134,1240,focused ultrasound,4.949384404924768,270.0
135,1938,patients demonstrated,4.91351351351352,303.0
136,2374,patients categorized,4.900000000000004,161.0
137,2591,studies examined,4.897619047619037,187.0
138,2290,patients completed,4.888888888888897,220.0
139,3174,patients identified,4.869200524246406,432.0
140,3431,target vessel,4.783685800604239,203.0
141,1802,mean time,4.76366612111292,539.0
142,1338,acute ischemic,4.724999999999995,540.0
143,2912,prognostic factors,4.64860267314702,407.0
144,2,lesions patients,4.647945205479448,468.0
145,2732,article review,4.6175438596491105,188.0
146,3318,photoelectron spectroscopy,4.6000000000000085,207.0
147,326,aimed examine,4.5789473684210815,145.0
148,507,body mass,4.577117299091065,2060.0
149,2604,examination showed,4.574468085106397,325.0
150,845,articular cartilage,4.560189253126064,404.0
151,240,however little,4.511111111111116,406.0
152,592,national institutes,4.504380475594492,305.0
153,884,patients men,4.500625782227804,580.0
154,2483,women men,4.398080614203465,603.0
155,1685,imaging biomarkers,4.364350453172212,233.0
156,3599,successful patients,4.355852842809353,176.0
157,3578,thoracic aorta,4.316641679160408,236.0
158,3346,fluorescently labeled,4.31304347826086,144.0
159,1805,values higher,4.292307692307668,279.0
160,136,cells vitro,4.266666666666664,216.0
161,337,systolic dysfunction,4.2638228055783225,356.0
162,964,breast lesions,4.254310344827573,423.0
163,2021,volume changes,4.222580645161287,187.0
164,286,acuity bcva,4.211842105263155,291.0
165,2972,lesions found,4.1666666666666625,125.0
166,703,based computed,4.162499999999998,111.0
167,2969,using functional,4.154672897196256,523.0
168,1332,neuroimaging findings,4.125000000000006,165.0
169,3046,rarely reported,4.106007067137798,166.0
170,2001,squamous cell,4.102310231023113,565.0
171,1093,rv dysfunction,4.0916299559471225,258.0
172,504,drug delivery,4.082521357654104,893.0
173,2709,higher rates,4.065558633425663,259.0
174,412,peak systolic,4.037242073477621,382.0
175,816,conservative treatment,3.9957446808510384,313.0
176,755,support use,3.9461538461538397,171.0
177,1887,lung biopsy,3.918918918918904,175.0
178,339,change time,3.910112359550542,145.0
179,1794,myocardial infarction,3.9092592592592794,2111.0
180,3342,different patterns,3.817177914110437,183.0
181,1697,receiver operator,3.7560975609755785,154.0
182,260,conducted patients,3.748946135831378,276.0
183,2940,detection rates,3.720930232558151,288.0
184,2500,pain score,3.7034482758620597,179.0
185,2571,regression model,3.650831502980851,576.0
186,2180,tumor volume,3.6422267481330564,725.0
187,1182,microscopy showed,3.630075187969931,238.0
188,3203,brain atrophy,3.6227544910179854,275.0
189,2144,first reported,3.620253164556981,260.0
190,1860,among cases,3.61363636363635,159.0
191,1143,using standardized,3.591525423728817,163.0
192,1570,disease however,3.5881889763779364,217.0
193,1606,abdominal wall,3.5636863823933913,254.0
194,1496,physical examination,3.558790893437916,721.0
195,3564,important information,3.5574468085106385,152.0
196,2922,hypertension ph,3.544303797468368,175.0
197,1247,coherence tomography,3.49135729428584,2788.0
198,1709,among patients,3.488737538248957,1942.0
199,2048,central peripheral,3.479781420765025,199.0
200,803,cell carcinoma,3.4626363114597316,896.0
201,1216,descriptive statistics,3.443271767810027,225.0
202,1263,taken account,3.4192355117139273,295.0
203,848,drug resistance,3.400000000000018,119.0
204,3202,occurred cases,3.395454545454549,166.0
205,2177,higher sensitivity,3.388429752066095,246.0
206,454,review performed,3.3834710743801772,267.0
207,403,studies evaluating,3.3665271966527293,149.0
208,901,acute appendicitis,3.349462365591393,267.0
209,138,optical coherence,3.320613889808978,2802.0
210,3254,human subjects,3.2907216494845373,228.0
211,217,good excellent,3.2749999999999893,131.0
212,1859,mean months,3.2630789207906385,802.0
213,394,pulmonary vascular,3.233082706766916,172.0
214,2044,taken together,3.2277537796976223,729.0
215,1762,associated lower,3.211315610088621,673.0
216,149,sought investigate,3.208333333333337,154.0
217,1629,identify factors,3.2081218274111722,316.0
218,3027,hounsfield units,3.1339491916859026,295.0
219,2402,brain volume,3.1223583024779265,363.0
220,3510,widespread use,3.1086956521739117,195.0
221,682,texture analysis,3.0615384615384564,199.0
222,1033,patients enrolled,3.0539930555555537,718.0
223,2353,investigate association,3.0487521764364445,309.0
224,3334,chart review,3.0253666270313055,449.0
225,2890,cardiac surgery,2.9874739039665963,265.0
226,1763,left frontal,2.979844961240317,186.0
227,1303,disease activity,2.945671378091884,741.0
228,3314,identified cases,2.915887850467288,160.0
229,2319,associated greater,2.909090909090901,480.0
230,1548,together results,2.906793048973148,400.0
231,1949,patients undergone,2.894491525423723,621.0
232,1362,independent predictor,2.8836795252225422,904.0
233,243,groups similar,2.8798498122653258,195.0
234,3584,mean patients,2.8740904079382528,266.0
235,886,difference observed,2.870888661899892,299.0
236,1987,disease onset,2.865384615384601,149.0
237,992,difference found,2.864705882352931,487.0
238,2743,surgical planning,2.8575560375994153,304.0
239,1205,months range,2.83943089430894,889.0
240,1300,tomography oct,2.837589670014334,1023.0
241,2245,present patients,2.82947037231253,529.0
242,1100,microscopy images,2.8150537634408654,231.0
243,415,duration months,2.8128654970760056,185.0
244,2028,target volume,2.8062780269058116,447.0
245,3101,patients diabetes,2.7916295636687396,209.0
246,3140,screening program,2.7771038665655783,185.0
247,1066,patients bilateral,2.775108538350223,188.0
248,165,matched healthy,2.7615508885298894,231.0
249,1725,together data,2.743040685224829,183.0
250,3319,outcomes patients,2.7118346900438253,802.0
251,2790,studies reported,2.700513573000727,428.0
252,539,support hypothesis,2.6970618034447837,242.0
253,1574,structural changes,2.6968936303733853,573.0
254,2268,patients treated,2.6680158831817486,2422.0
255,362,patients using,2.657188244638596,389.0
256,3509,using dynamic,2.656830601092886,187.0
257,2362,immunofluorescence staining,2.6521739130434647,122.0
258,453,adverse effects,2.6469534050179178,422.0
259,876,well defined,2.6374100719424427,141.0
260,2837,identified using,2.6347762289068233,268.0
261,2198,cardiac dysfunction,2.6250990752972263,368.0
262,3074,previous reports,2.6250000000000067,245.0
263,535,multicenter randomized,2.621739130434769,134.0
264,152,imaging revealed,2.6083206494165476,485.0
265,2361,aim describe,2.604651162790707,210.0
266,1506,light microscopy,2.6040133779264143,458.0
267,2196,thyroid carcinoma,2.593750000000004,249.0
268,2611,natriuretic peptide,2.591803278688519,306.0
269,257,coronary atherosclerosis,2.5879081015719403,261.0
270,1994,highlight importance,2.5874999999999986,138.0
271,3169,stable patients,2.58489425981873,138.0
272,2116,occipital cortex,2.579505300353361,146.0
273,1974,findings associated,2.5633986928104577,159.0
274,953,artery disease,2.562542339111374,1803.0
275,3369,syndrome patients,2.545454545454557,140.0
276,3260,common type,2.544785276073628,122.0
277,2097,proliferation differentiation,2.541552511415524,121.0
278,1157,associated improved,2.5323741007194287,160.0
279,849,taking advantage,2.5162995594713697,136.0
280,2419,used obtain,2.5156249999999987,161.0
281,1043,found patients,2.5088218554353916,760.0
282,2342,present cases,2.5010466222645134,337.0
283,3160,safety profile,2.479120879120877,141.0
284,2600,investigate effects,2.479041916167665,230.0
285,3119,especially patients,2.473152242577386,261.0
286,3583,cardiovascular disease,2.4607287449392548,1013.0
287,1857,using quantitative,2.456973293768543,276.0
288,2161,lung cancer,2.455979925458503,2429.0
289,2518,cell density,2.447144006436039,227.0
290,2882,evidence suggests,2.4350877192982554,347.0
291,3261,showed changes,2.423821339950373,148.0
292,1367,multivariate cox,2.4219306466729114,219.0
293,1288,patients presenting,2.4196428571428554,813.0
294,431,randomized trials,2.416023738872403,207.0
295,397,patients higher,2.4086642599278005,417.0
296,774,imaging dti,2.3986486486486513,639.0
297,2421,patients undergo,2.370862800565774,289.0
298,356,better understanding,2.364203027604635,531.0
299,1874,showed evidence,2.363513513513511,159.0
300,1680,prospectively enrolled,2.3629629629629587,319.0
301,3353,elderly patients,2.361772853185595,294.0
302,2893,tested hypothesis,2.3577464788732367,248.0
303,3409,patients symptomatic,2.3422037422037363,393.0
304,3171,associated low,2.3419354838709756,121.0
305,610,purpose investigate,2.3373271889400873,634.0
306,1784,greater activation,2.336395759717307,174.0
307,1950,imaging technique,2.3328324567994025,675.0
308,1241,independent prognostic,2.327238805970146,189.0
309,846,structural connectivity,2.3197448844007433,278.0
310,40,cuff tears,2.316901408450704,210.0
311,842,close proximity,2.2972188633615453,161.0
312,1824,use imaging,2.294117647058828,273.0
313,2384,regional brain,2.2804733727810653,141.0
314,2860,normal control,2.2768558951965057,237.0
315,3420,available patients,2.255421686746989,216.0
316,1298,better understand,2.2505694760820054,380.0
317,1701,methods used,2.2499999999999876,405.0
318,482,anterior cruciate,2.246788990825684,316.0
319,3592,tomography images,2.2415094339622645,474.0
320,2660,groups b,2.2350305498981706,177.0
321,576,neurological symptoms,2.233976833976835,263.0
322,130,older patients,2.2296296296296325,301.0
323,2175,time months,2.2238887003732577,331.0
324,3291,hazard hr,2.2136811023622034,459.0
325,190,adverse cardiac,2.2095238095238043,348.0
326,773,using multiple,2.201136363636368,149.0
327,1428,green icg,2.1908902691511347,143.0
328,2474,open repair,2.1836153161175424,183.0
329,2301,adult population,2.180412371134017,141.0
330,640,images analyzed,2.1764705882352926,185.0
331,2382,rate higher,2.162499999999985,173.0
332,2777,imaging used,2.1565411852404006,526.0
333,2392,additional imaging,2.1428571428571397,150.0
334,3224,cortical regions,2.140022805017108,408.0
335,1455,spin echo,2.1390728476821175,190.0
336,1937,treated using,2.116304347826082,177.0
337,502,univariate multivariate,2.110113704368638,410.0
338,1405,using magnetic,2.108229988726039,550.0
339,1764,patients coronary,2.1065637065637097,341.0
340,3357,scale vas,2.106382978723405,261.0
341,692,sonographic findings,2.1038626609442015,171.0
342,3233,arterial hypertension,2.100000000000007,324.0
343,652,vivo imaging,2.0875000000000545,501.0
344,2085,ventricular mass,2.079885057471265,329.0
345,2982,cox proportional,2.0763513513513354,439.0
346,354,matched gender,2.0756756756756727,128.0
347,3182,knockout mice,2.0659722222222188,238.0
348,2642,months months,2.0595202398800545,723.0
349,3385,mycobacterium tuberculosis,2.0540540540540553,140.0
350,2973,respectively difference,2.0457364341085285,364.0
351,265,levels serum,2.0428571428571325,143.0
352,1230,type collagen,2.032653061224488,166.0
353,1517,using linear,2.0313099041533533,289.0
354,1732,scores patients,2.0298044504382986,173.0
355,3388,medical center,2.0279237135660297,386.0
356,1135,patients newly,2.027184466019424,174.0
357,2325,electron microscope,2.0259927797833837,488.0
358,0,cerebrospinal fluid,2.0234974029186175,909.0
359,662,inferior parietal,2.021965317919072,477.0
360,352,blood flow,2.015737650200269,3097.0
361,3057,determine optimal,2.0144578313253008,209.0
362,1210,system based,2.0140845070422486,165.0
363,400,including patients,1.9979381443298994,323.0
364,191,volume index,1.9976958525345692,289.0
365,288,studies shown,1.992857142857126,558.0
366,3267,ultrasound guidance,1.9924736117485116,324.0
367,1899,studies performed,1.972925199396414,526.0
368,3410,coronary artery,1.9669668069689308,4102.0
369,116,major adverse,1.965272296764013,498.0
370,1022,confounding factors,1.9619565217391295,190.0
371,989,iliac artery,1.958728557013113,329.0
372,2994,changes observed,1.9570234113712366,249.0
373,2612,natural history,1.953316326530609,403.0
374,368,data exist,1.9529411764705893,166.0
375,543,hyaluronic acid,1.9529411764705873,166.0
376,465,used determine,1.9505108840515382,757.0
377,3629,using echocardiography,1.9435582822085864,176.0
378,857,thoracic endovascular,1.9384615384615391,168.0
379,1929,systematic review,1.9377031987415025,596.0
380,2283,suspected coronary,1.9333333333333305,145.0
381,2590,bladder cancer,1.9265306122448995,236.0
382,3536,thirty patients,1.9241224794622838,226.0
383,1540,model using,1.9181494661921679,231.0
384,2615,visual analogue,1.9140271493212682,235.0
385,3449,health organization,1.9013774104683139,203.0
386,3229,management patients,1.875232662864006,512.0
387,1945,article describes,1.873239436619724,190.0
388,528,smooth muscle,1.8683544303797412,369.0
389,532,achieved patients,1.868320610687024,445.0
390,1720,salivary glands,1.8637106184364067,198.0
391,1523,findings provide,1.8626865671641757,416.0
392,1760,oct images,1.850816056462285,259.0
393,1104,single surgeon,1.8499999999999819,111.0
394,3558,respiratory distress,1.8456928838951325,224.0
395,1351,minimally invasive,1.8364888123924215,1067.0
396,1527,compare diagnostic,1.830592105263151,265.0
397,2849,inflammatory markers,1.829906542056074,178.0
398,422,feasibility using,1.828571428571425,256.0
399,3526,postoperative day,1.8214876033057816,232.0
400,2623,higher patients,1.8208463088477709,700.0
401,3511,retrospective observational,1.817670682730926,219.0
402,1843,blood cell,1.8168865435356214,313.0
403,781,observed patients,1.816423804984334,1026.0
404,1957,filtered back,1.8074074074074005,122.0
405,3185,effective treatment,1.7998250218722636,556.0
406,2023,stroke scale,1.7948546927108162,299.0
407,858,patients without,1.7865412445731284,2469.0
408,713,model model,1.7858267716535452,126.0
409,3601,ischemic heart,1.7856468366383356,155.0
410,2093,pain patients,1.783783783783784,165.0
411,2789,higher mortality,1.7818791946308705,177.0
412,1224,associated reduced,1.7646090534979413,416.0
413,2065,analysis software,1.7523178807947144,147.0
414,533,fluorescence intensity,1.751351351351352,216.0
415,3519,using modified,1.7493001555209975,304.0
416,2516,cell carcinomas,1.7481481481481498,118.0
417,3589,provides first,1.7450381679389286,127.0
418,2101,treatment treatment,1.7359223300970894,149.0
419,2248,spectroscopy nirs,1.724999999999992,161.0
420,2193,microscopy used,1.7245235069885634,174.0
421,2608,prospective multicenter,1.7116071428571462,213.0
422,1092,health care,1.7106267029972722,511.0
423,2736,play role,1.70741301059002,513.0
424,1254,lv function,1.7070657507360156,355.0
425,2450,median time,1.7055063199186429,559.0
426,822,cardiac output,1.7027027027027002,315.0
427,3531,coil embolization,1.7015437392795885,320.0
428,983,early onset,1.7007874015748001,144.0
429,836,right side,1.700149925037477,324.0
430,1398,high prevalence,1.698683613254652,297.0
431,1441,multivariate regression,1.698643649815042,336.0
432,1438,grading system,1.6959208899876395,245.0
433,793,series patients,1.691832669322709,447.0
434,2955,tomography showed,1.6912912912912936,256.0
435,396,enrolled patients,1.6910819840657894,700.0
436,2345,logistic regression,1.6862813716016956,2713.0
437,2246,cerebral amyloid,1.6798353909465011,157.0
438,1758,hemorrhage ich,1.6784140969162933,127.0
439,1024,level trauma,1.6781609195402258,146.0
440,3335,obstructive pulmonary,1.6689930209371922,186.0
441,2194,controls hc,1.6632530120481903,251.0
442,2989,network dmn,1.6608996539792407,288.0
443,42,coronary syndromes,1.660209424083767,151.0
444,2208,odds ratios,1.6590841949778448,312.0
445,1411,many patients,1.6524338172502147,225.0
446,1833,temporal cortex,1.652421367948076,247.0
447,2925,obtained different,1.6502283105022817,139.0
448,128,provide overview,1.650000000000002,176.0
449,550,treatment outcomes,1.649999999999998,276.0
450,1005,sciatic nerve,1.6428571428571448,184.0
451,619,studies suggested,1.639700374531835,199.0
452,1616,efficacy safety,1.6375448028673847,425.0
453,2341,within months,1.6374954495813632,459.0
454,120,best knowledge,1.633527696793003,431.0
455,101,transcranial doppler,1.6304064536146452,302.0
456,1449,evaluated patients,1.630073487846236,486.0
457,1643,arterial stiffness,1.626671551566225,400.0
458,636,scoring system,1.6101946246524497,511.0
459,407,recruited patients,1.6083333333333347,193.0
460,1992,mammography screening,1.6040914560770174,155.0
461,3525,different patients,1.5950495049504996,179.0
462,3007,days respectively,1.5854922279792725,153.0
463,1032,patients recurrent,1.5778175313058975,210.0
464,2134,current imaging,1.5753694581280753,123.0
465,3191,cell viability,1.5739478957915556,561.0
466,1323,disability index,1.5721153846153852,218.0
467,2944,flow reserve,1.5708647290993867,398.0
468,1871,autosomal dominant,1.5658362989323842,264.0
469,66,groups differences,1.5629629629629602,211.0
470,2667,respectively median,1.5616438356164484,190.0
471,3463,low back,1.561394302848576,393.0
472,1325,radiofrequency ablation,1.5595484477892811,307.0
473,1381,preserved ejection,1.5587828492392795,161.0
474,1036,procedural success,1.5579678679982647,276.0
475,968,traumatic brain,1.5490254872563662,492.0
476,1011,systolic excursion,1.5481481481481465,209.0
477,954,males females,1.5474500879280035,1084.0
478,3572,outpatient clinic,1.5473684210526393,147.0
479,2086,fundus autofluorescence,1.5419642857142861,157.0
480,1736,invasive breast,1.533083912346336,202.0
481,1026,operating characteristics,1.5218658892128265,174.0
482,2537,reported literature,1.518461198319699,404.0
483,1705,scans patients,1.516666666666667,364.0
484,2003,software used,1.516022099447514,196.0
485,2205,early stage,1.5156487389851105,580.0
486,896,used describe,1.513043478260867,116.0
487,2150,alcohol consumption,1.5067340067340054,179.0
488,2851,healthy adult,1.5000000000000029,158.0
489,3503,findings including,1.4755813953488315,141.0
490,1344,ascending aorta,1.4748164049260006,588.0
491,2996,data showed,1.470967741935486,228.0
492,347,low dose,1.469831053901851,261.0
493,1309,identify predictors,1.4669291338582655,162.0
494,1326,total women,1.465255731922394,134.0
495,1613,u test,1.4639705882352925,181.0
496,3041,molecular mechanisms,1.4636363636363652,322.0
497,1656,useful information,1.4462693571093415,230.0
498,2469,years included,1.4462515883100302,271.0
499,699,surgery performed,1.444444444444442,290.0
500,1749,observed using,1.4357142857142842,134.0
501,3178,using computed,1.4321802091713614,387.0
502,121,different types,1.4294852060885939,529.0
503,445,tomography mdct,1.4241758241758298,216.0
504,1284,associated higher,1.4198446937014575,968.0
505,962,fa values,1.417308766052481,334.0
506,2331,nerve fiber,1.41293103448276,596.0
507,2401,systolic velocity,1.4121132323897303,275.0
508,1981,tumor growth,1.4102920723226682,507.0
509,1975,tomographic angiography,1.4092250922509195,201.0
510,3562,pd patients,1.4069478908188668,567.0
511,3576,findings indicate,1.4010649627263003,506.0
512,924,patients showed,1.392650834403078,1315.0
513,3228,present results,1.390384615384614,241.0
514,860,progressive disease,1.380525502318394,154.0
515,2078,level evidence,1.3804878048780524,283.0
516,2029,type type,1.3767857142857145,257.0
517,2640,ankle society,1.3743589743589746,134.0
518,3609,time surgery,1.372188139059305,183.0
519,2573,congestive heart,1.3698630136986323,200.0
520,2766,health insurance,1.3670886075949369,120.0
521,1046,longitudinal studies,1.363350785340313,217.0
522,2081,patients included,1.3588845014807514,1449.0
523,923,thoracic aortic,1.3582017010935563,207.0
524,287,control participants,1.3573131094257855,232.0
525,591,range median,1.3518518518518512,219.0
526,2260,included studies,1.3493794659646479,260.0
527,2911,patients evaluated,1.3402261712439374,612.0
528,2412,carcinoma situ,1.3345679012345675,188.0
529,3199,internal external,1.3305785123966927,161.0
530,1140,reconstructed using,1.3259786476868334,243.0
531,1363,findings included,1.318918918918925,122.0
532,2888,median iqr,1.3168141592920357,186.0
533,802,value ppv,1.3165760869565213,255.0
534,1217,cell surface,1.3150816522574453,370.0
535,376,liver function,1.315045817321904,268.0
536,1668,analysis based,1.3140495867768633,159.0
537,1962,currently available,1.3080200501253116,307.0
538,1508,median range,1.3059097978227068,311.0
539,483,nasal cavity,1.2988082340195017,162.0
540,1731,necrosis factor,1.2966824644549764,171.0
541,801,used fmri,1.29642857142857,121.0
542,1452,inferior temporal,1.294117647058824,165.0
543,629,aim identify,1.2919463087248322,175.0
544,2676,subgroup patients,1.2852040816326489,229.0
545,3264,using optical,1.2700507614213228,417.0
546,1739,performed retrospective,1.2667404537908145,327.0
547,2981,matched control,1.2660550458715576,138.0
548,3292,treatment efficacy,1.2565130260520998,165.0
549,3473,patients suspected,1.248528150900268,809.0
550,2493,technical success,1.24629861982434,946.0
551,1946,patients type,1.24117321527393,534.0
552,2976,period patients,1.2380090497737557,342.0
553,81,patients cancer,1.2380090497737555,152.0
554,1076,neural activity,1.2370178041542985,667.0
555,1091,motor area,1.2369575361642535,282.0
556,1672,functional recovery,1.2275449101796376,205.0
557,1783,well suited,1.2266187050359725,155.0
558,3514,decision making,1.218326297491931,481.0
559,1307,data suggest,1.2082484000948153,944.0
560,3266,cardiac disease,1.2039072039072063,170.0
561,3433,difference groups,1.2016464131713074,393.0
562,1640,bone volume,1.1995298266235694,314.0
563,3447,functional changes,1.1977084659452546,192.0
564,451,showed mean,1.1969762419006493,163.0
565,1979,using scanner,1.1957547169811267,169.0
566,2428,surgical correction,1.1929824561403481,136.0
567,2211,results support,1.1902901785714277,395.0
568,1077,abdomen pelvis,1.1819620253164558,166.0
569,1587,prognostic significance,1.1806543385490749,166.0
570,761,chinese patients,1.1796610169491548,116.0
571,1233,flow cytometry,1.1784810126582255,627.0
572,519,performed months,1.1742006615214962,213.0
573,2009,data collected,1.1690340350186856,803.0
574,970,fourteen patients,1.1679389312977069,204.0
575,1688,month months,1.1640138408304535,174.0
576,3474,trial patients,1.159414990859233,151.0
577,3487,vertebral artery,1.1567229873633387,438.0
578,114,nervous system,1.1531406817788505,1360.0
579,710,abdominal ultrasound,1.15229357798165,157.0
580,3176,january july,1.1499999999999972,161.0
581,2638,survival months,1.1492589363557106,169.0
582,3123,value sensitivity,1.1483492296404987,182.0
583,1065,health stroke,1.147874306839187,270.0
584,3632,range years,1.1423635107118142,1653.0
585,2747,outcomes included,1.141129032258064,283.0
586,1965,yag laser,1.1397048489107513,153.0
587,1943,young modulus,1.1388888888888886,205.0
588,186,oral cavity,1.137323943661971,170.0
589,2977,imaging showed,1.1351973684210488,493.0
590,587,structural functional,1.1283834586466137,667.0
591,810,patients median,1.127892440146244,621.0
592,3031,status patients,1.123629112662013,161.0
593,1765,chronic pancreatitis,1.1226890756302532,167.0
594,318,wall shear,1.1203608247422685,189.0
595,1592,pearson coefficient,1.1160289555325744,284.0
596,3597,treatment patients,1.110293200249535,809.0
597,1611,respectively conclusion,1.1078804347826077,151.0
598,180,aimed identify,1.1067961165048514,190.0
599,1659,quantitative analysis,1.1062531774275555,640.0
600,232,adverse outcomes,1.1000714796283053,285.0
601,804,artery patients,1.0893617021276558,128.0
602,303,intracerebral hemorrhage,1.0865210169924608,421.0
603,1138,blood glucose,1.0749116607773859,169.0
604,3424,using model,1.0740740740740722,203.0
605,688,patients years,1.0702303555662551,1130.0
606,3436,new zealand,1.0687601515971878,282.0
607,1970,angiography cta,1.0670241286863231,398.0
608,143,years male,1.0611353711790383,405.0
609,2936,men women,1.060804987622625,1411.0
610,2157,observed groups,1.0598821638993035,194.0
611,2668,analysed using,1.0594594594594582,224.0
612,222,exclusion criteria,1.0590809628008746,220.0
613,1,vs patients,1.0569190600522171,184.0
614,1502,protein kinase,1.0555050045495902,200.0
615,370,cbct imaging,1.0526315789473688,150.0
616,2812,parkinson disease,1.0513157894736824,833.0
617,1301,however differences,1.0490797546012236,171.0
618,1834,cardiac resynchronization,1.0490018148820315,170.0
619,1563,association found,1.0481927710843408,145.0
620,3088,gene expression,1.0432667589479945,977.0
621,2576,use different,1.0413223140495838,126.0
622,67,regression analysis,1.0375994215473792,2583.0
623,1941,associated adverse,1.036932958651143,205.0
624,3192,healthy individuals,1.035917348495354,450.0
625,115,values obtained,1.0309392265193378,311.0
626,1825,ultrasound performed,1.0281543274243998,170.0
627,3163,abdominal computed,1.0273972602739716,125.0
628,1781,routine use,1.0272189349112435,217.0
629,1932,images taken,1.0267686424474183,179.0
630,2620,boys girls,1.025720620842573,257.0
631,142,first months,1.0201749871333006,187.0
632,2566,false lumen,1.0171337916446326,163.0
633,1652,lower levels,1.0170040485829936,157.0
634,2651,brachial plexus,1.0158311345646418,175.0
635,1447,eyes patients,1.008063300678225,637.0
636,193,participants underwent,1.0031746031746087,316.0
637,770,stress echocardiography,1.0015132408575043,209.0
638,2674,years older,1.000000000000011,315.0
639,973,tertiary care,1.0000000000000016,255.0
640,2338,central nervous,0.9984861771357371,1071.0
641,1139,cardiovascular events,0.9963476070528979,586.0
642,2256,acute myocardial,0.9846153846153859,384.0
643,2404,chest pain,0.9834710743801613,595.0
644,3611,values calculated,0.9782608695652198,225.0
645,1971,cancer patients,0.9779552007096916,1378.0
646,1279,left common,0.9744769874476974,137.0
647,785,cases reported,0.9722627737226246,333.0
648,247,work provides,0.9708661417322838,137.0
649,2619,heart catheterization,0.9672935404742437,169.0
650,2030,cox regression,0.9669700910273084,507.0
651,2329,patients received,0.963938066744806,1532.0
652,811,tomographic imaging,0.9617021276595764,113.0
653,823,presence absence,0.9606230311515565,499.0
654,315,vessel disease,0.9576102418207678,374.0
655,2286,days days,0.9563318777292575,219.0
656,3205,limb ischemia,0.9556919300398884,179.0
657,1356,imaging technologies,0.9539823008849547,154.0
658,3015,multivariable analysis,0.9522110162916988,361.0
659,868,multidetector computed,0.9509918971779823,254.0
660,1451,medial temporal,0.9507434944237911,310.0
661,900,activation left,0.9504587155963278,148.0
662,3302,blot analysis,0.9402795425667076,148.0
663,897,analysis method,0.938690476190475,166.0
664,1881,young children,0.9386581469648556,226.0
665,195,patients lower,0.9385650224215243,299.0
666,1291,syndrome acs,0.9333333333333338,182.0
667,1337,low sensitivity,0.928703047484054,168.0
668,3092,osteoarthritis oa,0.9284280936454862,347.0
669,2816,events mace,0.9277310924369736,184.0
670,244,remains major,0.9223367697594534,122.0
671,1624,mitral regurgitation,0.921195652173917,565.0
672,3032,analysis identified,0.9179628355127295,351.0
673,1453,intracranial pressure,0.9176233635448133,204.0
674,2383,fractures treated,0.9166144200626959,172.0
675,2671,bone microarchitecture,0.9161290322580647,142.0
676,3273,liver spleen,0.9152571926765471,181.0
677,2682,superior temporal,0.9150789851603622,486.0
678,1370,respectively sensitivity,0.9146341463414629,125.0
679,2050,ventricular ejection,0.9091334894613631,647.0
680,1791,provides new,0.9090909090909084,186.0
681,3602,patients af,0.9088838268792719,190.0
682,3523,multivariable logistic,0.9045685279187781,297.0
683,529,percentage change,0.9032258064516131,140.0
684,2899,alkaline phosphatase,0.9028796605031829,281.0
685,7,subchondral bone,0.9017307904310448,338.0
686,3295,electronic medical,0.8957345971563985,135.0
687,2761,situ hybridization,0.8944903581267224,191.0
688,974,emotion regulation,0.8930966469427999,283.0
689,748,idiopathic pulmonary,0.8891344383057093,142.0
690,1708,higher frequency,0.8851405622489941,174.0
691,2614,controls underwent,0.880788766059158,268.0
692,111,improved outcomes,0.8798605056669578,174.0
693,219,young adult,0.8796296296296298,150.0
694,1475,showed greater,0.8788951841359771,365.0
695,1198,patients isolated,0.8784965034965038,201.0
696,1584,nucleus accumbens,0.8775995246583485,211.0
697,414,sentinel lymph,0.8741188318227581,217.0
698,799,selected patients,0.8704883227176213,450.0
699,2152,within normal,0.8695652173913019,200.0
700,649,web science,0.8642045454545444,169.0
701,2403,mean absolute,0.8633204633204623,172.0
702,2284,stem cell,0.8624577226606545,765.0
703,2270,asymptomatic patients,0.8612827261393545,464.0
704,3378,investigate feasibility,0.8596774193548371,164.0
705,553,maximum diameter,0.8593749999999993,220.0
706,2918,patients malignant,0.8547486033519568,170.0
707,167,assess effect,0.8512733446519501,218.0
708,246,laboratory data,0.8491694352159457,142.0
709,2155,superior inferior,0.845717559438556,242.0
710,1980,patients present,0.8412514484356892,330.0
711,1400,differences patients,0.8410071942446029,167.0
712,2263,ultrasound examination,0.8397757255936673,439.0
713,129,care patients,0.8366998577524895,173.0
714,534,echocardiographic examination,0.83529411764706,142.0
715,3168,short axis,0.8352941176470594,142.0
716,3402,patients improved,0.8293838862559225,125.0
717,1202,bone turnover,0.8288522694420348,235.0
718,3237,cortical thinning,0.8132871536523933,287.0
719,1028,colon cancer,0.8123125493291237,166.0
720,3555,fluorescent proteins,0.8062499999999995,172.0
721,2693,brain stimulation,0.8054299670566843,303.0
722,1197,parietal lobe,0.8043478260869512,185.0
723,3456,mean adc,0.8032449544914928,199.0
724,894,new approach,0.8016903572800618,282.0
725,2041,described literature,0.8009708737864065,225.0
726,1839,analysis confirmed,0.8008264462809925,171.0
727,3442,linear regression,0.7994134897360651,1363.0
728,3308,success rate,0.799222178613478,1009.0
729,1564,functional network,0.7987730061349696,189.0
730,2711,deep vein,0.7986223420185687,199.0
731,160,embolism pe,0.7981900452488678,168.0
732,1768,flow velocity,0.7980637813211853,539.0
733,2765,included retrospective,0.7969465648854948,174.0
734,1599,small animal,0.7959862946647075,173.0
735,2760,high mortality,0.7949044585987207,208.0
736,1798,years respectively,0.7948051948051928,408.0
737,3023,followed months,0.7944020356234086,223.0
738,925,patients tumor,0.7939393939393872,131.0
739,41,lesions showed,0.7919388464211262,154.0
740,2455,cases cases,0.7897700610042235,255.0
741,3225,first years,0.787363834422658,139.0
742,670,use ultrasound,0.7847980997624691,236.0
743,3187,acute phase,0.7778998778998788,277.0
744,3279,system cns,0.7774038461538461,231.0
745,2652,median days,0.7762842054728752,231.0
746,2875,cartilage damage,0.775438596491229,221.0
747,383,four types,0.7684210526315781,146.0
748,92,visual field,0.7640750670241283,575.0
749,314,scan showed,0.7624595469255672,186.0
750,1313,layer rnfl,0.7623892540725907,234.0
751,2540,cbct images,0.7617545588960065,336.0
752,446,detailed analysis,0.7604938271604942,132.0
753,1109,patients exhibited,0.7570569508312699,261.0
754,3127,population patients,0.756676557863502,225.0
755,835,mean diameter,0.7556851311953354,216.0
756,2783,second third,0.7552447552447551,180.0
757,1056,number patients,0.7542192046556743,432.0
758,3344,preoperative planning,0.7538961038961041,301.0
759,1128,histological analysis,0.753591160220995,242.0
760,578,proportion patients,0.7525844245347999,420.0
761,47,prospectively collected,0.7524440762220391,239.0
762,306,cardiovascular factors,0.7515291936978695,477.0
763,3156,worse outcomes,0.7499999999999997,135.0
764,2609,free wall,0.7496606027694811,251.0
765,2949,cognitive performance,0.7477520113582572,300.0
766,3389,pulmonary hypertension,0.7475935828876987,699.0
767,1189,superior parietal,0.7449197860962563,199.0
768,1454,mice bearing,0.7428571428571428,143.0
769,2906,initial imaging,0.7420479302832231,131.0
770,1122,together findings,0.7416609155739574,248.0
771,3585,american orthopaedic,0.7408071748878933,118.0
772,2049,orthopaedic foot,0.7408071748878933,118.0
773,3313,information available,0.7389380530973457,167.0
774,385,respectively however,0.7372549019607852,188.0
775,386,objective investigate,0.7350923482849628,199.0
776,364,alveolar bone,0.7317422434367538,294.0
777,278,animal models,0.7272280270436389,493.0
778,3107,higher levels,0.7251533742331377,394.0
779,1083,volume reduction,0.7244725738396629,202.0
780,1757,confirmed presence,0.7228391528334285,154.0
781,838,lobe epilepsy,0.7219201359388274,293.0
782,3325,patients single,0.7215499660095174,183.0
783,3634,determine prevalence,0.7187500000000002,230.0
784,1826,pulmonary arterial,0.7177844762622466,381.0
785,2734,twin pregnancies,0.7152454780361756,173.0
786,941,electron microscopy,0.7143815055942683,4363.0
787,330,still unclear,0.7077994428969363,231.0
788,3214,presenting symptoms,0.7052104208416838,153.0
789,2226,oct imaging,0.703463855421686,173.0
790,1017,classified groups,0.6928257686676428,182.0
791,3326,measurements taken,0.6922723794950252,156.0
792,1317,ventricular dysfunction,0.6891218872870256,239.0
793,1270,degenerative changes,0.6843547224224953,226.0
794,2485,brain functional,0.6825439783491167,194.0
795,1378,phylogenetic analysis,0.6818791946308724,127.0
796,2625,bone defects,0.6794906529395824,220.0
797,3118,ex vivo,0.6792868957912173,1320.0
798,2870,poor prognosis,0.6785060598565419,508.0
799,1086,females males,0.6774528914879787,401.0
800,2397,grip strength,0.6774111675126901,157.0
801,2389,right ventricle,0.6768363402061854,447.0
802,806,activation patterns,0.6747141041931396,177.0
803,223,structural integrity,0.6721649484536079,163.0
804,411,patients groups,0.6698161954676308,698.0
805,3017,median years,0.6696589214412869,1141.0
806,2547,inversely correlated,0.6688547984302528,218.0
807,126,ms ms,0.6669975186104206,224.0
808,506,trauma center,0.6663900414937761,146.0
809,2635,prospective randomized,0.66605504587156,264.0
810,3386,underwent magnetic,0.6657963446475189,255.0
811,1551,factors including,0.6625482625482613,286.0
812,497,cell division,0.6622176591375768,225.0
813,1660,orbitofrontal cortex,0.6614617940199358,362.0
814,1830,delivery systems,0.6602284527518155,187.0
815,1137,concentration range,0.6571428571428558,115.0
816,1845,plexiform layer,0.6556131260794463,146.0
817,106,january january,0.6549707602339188,224.0
818,28,important implications,0.6549391069012189,220.0
819,2378,tomography scan,0.6536576444769561,777.0
820,3435,abnormal findings,0.6507936507936504,205.0
821,1382,early postoperative,0.6505694760820032,238.0
822,764,initial presentation,0.6500000000000007,188.0
823,2446,implantation tavi,0.6492985971943919,180.0
824,853,cmr imaging,0.6482496836777735,145.0
825,3362,extracellular matrix,0.6481288849422816,482.0
826,956,cruciate ligament,0.6474287393476342,408.0
827,2011,operation time,0.6441176470588234,219.0
828,62,patients among,0.6408163265306127,157.0
829,508,department ed,0.6405326674989583,208.0
830,2965,functional networks,0.6403162055335964,210.0
831,1391,ability detect,0.6395759717314475,181.0
832,2513,patients found,0.6387857610832065,375.0
833,2841,low doses,0.6377952755905503,135.0
834,1951,zika virus,0.6376811594202881,220.0
835,2865,blood supply,0.6373239436619743,181.0
836,1289,wave velocity,0.6372261124915307,403.0
837,705,normal abnormal,0.6368226186469196,220.0
838,831,bone strength,0.6328767123287637,231.0
839,1861,immune cells,0.6325581395348815,136.0
840,2539,patients previously,0.6316169828364943,184.0
841,317,diagnostic performance,0.6301376364499293,1207.0
842,3069,third trimester,0.6297699594046003,179.0
843,1893,urinary tract,0.6296466765940145,456.0
844,2569,years old,0.6251687259889976,1115.0
845,2898,interobserver variability,0.6245602814198917,217.0
846,567,working memory,0.6230731467844873,668.0
847,2227,successful treatment,0.621855269548324,194.0
848,133,medical treatment,0.6215827338129487,336.0
849,3415,brain stem,0.6204953031596916,173.0
850,1203,aqueous solution,0.6189781021897791,212.0
851,1666,male presented,0.6183294663573092,205.0
852,523,features patients,0.6127659574468071,144.0
853,978,external beam,0.6096774193548357,189.0
854,2521,tissue plasminogen,0.608356545961003,182.0
855,2239,remain unclear,0.6059079061685487,317.0
856,3429,aortic aneurysm,0.6044366392457705,519.0
857,2556,endoscopic ultrasound,0.6032992411745295,223.0
858,80,weeks treatment,0.6011834319526621,127.0
859,733,based data,0.6000000000000005,156.0
860,211,higher mean,0.6000000000000004,234.0
861,3341,media thickness,0.5988200589970495,145.0
862,479,current knowledge,0.5981424148606824,138.0
863,1510,analysis patients,0.5979673835972538,550.0
864,2889,cardiac remodeling,0.5973597359736005,181.0
865,734,determine factors,0.5968652037617562,136.0
866,238,regression models,0.5931625339813833,766.0
867,834,failure hf,0.5919839679358696,211.0
868,2460,cataract surgery,0.5912287633346505,258.0
869,2197,observed cases,0.5912061794414746,199.0
870,3084,safety efficacy,0.58513607815771,559.0
871,913,plasma membrane,0.5821178965633583,554.0
872,1145,major role,0.5802656546489555,139.0
873,1286,indocyanine green,0.5793650793650801,365.0
874,525,end point,0.5788530465949805,510.0
875,2060,controlled trials,0.5786507258753215,308.0
876,35,fmri studies,0.578636607622114,154.0
877,1261,median period,0.5771230502599666,185.0
878,2145,total resection,0.5768194070080854,214.0
879,336,aims assess,0.5765624999999999,123.0
880,1913,total occlusion,0.5748587570621471,185.0
881,1209,diameter cm,0.571428571428574,160.0
882,2057,tumor recurrence,0.5697325888921533,262.0
883,3296,modified rankin,0.5685355079850487,356.0
884,695,anatomical landmarks,0.5682539682539671,179.0
885,31,current literature,0.5679611650485439,234.0
886,2187,structural magnetic,0.5677177177177177,199.0
887,345,patients stroke,0.5663337032926375,178.0
888,2750,lung nodules,0.5652173913043477,130.0
889,603,stemi patients,0.5644832605531286,277.0
890,3337,anatomical structures,0.5644809659567336,306.0
891,2364,biodistribution studies,0.5643939393939387,149.0
892,2083,image segmentation,0.5642248722316889,184.0
893,3462,frequently observed,0.5642201834862417,205.0
894,779,tumor resection,0.5639624252775394,254.0
895,936,angiography patients,0.563587201442091,169.0
896,118,identified patients,0.5606922126081573,756.0
897,1064,neural substrates,0.5605536332179928,162.0
898,1554,eyes healthy,0.5574912891986062,160.0
899,1862,abdominal aortic,0.5565140062249903,596.0
900,2636,therapeutic strategies,0.5562998405103659,218.0
901,1973,neurodegenerative diseases,0.555332887998219,290.0
902,1601,patients ischemic,0.5530726256983222,165.0
903,3241,endovascular aneurysm,0.5525529265255308,261.0
904,602,characteristics patients,0.5509433962264154,292.0
905,2167,weight kg,0.5508938186517336,203.0
906,2302,december patients,0.5503823279524211,237.0
907,199,liver fibrosis,0.5498968464485704,491.0
908,1188,distress syndrome,0.5490196078431371,140.0
909,2804,less frequently,0.5485051860890781,155.0
910,22,total subjects,0.5461254612546114,185.0
911,3437,length width,0.5454545454545449,130.0
912,1804,much less,0.544520547945205,159.0
913,137,rv systolic,0.5441176470588235,185.0
914,183,neural network,0.5433673469387746,213.0
915,3504,vein occlusion,0.540880503144656,215.0
916,562,salivary gland,0.5396151293961524,214.0
917,2102,patients aim,0.5395348837209335,116.0
918,908,acute coronary,0.5394812680115273,576.0
919,38,nuclear magnetic,0.5390946502057645,131.0
920,1161,generalized estimating,0.5365853658536595,132.0
921,433,cancer detection,0.5357142857142863,325.0
922,2561,rankin scale,0.5335407057814007,323.0
923,228,retrospectively evaluated,0.5304743339831063,314.0
924,2515,underwent complete,0.5300813008130076,163.0
925,150,image data,0.5281873373807439,315.0
926,724,lung volume,0.5268125494331664,291.0
927,438,cell type,0.5263803680981626,143.0
928,2236,average years,0.5262421496144364,494.0
929,2759,time periods,0.5238095238095261,154.0
930,3097,direct comparison,0.5225416036308608,157.0
931,166,cardiac hypertrophy,0.5199883279836587,198.0
932,957,breast cancer,0.5190835333104755,3950.0
933,581,difference mean,0.5185185185185186,210.0
934,891,patients likely,0.5136690647482024,153.0
935,1875,disease characterized,0.5119691119691177,221.0
936,268,used compare,0.5109735973597347,563.0
937,3196,portal venous,0.5079926784624781,181.0
938,870,critical role,0.5078305519897298,344.0
939,568,complications including,0.5069958847736625,154.0
940,285,results highlight,0.5006922011998164,217.0
941,885,identifying patients,0.500317748524738,167.0
942,3089,interstitial lung,0.4969258589511747,229.0
943,3000,investigated using,0.4958985831469032,399.0
944,2004,interobserver agreement,0.4924623115577885,588.0
945,2818,independently associated,0.49106987303011745,1208.0
946,3458,retrospectively identified,0.49090909090909124,243.0
947,3223,quality life,0.4904931721318605,1007.0
948,429,stroke patients,0.4890913418882957,813.0
949,2867,frequency bands,0.48823529411764766,166.0
950,234,plasminogen activator,0.4867751547100609,287.0
951,639,hearing loss,0.48356973089013205,432.0
952,3604,small vessel,0.48264136022143167,359.0
953,79,knee osteoarthritis,0.48214285714285704,270.0
954,2724,moderate severe,0.4801630434782601,589.0
955,2119,biopsy performed,0.4798801797304044,178.0
956,168,effective method,0.478238341968912,213.0
957,2359,structural brain,0.477386934673366,247.0
958,2658,grade iii,0.4759878419452891,174.0
959,503,back projection,0.47500000000000114,133.0
960,3193,resynchronization therapy,0.4741482965931859,169.0
961,2324,epilepsy surgery,0.47308868501529044,182.0
962,104,complication rates,0.4710921731329885,389.0
963,3283,years median,0.4699738903394248,300.0
964,2138,previously published,0.46991869918698964,289.0
965,2859,tissue damage,0.46947988223748544,184.0
966,1891,analyzed using,0.4680100755667491,929.0
967,1495,reflectance confocal,0.46648044692737506,167.0
968,2514,rating scale,0.4660301138450231,423.0
969,2255,respectively results,0.46538461538461484,242.0
970,3257,patients affected,0.46458333333333346,223.0
971,1336,united states,0.46433710174717224,502.0
972,1625,order determine,0.46357615894039766,150.0
973,1283,imaging results,0.46330935251798266,322.0
974,1459,lung injury,0.4631621187800958,199.0
975,428,detected using,0.46135831381733383,197.0
976,2108,within days,0.4598698481561873,636.0
977,1234,arterial blood,0.45714285714285763,282.0
978,1206,data set,0.456613934702119,323.0
979,161,days later,0.45507246376811633,157.0
980,1982,hodgkin lymphoma,0.45502846299810273,218.0
981,1365,mean duration,0.45419198055893284,267.0
982,2418,different groups,0.4537874339401042,644.0
983,2349,artery dissection,0.4502617801047119,215.0
984,2560,spectroscopy mrs,0.4501108647450102,145.0
985,2084,left side,0.44842707340324,336.0
986,1774,data consecutive,0.444276539478655,168.0
987,2555,superior mesenteric,0.4439897698209716,248.0
988,3252,diabetic retinopathy,0.44188861985472105,365.0
989,3366,performed single,0.44166666666666365,159.0
990,132,side effects,0.4395061728395075,712.0
991,77,difficult diagnose,0.4387755102040829,129.0
992,1921,vas score,0.43860535624052577,140.0
993,29,complications occurred,0.4366013071895472,334.0
994,1515,multimodal imaging,0.4338528452337796,285.0
995,681,internal fixation,0.43311481550852204,246.0
996,521,assessed whether,0.43295711060947945,137.0
997,3345,brain metastases,0.432340837569596,190.0
998,1215,time min,0.4290123456790113,278.0
999,2456,demonstrated higher,0.42896174863387926,157.0
1000,2219,myocardial dysfunction,0.4267753201396968,141.0
1001,1838,across multiple,0.42439862542955276,190.0
1002,231,computer tomography,0.42366412213740473,185.0
1003,1836,time years,0.4233687405159332,155.0
1004,1439,brain activation,0.4224868761263028,473.0
1005,726,changes brain,0.422298793994586,373.0
1006,721,chronic total,0.42020202020202296,208.0
1007,2490,months mean,0.41956848971399696,339.0
1008,2505,determine relationship,0.4193548387096765,210.0
1009,2945,radial artery,0.41720590985599415,286.0
1010,1602,classified according,0.41698754246885644,263.0
1011,1397,high levels,0.41488298711543475,343.0
1012,2123,function tests,0.4145430286857878,239.0
1013,2792,review literature,0.41300210357607814,589.0
1014,196,aim compare,0.4123592694520882,603.0
1015,2366,procedures performed,0.41054251635244376,485.0
1016,3039,however data,0.4084507042253514,145.0
1017,105,data including,0.40660134089737004,146.0
1018,1212,range mean,0.40422264875239927,243.0
1019,1098,results confirmed,0.40403800475059426,189.0
1020,1219,fully automated,0.4029438635671502,223.0
1021,1090,could lead,0.4020544427324092,206.0
1022,2035,episodic memory,0.4018547140649151,325.0
1023,448,care unit,0.4018475750577361,435.0
1024,1444,different sizes,0.4000000000000016,124.0
1025,1598,left heart,0.4000000000000004,194.0
1026,3285,tomography findings,0.3999999999999963,142.0
1027,3043,coronary plaque,0.3988970588235289,217.0
1028,2568,findings show,0.3981373690337607,190.0
1029,1573,choroidal thickness,0.3976978926863812,591.0
1030,789,surface modification,0.3970588235294121,135.0
1031,1394,groups control,0.39625292740046764,188.0
1032,2979,associated poor,0.395537525354968,325.0
1033,2489,solid tumors,0.3945011783189318,279.0
1034,1359,volume patients,0.39435702658708705,158.0
1035,3271,cardiac involvement,0.390894819466249,166.0
1036,1591,intensive care,0.3905236907730682,522.0
1037,1618,therapy treatment,0.3899799599198408,139.0
1038,2346,h h,0.38901098901098885,177.0
1039,999,tricuspid annular,0.387579724739846,251.0
1040,1039,beam computed,0.38698630136986406,452.0
1041,1003,ischemic attack,0.3867595818815318,185.0
1042,1268,patients followed,0.3857563850687634,561.0
1043,458,flow cbf,0.3856485740570387,262.0
1044,39,treatment option,0.38231859883236163,382.0
1045,2773,performed using,0.38081534772186787,1588.0
1046,1775,review current,0.38016528925620025,184.0
1047,631,failure patients,0.3796696315120705,166.0
1048,382,fellow eyes,0.37911025145067667,196.0
1049,1418,open surgery,0.3781447304516755,229.0
1050,586,review discuss,0.3758389261744954,168.0
1051,3093,photodynamic therapy,0.37576948264571003,302.0
1052,2791,performed identify,0.3753714429614703,257.0
1053,1316,total patients,0.375269927706335,2855.0
1054,878,vascular disease,0.37464788732394366,247.0
1055,1546,gyrus left,0.37450462351387015,189.0
1056,1069,associated severe,0.37430555555555634,154.0
1057,2032,chronic obstructive,0.37367431365174925,216.0
1058,3236,matter lesions,0.37094791329666765,147.0
1059,3380,levels higher,0.37053910402429757,244.0
1060,1262,renal cell,0.3695678636640292,276.0
1061,3620,supplementary motor,0.368692243069168,227.0
1062,3240,therapeutic target,0.3678355501813778,169.0
1063,3235,cell lung,0.36783149832455775,452.0
1064,1179,gestational weeks,0.3668726095910563,215.0
1065,613,stress disorder,0.3660550458715593,133.0
1066,2929,diabetic macular,0.3637795275590553,143.0
1067,3403,visual analog,0.3629836457917835,350.0
1068,153,surgical management,0.36293900184842925,357.0
1069,1421,prognostic value,0.36079883613278824,744.0
1070,1879,mean range,0.3604074402125772,313.0
1071,1103,studied patients,0.35977011494252903,313.0
1072,645,mouse model,0.3568102267539194,617.0
1073,2508,inclusion criteria,0.3556883861087793,973.0
1074,389,effective dose,0.3545339519190205,467.0
1075,2862,coronary computed,0.35437911685777046,269.0
1076,995,venous sinus,0.35413450937155494,146.0
1077,44,fusiform gyrus,0.3535175879396978,201.0
1078,3139,radiographic findings,0.35181644359464465,184.0
1079,1136,reaction time,0.35126582278481033,185.0
1080,109,highlights importance,0.3512195121951229,162.0
1081,1993,surgical excision,0.34904458598726135,274.0
1082,2978,rnfl thickness,0.34820446612155115,662.0
1083,1027,muscle strength,0.34720620610126846,240.0
1084,2147,present work,0.34703748488512876,287.0
1085,2692,propensity score,0.3465346534653467,175.0
1086,2317,based imaging,0.3462235649546831,191.0
1087,3070,angiography dsa,0.34565217391304304,159.0
1088,3082,core needle,0.3447246525990726,197.0
1089,1895,without complications,0.34467120181405947,190.0
1090,140,regions interest,0.3438558031908425,743.0
1091,3300,new imaging,0.34313725490196073,175.0
1092,3234,coronary angiography,0.34261823249613715,1767.0
1093,2819,patients new,0.3425675675675678,169.0
1094,694,imaging positron,0.34220963172804514,151.0
1095,2122,months treatment,0.3401339109885788,254.0
1096,1569,component analysis,0.33832870798643216,422.0
1097,1062,needle biopsy,0.33644092641453993,302.0
1098,2786,relative controls,0.33535952557449983,174.0
1099,683,retinal layers,0.3347826086956521,198.0
1100,2886,used estimate,0.3333333333333364,321.0
1101,2856,pressure iop,0.33333333333333176,135.0
1102,2091,diagnostic test,0.3322820037105754,199.0
1103,960,interquartile range,0.3318774795382256,876.0
1104,1789,male patients,0.3312735034048178,379.0
1105,3115,zeta potential,0.3293134951709723,332.0
1106,1068,protein levels,0.32927983178552633,324.0
1107,1257,patients persistent,0.3292576419213975,203.0
1108,2629,bone mass,0.3290015847860555,346.0
1109,419,quantified using,0.32795698924731115,305.0
1110,623,caudate nucleus,0.32723222572860583,226.0
1111,2441,normal tissue,0.32714217328865497,201.0
1112,3416,diagnostic value,0.3252788806957834,506.0
1113,3640,consecutive patients,0.32507316814768233,3147.0
1114,1305,lesions detected,0.3247706422018361,236.0
1115,655,repair evar,0.3245283018867928,172.0
1116,1353,ages years,0.32342675832892664,278.0
1117,3306,subclinical atherosclerosis,0.3223566133437376,243.0
1118,665,patients renal,0.3185689948892662,187.0
1119,406,frontal lobe,0.31844660194174834,328.0
1120,1478,experiments performed,0.31714995857497946,174.0
1121,808,cava ivc,0.31645569620252734,125.0
1122,1396,central retinal,0.3141232518825881,292.0
1123,2673,least months,0.3139700078926591,221.0
1124,1468,pulmonary disease,0.31381733021077346,268.0
1125,2422,acute stroke,0.31155584247901846,381.0
1126,2723,open surgical,0.31125034050667433,197.0
1127,2451,experimental data,0.3084402956048216,305.0
1128,1911,sensitivity predictive,0.3081570996978849,170.0
1129,1304,data used,0.30553056364117426,251.0
1130,1831,assess accuracy,0.30508474576271366,180.0
1131,2183,important factor,0.30502793296089176,273.0
1132,3052,reconstruction using,0.3050067658998653,161.0
1133,2042,using logistic,0.3033707865168549,165.0
1134,660,artery stenosis,0.30319436924742915,560.0
1135,1425,mortality rate,0.3022634939059762,372.0
1136,187,patients cervical,0.30209790209790216,168.0
1137,3548,pancreatic duct,0.3008547008547009,240.0
1138,2462,could help,0.2978021978022079,271.0
1139,485,therapy patients,0.2974416017797552,382.0
1140,3446,distal radius,0.2968601332064701,240.0
1141,2641,using conventional,0.29628046173578576,315.0
1142,626,standardized uptake,0.296099183550044,544.0
1143,1058,injury severity,0.29583333333333345,142.0
1144,2203,regions involved,0.2954796030871013,268.0
1145,225,intraclass coefficients,0.29526649273201633,233.0
1146,1320,local recurrence,0.29473423490365114,419.0
1147,2224,studies required,0.29342693044033236,209.0
1148,2204,imaging examinations,0.2931698774080563,186.0
1149,97,day day,0.2922094508301407,176.0
1150,861,five groups,0.2912133891213377,116.0
1151,1547,interest rois,0.29052750992626175,197.0
1152,3268,atrial la,0.2897282358360198,185.0
1153,1916,cardiac catheterization,0.2868686868686904,142.0
1154,3075,using diffusion,0.28684516880093164,176.0
1155,1850,inner outer,0.28676470588235276,130.0
1156,605,analog scale,0.28605697151424253,306.0
1157,3338,regression analyses,0.2854617764030025,646.0
1158,584,preoperative evaluation,0.28228438228438285,173.0
1159,940,laser irradiation,0.28157061431285607,171.0
1160,1870,relatively high,0.2804931748128581,245.0
1161,1373,foreign bodies,0.2793017456359091,224.0
1162,2453,objective compare,0.27919463087248275,208.0
1163,2491,saphenous vein,0.27854145295159904,262.0
1164,98,common patients,0.2759460635058723,244.0
1165,346,routinely used,0.2756756756756768,136.0
1166,1490,microscopy imaging,0.27485648679678515,133.0
1167,657,data using,0.2736111111111093,197.0
1168,3364,lower mean,0.27330016583747907,206.0
1169,3310,mean days,0.2703910614525144,198.0
1170,3591,predictive values,0.269377162629758,519.0
1171,2664,patients idiopathic,0.2693586698337283,189.0
1172,1244,artery mca,0.26825156688999285,214.0
1173,1674,patients mild,0.26740453790813495,302.0
1174,1849,retrospectively studied,0.26578411405295277,174.0
1175,2616,lesions associated,0.26538461538462227,138.0
1176,2902,less likely,0.26403326403326405,381.0
1177,668,mr angiography,0.263888888888889,190.0
1178,1176,complete resection,0.26355140186915876,188.0
1179,486,data demonstrate,0.26342943854324824,248.0
1180,2672,could detected,0.2621748924841285,173.0
1181,911,middle cerebral,0.26176886126024285,772.0
1182,3612,respectively multivariate,0.2603833865814692,163.0
1183,3029,showed higher,0.2592489568845634,932.0
1184,1811,present investigate,0.25840853158326543,175.0
1185,1746,coronary stenosis,0.2571428571428566,195.0
1186,51,following surgery,0.2569903948772676,172.0
1187,1228,ductal carcinoma,0.25605667876274396,239.0
1188,1553,brachial artery,0.2559139784946227,221.0
1189,955,protein expression,0.25552050473186105,405.0
1190,1035,selected cases,0.2537623248572909,163.0
1191,2946,patients healthy,0.2520057999033327,869.0
1192,2639,functional structural,0.25194961007798383,300.0
1193,702,back pain,0.2515176374077128,657.0
1194,1796,microscopy tem,0.2511100386100384,473.0
1195,3265,tyrosine kinase,0.2500000000000014,135.0
1196,867,eye movement,0.2491783805187087,203.0
1197,432,remains unknown,0.24812030075188152,330.0
1198,2840,neural basis,0.24795321637426926,212.0
1199,182,proximal femur,0.24788135593220423,195.0
1200,3133,subjects years,0.24700239808153532,206.0
1201,1795,days patients,0.24692049272116445,245.0
1202,1797,response evaluation,0.24652567975830875,204.0
1203,221,overall patients,0.24637681159420458,255.0
1204,2928,inner ear,0.2450869663428957,217.0
1205,931,lung adenocarcinoma,0.24506283662477524,195.0
1206,782,cerebral small,0.24492753623188357,169.0
1207,404,level iv,0.2446991404011467,244.0
1208,2892,basilar artery,0.24461315979754114,199.0
1209,837,angiography ccta,0.24369900271985545,224.0
1210,2669,studies patients,0.24331797235023053,264.0
1211,384,method applied,0.2400625978090767,236.0
1212,18,effects observed,0.23938223938223918,155.0
1213,1119,deep brain,0.2380372992919118,306.0
1214,2498,male mean,0.23747649885105515,196.0
1215,3373,learning curve,0.23742690058479546,203.0
1216,123,laboratory tests,0.23639568186825272,185.0
1217,1532,response inhibition,0.23466884709730204,205.0
1218,2504,renal disease,0.23463368220741973,274.0
1219,1940,disease chd,0.2346028291621318,154.0
1220,2055,used treat,0.2316995544239324,260.0
1221,1335,cerebral artery,0.23048564743480013,878.0
1222,3180,healthy young,0.22758620689655193,191.0
1223,1434,arteriovenous fistula,0.22577090699777955,288.0
1224,3532,analysis conducted,0.22432432432432495,332.0
1225,730,symptom severity,0.2240365774003931,245.0
1226,2943,associated high,0.22385797791729747,470.0
1227,918,area curve,0.2225676574589502,1382.0
1228,1310,normal eyes,0.2218792555605988,188.0
1229,2780,method could,0.22133473462953238,162.0
1230,444,last decade,0.22088414634146328,161.0
1231,3138,potential complications,0.22014388489208625,153.0
1232,1501,image analysis,0.21987346483066633,844.0
1233,3025,imaging tests,0.21951381951381946,206.0
1234,1752,obtained patients,0.21847507331378319,447.0
1235,1699,myocardial blood,0.2177285318559557,131.0
1236,2785,associated worse,0.21718750000000053,278.0
1237,95,information obtained,0.2163155051323612,182.0
1238,332,structural features,0.2153846153846149,140.0
1239,679,purpose compare,0.21518034963487534,286.0
1240,1407,retrospective included,0.21497558328811767,283.0
1241,309,proportional hazard,0.21456953642384383,162.0
1242,3600,nerve block,0.2141025641025641,167.0
1243,1259,phase contrast,0.21352893235533765,262.0
1244,1677,national health,0.21308411214952455,114.0
1245,3282,multiple logistic,0.21199351701782823,218.0
1246,1432,findings demonstrate,0.21044045676998424,258.0
1247,2947,frequently used,0.20961060480530275,253.0
1248,1410,score mean,0.20836445108289786,155.0
1249,353,cancer res,0.2078451349974527,136.0
1250,1876,standing position,0.20749279538904938,144.0
1251,2844,transcription factor,0.20742892716331196,294.0
1252,1321,events patients,0.2070331847449232,190.0
1253,1401,advanced imaging,0.20662768031189083,265.0
1254,1085,lumbar spine,0.20634390651085296,927.0
1255,3500,patients older,0.20621761658031018,199.0
1256,175,cerebral ischemia,0.20583113990686408,221.0
1257,1778,manual segmentation,0.20549746041230965,181.0
1258,1445,upper limb,0.20544056771141347,193.0
1259,3414,nihss score,0.2054024255788314,207.0
1260,52,wt mice,0.20273711012094217,245.0
1261,2583,medical images,0.20192307692307726,210.0
1262,3321,bypass graft,0.1998946814112687,146.0
1263,3320,graphene oxide,0.19851301115241668,267.0
1264,2326,hippocampal volume,0.19698641765704625,442.0
1265,2249,parameters including,0.19692085005592452,365.0
1266,2038,female male,0.19532044760935974,320.0
1267,308,bone remodeling,0.19377652050919392,137.0
1268,252,obtained results,0.1933014354066989,202.0
1269,2808,thickness measurements,0.190446841294299,206.0
1270,3404,different concentrations,0.190361445783132,158.0
1271,1848,gastrointestinal tract,0.19027533684827164,232.0
1272,398,postoperative period,0.18968535604447578,211.0
1273,259,death myocardial,0.18886198547215444,195.0
1274,2079,artery calcium,0.18842069201781467,250.0
1275,1302,negatively correlated,0.187379972565152,683.0
1276,2846,peripapillary retinal,0.18706697459584262,135.0
1277,3,intervention patients,0.18678526048284674,147.0
1278,2549,b c,0.18640776699029124,288.0
1279,2633,liver cancer,0.18599592114208063,152.0
1280,2054,patients often,0.18523489932885906,138.0
1281,1898,lower extremity,0.1843118835133864,436.0
1282,3641,brain lesions,0.18428409520211628,271.0
1283,2121,literature search,0.1838088918380899,277.0
1284,742,although several,0.18312655086848537,123.0
1285,1721,water content,0.18307597282272997,228.0
1286,1635,ventricular assist,0.18274111675126944,140.0
1287,3259,calcium score,0.18218623481781385,225.0
1288,2476,vascular complications,0.1805324459234606,155.0
1289,749,sinus thrombosis,0.18001978239367028,130.0
1290,3034,oxygen saturation,0.1794019933554817,270.0
1291,1976,underwent preoperative,0.1793809841906032,212.0
1292,1572,patients respectively,0.1781361398743814,583.0
1293,1235,patients least,0.1776937618147449,282.0
1294,2809,open reduction,0.17669172932330834,235.0
1295,1873,electron microscopic,0.17657935285053974,191.0
1296,3280,associated development,0.17543859649122961,150.0
1297,3606,disease control,0.1745098039215688,178.0
1298,2452,critical care,0.1744350282485877,190.0
1299,2986,individual patients,0.17394341599720542,166.0
1300,2877,included mean,0.1732435033686235,300.0
1301,254,women years,0.1730360600826921,271.0
1302,2296,met criteria,0.1727272727272732,171.0
1303,883,host cell,0.17131258457374932,211.0
1304,374,antiplatelet therapy,0.17124735729386917,135.0
1305,2661,patients retrospectively,0.17108433734939818,213.0
1306,476,disc herniation,0.16802987197724023,189.0
1307,457,used create,0.16707317073170685,137.0
1308,2880,four different,0.16683937823834247,322.0
1309,393,chronic inflammatory,0.16622114216281897,171.0
1310,1463,could useful,0.1657028913260208,277.0
1311,1282,bacterial cells,0.16508254127063565,150.0
1312,3417,female presented,0.16476218965001524,162.0
1313,642,cases patients,0.16455493183640751,342.0
1314,466,neoadjuvant chemotherapy,0.1635738831615155,238.0
1315,2447,globus pallidus,0.16313559322033955,154.0
1316,2163,measurements performed,0.16303917688959088,412.0
1317,1118,median nerve,0.1605659280315269,289.0
1318,1907,images using,0.1599621391386655,338.0
1319,1968,temporomandibular joint,0.1595725734639356,256.0
1320,342,hydrogen peroxide,0.15822130299896703,153.0
1321,179,correlated well,0.1573579407479353,180.0
1322,245,tumor necrosis,0.15718813022183756,248.0
1323,1214,common carotid,0.15698756023758867,412.0
1324,2665,stroke volume,0.15660443818245862,342.0
1325,171,partial least,0.15642458100558582,180.0
1326,46,foot ankle,0.1561618062088423,332.0
1327,2696,scale score,0.15515370705244166,429.0
1328,1267,ejection fraction,0.15324707638715562,2053.0
1329,3547,ganglion cell,0.1510442235724921,272.0
1330,2278,months initial,0.1500000000000002,138.0
1331,2399,transform infrared,0.14842767295597814,590.0
1332,704,angiography showed,0.1465616045845271,186.0
1333,583,artery occlusion,0.14655858619052825,329.0
1334,1654,woman presented,0.14564983888291932,339.0
1335,634,current guidelines,0.14543715324277778,181.0
1336,2708,normal subjects,0.14529914529914642,255.0
1337,1403,high incidence,0.14432989690721756,210.0
1338,2757,spectroscopy xps,0.1438423645320183,146.0
1339,3616,improve understanding,0.14341692789968605,183.0
1340,790,incidence rate,0.14313534566699096,147.0
1341,1060,response therapy,0.14290159471022953,167.0
1342,256,scans performed,0.14276527331189678,444.0
1343,2558,relaxation time,0.14256954612005823,410.0
1344,1399,years years,0.14221002059025462,592.0
1345,3516,healthy adults,0.1411798451094755,321.0
1346,3286,lesion volume,0.1406578026592017,335.0
1347,2966,medial lateral,0.1399276236429435,290.0
1348,1733,status epilepticus,0.13990351481736732,145.0
1349,1465,common iliac,0.13961218836565067,196.0
1350,156,patients left,0.13878364905283952,232.0
1351,1034,aneurysm repair,0.13834286704801507,347.0
1352,2680,higher control,0.137417943107221,157.0
1353,745,disease ckd,0.1359011627906983,187.0
1354,3051,ultrasound examinations,0.13537469782433517,210.0
1355,399,mr image,0.13475753851970868,216.0
1356,2607,animal model,0.13451043338683943,419.0
1357,944,cerebral microbleeds,0.13374613003095967,216.0
1358,102,determine incidence,0.13359683794466398,169.0
1359,3249,remained unchanged,0.13324269204622693,245.0
1360,559,patients history,0.13260687342833227,339.0
1361,1620,structural abnormalities,0.13153406428638373,242.0
1362,1634,vascular endothelial,0.13062385014216424,355.0
1363,3049,data analysis,0.1304514154552415,341.0
1364,2657,expression level,0.12925764192139672,148.0
1365,1803,without compromising,0.1288944723618088,171.0
1366,1728,echocardiography tte,0.12877138413685899,138.0
1367,905,cartilage thickness,0.12877138413685887,138.0
1368,1264,quantitative assessment,0.12818745692625497,310.0
1369,2162,techniques including,0.12789699570815388,149.0
1370,1195,total participants,0.12767857142857034,143.0
1371,625,pain relief,0.1274560230428967,295.0
1372,2240,however role,0.12708757637474577,156.0
1373,1507,little information,0.125150100066711,134.0
1374,1958,basal ganglia,0.12407920903005372,886.0
1375,292,lv volume,0.12299168975069016,222.0
1376,1456,years later,0.12254259501965913,187.0
1377,2782,fatty acid,0.12234446889377866,278.0
1378,996,cognitive decline,0.12194304857621358,364.0
1379,938,communicating artery,0.12177121771217646,165.0
1380,1374,imaging analysis,0.121480289621883,151.0
1381,3356,postmenopausal women,0.12053140096618609,499.0
1382,1194,global longitudinal,0.11896386312759907,372.0
1383,2336,patients different,0.118913377754997,290.0
1384,2778,public health,0.11789077212806708,313.0
1385,1671,moyamoya disease,0.11631205673758864,246.0
1386,609,different levels,0.11627218934911243,262.0
1387,2524,pituitary adenoma,0.11614477429849632,204.0
1388,1308,potential applications,0.11490978157644793,242.0
1389,1127,survival rates,0.11435717858929349,381.0
1390,3019,outcomes assessed,0.11235955056179762,150.0
1391,545,blood volume,0.11221210498125297,419.0
1392,16,normal controls,0.11186440677965998,374.0
1393,2903,imaging assessment,0.11090047393364874,117.0
1394,1983,spontaneous preterm,0.11057636328352412,259.0
1395,1852,cell cycle,0.10932568149210888,381.0
1396,2954,studies identified,0.10678442392613417,190.0
1397,2337,matter hyperintensities,0.10510279544446079,323.0
1398,1165,associated mortality,0.10477215644061615,292.0
1399,1331,patients experienced,0.10442144873001052,555.0
1400,595,verbal memory,0.10413223140495685,126.0
1401,1998,vein thrombosis,0.10399612496972659,339.0
1402,3505,imaging agents,0.1032930188001439,227.0
1403,3227,patients excluded,0.10079744816586929,158.0
1404,1944,cases without,0.10043591979075847,192.0
1405,2601,included analysis,0.09967524356732257,399.0
1406,1933,man presented,0.09954751131221651,352.0
1407,2690,pulmonary nodules,0.09863013698630174,252.0
1408,3327,patients including,0.0986149584487564,356.0
1409,3065,valve repair,0.09828009828009875,200.0
1410,1480,posterior cingulate,0.0950082943749054,450.0
1411,17,plain radiographs,0.09474974919184037,250.0
1412,760,sudden cardiac,0.09418604651162671,162.0
1413,2866,hematoxylin eosin,0.09372693726937152,127.0
1414,522,pulmonary function,0.09269853970794197,331.0
1415,2572,tests used,0.09040878423071848,201.0
1416,13,histological examination,0.09024039449352858,244.0
1417,3485,tibial plateau,0.08946195479146749,281.0
1418,1330,different brain,0.08817766165904735,225.0
1419,2267,atherosclerotic plaque,0.08810500410172288,179.0
1420,2703,ms patients,0.08742921857304654,386.0
1421,2367,artery left,0.08700629650829952,152.0
1422,3184,postoperative course,0.08695652173913018,160.0
1423,1927,automated segmentation,0.08652037617554814,138.0
1424,3444,current evidence,0.08641470888661991,141.0
1425,2722,cerebral blood,0.08525425389463986,1004.0
1426,1571,coronary arteries,0.08481918391026956,731.0
1427,1004,gradient echo,0.08474576271186424,225.0
1428,2409,participants mean,0.08349328214971251,145.0
1429,1537,systolic function,0.0830818109610801,523.0
1430,1977,images evaluated,0.08190045248868784,181.0
1431,1435,patients younger,0.08143279658232067,177.0
1432,1755,aimed compare,0.08056042031523732,230.0
1433,2602,computed tomographic,0.08050541516245933,669.0
1434,921,emergency department,0.08024401689347797,855.0
1435,3170,value respectively,0.07882882882882877,175.0
1436,2637,aim examine,0.07874396135265659,163.0
1437,1514,retrospectively analyzed,0.07867642948968705,782.0
1438,1509,corticospinal tract,0.07813446396123554,215.0
1439,436,precentral gyrus,0.07780350645054569,168.0
1440,1559,regions associated,0.07754844144903089,263.0
1441,1169,navigation system,0.07635606266413143,248.0
1442,253,image contrast,0.07457627118643988,132.0
1443,2810,waist circumference,0.07418738049713199,194.0
1444,2914,patients scheduled,0.07310184416015932,200.0
1445,2125,cognitive impairment,0.07267786081723723,936.0
1446,3165,surgical outcomes,0.07254268574065492,262.0
1447,2051,prognosis patients,0.07226567200096291,273.0
1448,3305,normal range,0.07093023255813888,244.0
1449,1141,uric acid,0.07069369742104537,233.0
1450,1787,reported patients,0.07058823529412064,306.0
1451,2987,randomized receive,0.07006651884700824,158.0
1452,1484,vascular factors,0.06878751500600189,191.0
1453,2411,single nucleotide,0.06858638743455449,131.0
1454,1627,disease patients,0.06774716369530087,627.0
1455,1152,months postoperatively,0.06741965294178053,469.0
1456,590,patients patients,0.0648926792267214,2261.0
1457,2884,control patients,0.06393001345895041,475.0
1458,279,eighteen patients,0.06294964028776917,175.0
1459,125,acetabular component,0.06191646191646196,126.0
1460,1961,axial length,0.06157334728763326,353.0
1461,1070,based findings,0.06110458284371269,260.0
1462,3141,chest radiography,0.06037034887095841,208.0
1463,3289,cases diagnosed,0.060034502587694626,174.0
1464,2770,operating room,0.05993945509586274,297.0
1465,1181,january march,0.05956607495069127,151.0
1466,2130,surface properties,0.05916752665978647,172.0
1467,3130,uptake value,0.05910710542863045,470.0
1468,2959,skull base,0.05883331669495198,520.0
1469,1828,however remains,0.05815831987076033,180.0
1470,2988,tested using,0.05707376058040719,236.0
1471,3580,unclear whether,0.05685372585096676,309.0
1472,1126,parietal lobule,0.05677799607072656,289.0
1473,2339,tomography patients,0.05641838351822507,178.0
1474,1928,fat content,0.05517466536075767,169.0
1475,1520,different methods,0.05490584737363741,277.0
1476,1379,cochrane library,0.053549060542797594,171.0
1477,2815,major challenge,0.05306565382528512,163.0
1478,2202,innate immune,0.052054794520548044,133.0
1479,2901,associated abnormal,0.052025586353944685,183.0
1480,1466,twenty patients,0.05156987148202409,317.0
1481,2863,invasive coronary,0.05113135468704084,174.0
1482,753,patients range,0.05081723625557223,171.0
1483,3030,multiple linear,0.05009242144177321,271.0
1484,2688,aim present,0.05001849796522394,676.0
1485,3639,higher prevalence,0.04880814869263902,332.0
1486,2463,venous thrombosis,0.047235444891980755,215.0
1487,691,stent graft,0.047208737864078074,389.0
1488,464,planning target,0.047166361974406414,129.0
1489,1799,upper extremity,0.0470209754214389,203.0
1490,754,cancer screening,0.04676781002638696,709.0
1491,3167,peripheral nerve,0.04669778832172682,339.0
1492,2475,coronary sinus,0.046464646464647014,138.0
1493,84,changes following,0.04606946983546622,126.0
1494,2484,complications observed,0.044923217969287416,196.0
1495,3569,glucose metabolism,0.04481894298970763,382.0
1496,2551,investigate role,0.04394829612220755,187.0
1497,3116,developmental delay,0.0435372053612695,157.0
1498,477,bone tissue,0.04341957255343055,386.0
1499,717,patients similar,0.04341534008683042,150.0
1500,380,slice thickness,0.04244521337946891,184.0
1501,2803,epithelial cell,0.04014510278113773,166.0
1502,1917,four groups,0.039875666074599345,449.0
1503,1113,image processing,0.037525548439842696,459.0
1504,3360,cognitive function,0.03717970189247888,370.0
1505,813,could predict,0.036487689113023136,205.0
1506,1102,pericardial effusion,0.03502919099249245,210.0
1507,2796,giant cell,0.03476562499999988,178.0
1508,1815,intracranial hemorrhage,0.03179765130984592,176.0
1509,3269,liver stiffness,0.031715818651185494,430.0
1510,1923,ethylene glycol,0.031393298059965005,178.0
1511,3340,measurements made,0.031094756209752005,169.0
1512,2433,colorectal cancer,0.030979498861047717,408.0
1513,3470,abdominal aorta,0.030401366353544977,178.0
1514,3244,wall motion,0.029765886287624718,267.0
1515,1199,trabecular bone,0.029179475053204205,617.0
1516,2883,assessment performed,0.028938356164383595,169.0
1517,365,impairment mci,0.028072837632777233,185.0
1518,2811,high sensitivity,0.027936393205638163,773.0
1519,2745,measurements obtained,0.027435064935064604,338.0
1520,1772,carotid plaque,0.026134473746733205,275.0
1521,2008,higher rate,0.026116354416114883,309.0
1522,32,prognostic factor,0.02529082943042685,279.0
1523,2251,versus versus,0.023436330589115897,274.0
1524,3011,cac score,0.022564382068401674,276.0
1525,598,lower limb,0.022049160379654098,453.0
1526,3365,imaging method,0.020624408703879753,327.0
1527,541,function patients,0.02049199904466409,429.0
1528,273,groups years,0.020470053070507976,135.0
1529,447,might help,0.020142180094786927,170.0
1530,934,optical properties,0.019634509137272053,231.0
1531,2166,patients based,0.017180825818699934,181.0
1532,577,sixteen patients,0.017133791644632267,162.0
1533,2737,patients whose,0.015338882282996921,258.0
1534,1536,tissue sections,0.014025245441795453,150.0
1535,1716,length stay,0.011598353320207649,324.0
1536,2369,mitral valve,0.009883767923826735,1019.0
1537,2068,microstructural changes,0.009775019394880147,189.0
1538,514,transesophageal echocardiography,0.007715020478140795,405.0
1539,205,key role,2.3844142219066798e-14,413.0
1540,708,coefficient icc,1.553119711707115e-14,287.0
1541,144,used combination,4.3700172977672314e-15,138.0
1542,1422,world health,3.222971622744706e-15,211.0
1543,2393,patients available,2.597237870512483e-15,124.0
1544,74,months patients,2.181144375194129e-15,829.0
1545,358,low frequency,1.942955965981838e-15,143.0
1546,3432,enrolled prospective,1.5206125988007594e-15,127.0
1547,2953,carlo simulations,1.3802792989851594e-15,148.0
1548,2586,images reviewed,1.305952018151581e-15,153.0
1549,2725,aim analyze,1.2032373751379904e-15,161.0
1550,1442,groups results,9.453627147638876e-16,134.0
1551,2958,schizophrenia patients,8.227893479794132e-16,158.0
1552,2871,present evaluated,6.157057136174212e-16,122.0
1553,1922,median duration,5.925489293275636e-16,180.0
1554,530,retrospective patients,4.213441146051254e-16,286.0
1555,3481,preterm birth,2.598613648235958e-16,627.0
1556,1072,chemical composition,2.1853582034699276e-16,204.0
1557,3493,energy transfer,1.5812962241022096e-16,286.0
1558,3393,bone regeneration,1.3358625709455279e-16,321.0
1559,3626,carotid arteries,1.3076899151336458e-16,371.0
1560,722,data available,0,436.0
1561,442,little known,0,1062.0
1562,1623,test hypothesis,0,389.0
1563,1855,magnetic resonance,0,15812.0
1564,3242,purpose determine,0,518.0
1565,3454,computed tomography,0,10510.0
1566,2869,left main,0,310.0
1567,3507,diffusion tensor,0,1352.0
1568,1079,quality assessed,0,141.0
1569,3071,results suggest,0,2881.0
1570,49,cardiac computed,0,187.0
1571,2005,artery aneurysm,0,181.0
1572,2142,question whether,0,124.0
1573,3150,data show,0.0,260.0
1574,119,multivariate analysis,0,1775.0
1575,2627,high spatial,0,315.0
1576,1744,major complications,0,410.0
1577,1925,safe effective,0,797.0
1578,1910,alternative treatment,0,146.0
1579,2647,provides useful,0,114.0
1580,531,mean deviation,0,496.0
1581,2855,interstitial pneumonia,-3.1982858941367324e-16,141.0
1582,663,preoperative imaging,-4.784696336713483e-16,265.0
1583,1457,knee injury,-6.150009433240331e-16,128.0
1584,1741,diseases including,-1.0071260407559356e-15,152.0
1585,3477,medical history,-1.3260957840424457e-15,368.0
1586,735,therapeutic efficacy,-1.401380711752485e-15,195.0
1587,2824,underwent surgery,-1.557971827976119e-15,425.0
1588,2552,studies necessary,-1.5957195753833615e-15,126.0
1589,3489,initial treatment,-1.9962614069603797e-15,239.0
1590,1123,carotid artery,-4.120121998680273e-15,1747.0
1591,3256,conducted determine,-5.297176093865211e-15,140.0
1592,1448,lower limbs,-1.1282642052438656e-14,269.0
1593,2530,shear wave,-0.0025930177594705715,576.0
1594,298,intervertebral disc,-0.0037494612842982064,261.0
1595,2300,survival rate,-0.005841510300108921,509.0
1596,2517,proximal distal,-0.006898153524561781,297.0
1597,2132,acoustic radiation,-0.007774756039033511,243.0
1598,852,growth rate,-0.009108769423111104,255.0
1599,2779,transit time,-0.009235668789808915,232.0
1600,2427,descending aorta,-0.010544727636181719,211.0
1601,784,force impulse,-0.011319612590798729,187.0
1602,2675,four cases,-0.011416390336333897,241.0
1603,1689,optical imaging,-0.012826603325415629,378.0
1604,783,within years,-0.013397706698853255,222.0
1605,2919,right heart,-0.013816007970774034,416.0
1606,3048,normal weight,-0.01471904525111832,148.0
1607,1155,mild cognitive,-0.015440115440115294,428.0
1608,650,patients metastatic,-0.01809573908469228,172.0
1609,1110,patients controls,-0.018526554098668213,982.0
1610,2444,subfoveal choroidal,-0.018617614269787988,167.0
1611,1690,tumor uptake,-0.020096852300242402,166.0
1612,2764,murine model,-0.020297699594045968,150.0
1613,2926,physical properties,-0.02099949520444189,208.0
1614,405,anterior segment,-0.021525679758307385,285.0
1615,1409,ventricular septal,-0.021692169216921804,241.0
1616,2295,energy absorptiometry,-0.021765096217650465,164.0
1617,3151,found associated,-0.024383744170553112,183.0
1618,1158,machine learning,-0.027047804997101767,341.0
1619,1025,years sd,-0.02716857610474614,166.0
1620,3036,tumor progression,-0.02728956575427059,221.0
1621,70,rate patients,-0.027387529597474432,347.0
1622,1609,doppler ultrasonography,-0.029341603053435118,205.0
1623,1580,images reconstructed,-0.030423138725229226,284.0
1624,1695,k trans,-0.030987581312832232,262.0
1625,2938,review conducted,-0.031319358816276226,127.0
1626,2934,screw placement,-0.031505898681471474,227.0
1627,677,mild moderate,-0.033219761499149195,390.0
1628,355,specificity predictive,-0.03342563291139223,845.0
1629,2873,index bmi,-0.033565092304005055,700.0
1630,3148,medical therapy,-0.03376168224298984,289.0
1631,1147,dual energy,-0.03479257391702971,253.0
1632,323,range iqr,-0.03594306049822035,202.0
1633,1395,imaging parameters,-0.03628185907046431,242.0
1634,1969,mechanical ventilation,-0.037195121951219,183.0
1635,1038,median survival,-0.037795275590550716,232.0
1636,1729,artery aneurysms,-0.03786531130876634,149.0
1637,720,inflammatory bowel,-0.03798449612403117,147.0
1638,1078,system using,-0.039124487004103335,143.0
1639,2678,incidental findings,-0.0393792434529592,203.0
1640,2376,duration years,-0.040760869565217225,150.0
1641,2464,knowledge first,-0.040823699421965474,565.0
1642,2755,patients poor,-0.04177040110650098,151.0
1643,3464,diagnostic challenge,-0.041883519206939286,169.0
1644,798,pressure gradient,-0.042622950819671816,234.0
1645,643,needed determine,-0.04266055045871546,186.0
1646,2957,pathological conditions,-0.04327485380116982,148.0
1647,2714,plays role,-0.04355251921434663,255.0
1648,1596,predictive value,-0.04369375755243685,2942.0
1649,2937,nerve root,-0.04384896467722228,180.0
1650,3078,using visual,-0.044171779141103935,144.0
1651,3239,associated presence,-0.04477611940298454,360.0
1652,696,left coronary,-0.044839000902798305,149.0
1653,1290,collected patients,-0.04515418502202638,205.0
1654,3617,data collection,-0.04741379310344756,220.0
1655,230,cervical cancer,-0.04882320744389632,446.0
1656,3539,immunohistochemical staining,-0.04978292329956498,172.0
1657,2088,recent years,-0.051214316148274826,601.0
1658,2477,newly formed,-0.0529209621993124,154.0
1659,1578,survival time,-0.053150343106674394,142.0
1660,2507,visual assessment,-0.05438373570520924,214.0
1661,687,trauma patients,-0.05486111111111055,237.0
1662,641,data obtained,-0.05503292568203201,585.0
1663,1959,reconstruction algorithm,-0.055080396852548556,161.0
1664,460,imaging evaluation,-0.0559714795008915,157.0
1665,170,immunosorbent assay,-0.05655877342419226,166.0
1666,1376,ten healthy,-0.05664488017429235,130.0
1667,3111,analysis using,-0.05705521472392651,372.0
1668,197,using univariate,-0.057692307692307904,135.0
1669,986,complication rate,-0.058196181698486005,442.0
1670,304,imaging demonstrated,-0.05873891153200636,175.0
1671,134,acute pancreatitis,-0.06030397123713009,205.0
1672,375,head circumference,-0.06189555125725358,160.0
1673,2848,disease ad,-0.06263048016701482,600.0
1674,2110,anterior chamber,-0.06355932203389819,300.0
1675,367,morphological changes,-0.06425223689816752,377.0
1676,515,broad range,-0.06518711923411644,214.0
1677,2907,information processing,-0.0656357388316135,191.0
1678,50,spinal canal,-0.06574899086664543,411.0
1679,301,examine whether,-0.06666666666666617,241.0
1680,993,brain tumor,-0.06742435004972282,339.0
1681,73,right atrial,-0.06867736048410342,275.0
1682,2231,articular surface,-0.06928116987940354,192.0
1683,2080,carotid atherosclerosis,-0.0693253820350354,186.0
1684,2095,patients vs,-0.07157584683357893,162.0
1685,3412,pulmonary embolism,-0.07189811539203719,621.0
1686,3016,high degree,-0.07270114942528713,253.0
1687,3298,used control,-0.07277075503928904,213.0
1688,2975,discriminant analysis,-0.07293485560779049,181.0
1689,1504,contact angle,-0.07466960352422906,226.0
1690,1341,connectivity right,-0.07541899441340824,135.0
1691,2535,respectively patients,-0.07586694975229923,536.0
1692,3058,partial response,-0.076025917926566,176.0
1693,1462,surgically treated,-0.07619047619047603,168.0
1694,1045,guidelines recommend,-0.07632311977715833,137.0
1695,3217,spinal stenosis,-0.07742998352553519,188.0
1696,2731,radiation force,-0.07749809305873344,254.0
1697,3124,carpal tunnel,-0.07821466524973471,184.0
1698,952,complete response,-0.07832657058905795,311.0
1699,520,binding sites,-0.07975830815710148,132.0
1700,2395,aged years,-0.07999021526418715,2180.0
1701,2529,pulse wave,-0.08069890288500588,331.0
1702,2169,laparoscopic surgery,-0.08085106382978711,152.0
1703,100,patients developed,-0.08119777158774154,583.0
1704,226,potential therapeutic,-0.08198121263876978,160.0
1705,1568,years treated,-0.08226270373921309,143.0
1706,1385,subarachnoid hemorrhage,-0.08246968026461235,374.0
1707,1183,lv dysfunction,-0.08312358825427545,184.0
1708,3220,pancreatic cancer,-0.08362627197039949,452.0
1709,1368,performed compare,-0.08423913043478198,155.0
1710,2372,contrast media,-0.08545485118547144,231.0
1711,3363,arteries patients,-0.08635097493036066,155.0
1712,2062,classification accuracy,-0.08645763842561653,216.0
1713,2037,magnetic field,-0.08714632174615929,539.0
1714,1051,motor function,-0.08730158730158778,220.0
1715,1661,low levels,-0.08740688187300466,176.0
1716,1245,mesenchymal stem,-0.08870164687859085,386.0
1717,1667,acute aortic,-0.08876080691642611,154.0
1718,2129,years female,-0.0900489396411089,184.0
1719,1589,years men,-0.09012299664554603,403.0
1720,1252,soft tissue,-0.09032889025636451,1787.0
1721,24,six months,-0.09083263246425542,432.0
1722,3047,due high,-0.09150326797386048,210.0
1723,3423,results indicated,-0.09155844155843379,564.0
1724,1121,well tolerated,-0.09169435215946832,276.0
1725,1694,survival analysis,-0.09178082191780808,201.0
1726,491,raman spectroscopy,-0.09196428571428636,206.0
1727,1406,patients requiring,-0.09209932279909659,204.0
1728,1543,longer duration,-0.0931389365351634,181.0
1729,1256,angiography revealed,-0.09406175771971494,154.0
1730,3056,smoking status,-0.0941558441558445,145.0
1731,188,using ultrasound,-0.09460298684016061,457.0
1732,2632,diagnostic evaluation,-0.09593592405814282,147.0
1733,555,light scattering,-0.09634040918259543,295.0
1734,2154,calcium phosphate,-0.09649236573719291,248.0
1735,1955,multidisciplinary approach,-0.09656652360514996,150.0
1736,261,cell cultures,-0.09662921348314721,129.0
1737,3014,surgical procedures,-0.09683504506392808,330.0
1738,617,compare results,-0.09715512614063268,181.0
1739,135,included eyes,-0.09721115537848642,122.0
1740,2624,surgical procedure,-0.09744560075685939,412.0
1741,500,findings consistent,-0.09945355191256802,182.0
1742,2437,participants completed,-0.09947862356621479,159.0
1743,3628,disease pd,-0.09951986032300565,380.0
1744,2702,value predictive,-0.10045713961214084,610.0
1745,3024,blood vessel,-0.10108932461873647,232.0
1746,2160,breast tissue,-0.10183659180266036,326.0
1747,1087,outer retinal,-0.10483484921014836,219.0
1748,2704,patients lung,-0.10679012345678997,173.0
1749,3361,survival patients,-0.1069076823757256,414.0
1750,427,nude mice,-0.10723684210526357,163.0
1751,2386,tumor tissue,-0.10986547085201762,196.0
1752,3222,diabetic patients,-0.1099211742321285,337.0
1753,430,renal failure,-0.11010215664018175,291.0
1754,3513,time first,-0.11070110701107022,150.0
1755,1131,achieved using,-0.11100244498777548,227.0
1756,2689,patients complete,-0.11205936920222642,302.0
1757,1748,cardiac events,-0.1128404669260685,435.0
1758,2347,mean number,-0.11371237458193971,204.0
1759,103,patients large,-0.11417816813048946,195.0
1760,3159,mdd patients,-0.11512494519947417,303.0
1761,2992,longitudinal strain,-0.11541578862052232,712.0
1762,2106,motor recovery,-0.11584875301689475,144.0
1763,1719,achieved cases,-0.11760154738878144,152.0
1764,2321,thyroid gland,-0.11788617886178836,145.0
1765,928,conducted prospective,-0.11806167400880936,134.0
1766,113,coronary interventions,-0.11806167400880936,134.0
1767,3370,adc values,-0.11837584591358796,758.0
1768,2653,text formula,-0.11900089206066022,253.0
1769,646,aim develop,-0.11923076923076893,186.0
1770,3270,lesions using,-0.12041284403669758,175.0
1771,2854,dynamic light,-0.12071401053037134,188.0
1772,1841,weeks months,-0.12143569292123574,203.0
1773,1430,knee pain,-0.12385402759234562,253.0
1774,3637,prediction model,-0.12594268476621398,167.0
1775,2272,wave elastography,-0.12646822204344307,262.0
1776,1702,liver transplantation,-0.12678571428571328,284.0
1777,2662,structural alterations,-0.12727272727272235,119.0
1778,3533,neural responses,-0.1274414062499999,290.0
1779,56,conservative management,-0.12771121829780657,216.0
1780,3573,patients aged,-0.12878349720454366,668.0
1781,1010,able detect,-0.12960526315789592,197.0
1782,1299,chest radiograph,-0.1296055151283032,188.0
1783,60,middle ear,-0.12996183206106868,227.0
1784,1786,sinus rhythm,-0.1303738317756996,186.0
1785,673,changes patients,-0.1305061559507524,212.0
1786,2120,propose new,-0.13248811410459638,209.0
1787,2754,present review,-0.13271889400921624,144.0
1788,984,imaging patients,-0.13400503778337702,532.0
1789,3328,disease duration,-0.1340160936356988,458.0
1790,263,class iii,-0.1359256128486914,268.0
1791,3091,first second,-0.1372848948374763,359.0
1792,644,anterior descending,-0.13772070626003122,429.0
1793,348,quantitative evaluation,-0.13782668500687778,167.0
1794,192,among different,-0.13801337153772641,289.0
1795,3142,hypertension diabetes,-0.1387022016222479,171.0
1796,2135,typically developing,-0.1391234202742665,199.0
1797,1817,cone beam,-0.13976705490848765,588.0
1798,2184,neck cancer,-0.14093567251462008,241.0
1799,2461,overweight obese,-0.141118421052632,143.0
1800,659,depressive disorder,-0.1417517721975243,347.0
1801,3079,reliable method,-0.14228226501868324,225.0
1802,892,method proposed,-0.14393939393939345,190.0
1803,3278,patency rates,-0.14404145077720112,139.0
1804,1931,successfully performed,-0.14573055028462997,192.0
1805,1220,peripheral quantitative,-0.14611872146118376,160.0
1806,9,analyzed data,-0.14672489082969445,168.0
1807,1120,reviewed retrospectively,-0.1479951397326868,203.0
1808,1334,functional magnetic,-0.1480976310121941,2063.0
1809,3243,fdg uptake,-0.14875061244488008,506.0
1810,361,patients known,-0.1489130434782621,137.0
1811,1900,procedure performed,-0.14933726067746708,169.0
1812,3347,paper propose,-0.14936156960448507,218.0
1813,608,posterior parietal,-0.15128205128204947,177.0
1814,1693,nucleus pulposus,-0.15192878338278976,128.0
1815,2323,using analysis,-0.15241635687732286,246.0
1816,651,vs vs,-0.1530490467180891,478.0
1817,1533,lateral wall,-0.15411255411255453,178.0
1818,181,temporal bone,-0.15454777938794642,245.0
1819,3540,patients clinically,-0.154807692307692,322.0
1820,1052,hospital stay,-0.15486661860129566,537.0
1821,492,within weeks,-0.15511811023622266,197.0
1822,1865,intellectual disability,-0.15673758865248166,221.0
1823,786,analysis methods,-0.15851063829787257,149.0
1824,1990,fraction ef,-0.1586802827965436,202.0
1825,1232,patients males,-0.15871470301849971,326.0
1826,3614,subretinal fluid,-0.1594684385382068,144.0
1827,1266,studies revealed,-0.16031128404669323,309.0
1828,2291,average months,-0.16079136690647505,149.0
1829,1963,diagnostic imaging,-0.16107594936708888,509.0
1830,300,located within,-0.16129032258064444,150.0
1831,667,patients pd,-0.16302464575918327,238.0
1832,2298,cortex left,-0.1644787644787644,142.0
1833,3343,likely due,-0.16542750929368039,178.0
1834,757,red blood,-0.16622516556291433,251.0
1835,2534,hela cells,-0.1678885630498533,229.0
1836,1526,facet joint,-0.168589174800355,190.0
1837,1924,cognitive functions,-0.16923723824741388,258.0
1838,551,cells cells,-0.16925880923450767,199.0
1839,715,cortical areas,-0.17274939172749465,355.0
1840,903,regurgitation mr,-0.17351129363449688,169.0
1841,2343,whole brain,-0.17353999084428676,428.0
1842,1074,patients ra,-0.1742043551088774,240.0
1843,1531,respectively overall,-0.1751412429378527,155.0
1844,2847,groups showed,-0.17515923566879002,275.0
1845,1318,dna damage,-0.17622994180920473,263.0
1846,2909,estrogen receptor,-0.1763888888888886,127.0
1847,1231,fine needle,-0.17691256830601088,259.0
1848,1577,examined using,-0.17745803357314027,370.0
1849,579,lesion revascularization,-0.1783327470981363,169.0
1850,1354,range motion,-0.180025922641381,455.0
1851,716,root canal,-0.18033682294037237,283.0
1852,280,shoulder arthroplasty,-0.1804154302670617,152.0
1853,1880,pulmonary vein,-0.18096590909090887,196.0
1854,494,venous drainage,-0.18102605863192192,171.0
1855,2738,five patients,-0.1811442965095418,839.0
1856,3277,diagnosed patients,-0.18128654970760294,155.0
1857,1519,blood vessels,-0.1819209039547982,483.0
1858,2073,particularly patients,-0.18247734138972757,151.0
1859,3303,children aged,-0.1825242718446596,329.0
1860,480,without use,-0.1839985149433818,236.0
1861,2580,breast cancers,-0.18436213991769523,224.0
1862,988,motor cortex,-0.18445229681978828,333.0
1863,1392,using software,-0.18482142857142939,207.0
1864,1761,test results,-0.18579234972677572,340.0
1865,3426,grey matter,-0.18685463067252872,598.0
1866,2335,rate per,-0.18716577540106932,150.0
1867,3631,frontal temporal,-0.18797468354430344,189.0
1868,1648,measurements using,-0.18807947019867685,142.0
1869,424,needed confirm,-0.18835978835978912,178.0
1870,2027,recorded patients,-0.18843653780362657,162.0
1871,3488,binding affinity,-0.18928571428571395,159.0
1872,241,patients mean,-0.19045996592844947,1677.0
1873,2833,patients recruited,-0.19064807219032048,166.0
1874,2655,weeks surgery,-0.19104477611940202,128.0
1875,1675,subgroup analysis,-0.19136690647482016,228.0
1876,2686,patients cases,-0.19205020920502042,153.0
1877,945,arterial spin,-0.19271332694151458,335.0
1878,2677,within week,-0.1929696082021238,155.0
1879,549,descending coronary,-0.1933541017653171,133.0
1880,2143,curve analysis,-0.1933852140077835,497.0
1881,1669,frequently associated,-0.19411764705882387,132.0
1882,11,escherichia coli,-0.19469442578912002,446.0
1883,3293,color doppler,-0.1953455236285927,457.0
1884,2092,differential scanning,-0.195918367346939,192.0
1885,517,increasingly used,-0.19824561403508895,339.0
1886,1084,depressive symptoms,-0.19827586206896544,360.0
1887,2536,provide additional,-0.2001571091908877,196.0
1888,2930,pediatric population,-0.20311563810665056,339.0
1889,1770,procedure patients,-0.2031390134529142,151.0
1890,2124,bold signal,-0.20320855614973268,380.0
1891,1579,ppv npv,-0.20348133943059396,209.0
1892,1750,disc degeneration,-0.2036745406824143,291.0
1893,3145,mechanisms underlying,-0.20405650126765637,626.0
1894,467,posterior approach,-0.20745829244357206,151.0
1895,3061,respectively mean,-0.2075043199210056,467.0
1896,5,morphological features,-0.20757967269595085,241.0
1897,674,aortic diameter,-0.20878447395301405,146.0
1898,2315,participants included,-0.20899303356554783,150.0
1899,3399,shear stress,-0.20910711836510787,363.0
1900,3450,median interquartile,-0.2098191214470285,203.0
1901,3316,benign tumors,-0.21016949152542394,124.0
1902,264,reconstructed images,-0.21033123028391174,254.0
1903,2630,analysis demonstrated,-0.2107587314331604,375.0
1904,1340,aortic wall,-0.21264108352144406,157.0
1905,2805,john sons,-0.21348755550965468,608.0
1906,401,hiv infection,-0.21462264150943408,182.0
1907,3045,multivariate linear,-0.22220835932626304,137.0
1908,3272,provide insights,-0.22222222222222213,150.0
1909,366,followed years,-0.2222583265637695,152.0
1910,3428,patients prior,-0.22237246465887922,201.0
1911,2565,breast density,-0.22287735849056564,486.0
1912,1014,international society,-0.22450592885375473,497.0
1913,2697,patients studied,-0.2252765672142145,224.0
1914,1737,somatosensory cortex,-0.2254323769133918,270.0
1915,2449,retinal thickness,-0.22552116234996855,420.0
1916,684,brain abnormalities,-0.2262418636519361,254.0
1917,965,specific brain,-0.22650602409638534,188.0
1918,3476,cortical area,-0.2272727272727273,125.0
1919,275,results confirm,-0.22813688212927768,200.0
1920,1967,vivo studies,-0.22888283378746496,280.0
1921,1112,therapeutic interventions,-0.23242986210175937,188.0
1922,3021,morphometry vbm,-0.23315217391304355,143.0
1923,2368,patients disease,-0.23414634146341537,176.0
1924,3443,used monitor,-0.2343165766514334,188.0
1925,1481,vivo vitro,-0.23471882640586847,160.0
1926,1253,lumbar spinal,-0.23572803078896715,175.0
1927,1713,controls using,-0.23593749999999933,151.0
1928,2293,automatic segmentation,-0.23617747440273015,173.0
1929,1167,negatively charged,-0.23728813559322237,140.0
1930,173,cellular uptake,-0.23777113910897424,339.0
1931,1200,could potentially,-0.2381201044386425,228.0
1932,1809,vertebral fractures,-0.23827844799478298,174.0
1933,1742,female gender,-0.23863636363636334,147.0
1934,1380,myocardial function,-0.23868175765645777,239.0
1935,305,height weight,-0.23928967813540522,196.0
1936,3037,without known,-0.23936889556724156,177.0
1937,628,autosomal recessive,-0.23957597173144904,226.0
1938,2340,predictive factors,-0.241699685749419,305.0
1939,1552,healthy subjects,-0.24184191443074654,1265.0
1940,1632,studies show,-0.2419142782014199,184.0
1941,1779,infrared spectroscopy,-0.24248417721518895,613.0
1942,2814,time consuming,-0.24281984334203635,155.0
1943,1619,patients schizophrenia,-0.2430944857812659,225.0
1944,1106,resonance medicine,-0.24318484042553215,385.0
1945,443,collagen fibrils,-0.2431969552806849,142.0
1946,2758,cardiac arrest,-0.24426877470355746,309.0
1947,3396,well characterized,-0.24435429344151502,139.0
1948,2800,help identify,-0.24565858082067565,258.0
1949,1251,aim review,-0.24602707474985303,190.0
1950,671,using fluorescence,-0.2476868327402136,232.0
1951,3348,high signal,-0.24792967846402983,233.0
1952,554,chronic liver,-0.24940944881889696,181.0
1953,1819,findings highlight,-0.24959078508638963,179.0
1954,2280,node dissection,-0.25003946329913157,176.0
1955,1561,patients selected,-0.2504288164665499,146.0
1956,791,residual tumor,-0.2506600660066006,217.0
1957,2831,often used,-0.2507916402786582,220.0
1958,3587,cancer mortality,-0.2511627906976738,162.0
1959,2473,scans obtained,-0.2521739130434823,203.0
1960,743,patients liver,-0.2537894030851779,172.0
1961,174,retrospective series,-0.2546740778170788,280.0
1962,2694,adc value,-0.25592255125284824,321.0
1963,1954,male female,-0.2562054208273883,898.0
1964,1700,pedicle screw,-0.256258032927352,265.0
1965,991,tricuspid regurgitation,-0.2567738668017219,260.0
1966,1057,state functional,-0.257323979376215,258.0
1967,787,society magnetic,-0.2574025449404163,354.0
1968,1328,overall mortality,-0.25753424657534196,188.0
1969,1255,patients admitted,-0.2580145920848994,389.0
1970,1067,right coronary,-0.25876777251182426,273.0
1971,2082,level dependent,-0.2601782042494852,146.0
1972,1393,distant metastases,-0.2602091359383598,197.0
1973,2990,using proposed,-0.2604759141033081,132.0
1974,48,major depressive,-0.2608391608391606,373.0
1975,369,literature regarding,-0.26145978614597865,148.0
1976,573,test scores,-0.2641298833079652,137.0
1977,1361,provides evidence,-0.26448903406439506,218.0
1978,2064,studies investigated,-0.2656716417910463,178.0
1979,1160,total volume,-0.2658730158730167,134.0
1980,2247,quality control,-0.266156787762906,174.0
1981,2995,patients cerebral,-0.26708074534161563,129.0
1982,210,ad patients,-0.26724436741767804,257.0
1983,391,years months,-0.26813186813186896,122.0
1984,3332,time patients,-0.269230769230769,217.0
1985,3608,cerebral cortex,-0.2699719363891488,222.0
1986,1810,tomography scans,-0.2700531842356454,861.0
1987,912,technique allows,-0.2706536856745483,139.0
1988,194,heart disease,-0.2709129511677294,1276.0
1989,1522,analysis performed,-0.27287965135770403,1628.0
1990,2006,preoperative computed,-0.2732761171944365,171.0
1991,2843,multiple comparisons,-0.2745479833101542,141.0
1992,2156,diagnostic accuracy,-0.2759630200308083,1791.0
1993,2253,systolic pressure,-0.2770182068017861,192.0
1994,237,volume fraction,-0.27809405940593945,321.0
1995,1426,noted patients,-0.2787878787878789,138.0
1996,2410,type b,-0.2797359471894383,304.0
1997,2700,additional information,-0.2801175318315383,286.0
1998,1988,patients lesions,-0.28017294626312583,324.0
1999,1347,support vector,-0.2805172035941264,256.0
2000,1149,vessel wall,-0.2809962100703838,346.0
2001,548,pain scores,-0.2817046289493022,213.0
2002,943,right hemisphere,-0.28191268191268226,226.0
2003,2168,patients required,-0.28378252064184284,396.0
2004,1567,volume loss,-0.28387468768018476,211.0
2005,3501,time period,-0.2843995510662176,181.0
2006,26,gm volume,-0.2855032014447544,235.0
2007,775,range days,-0.28580229627555326,243.0
2008,2159,provide new,-0.2862903225806444,355.0
2009,1489,vocal fold,-0.2866572371522866,304.0
2010,1187,dice similarity,-0.28669950738916283,194.0
2011,218,hepatitis b,-0.2872057795385691,158.0
2012,2118,chest computed,-0.28750000000000003,276.0
2013,462,implant placement,-0.29171974522292765,229.0
2014,1272,cardiac imaging,-0.29272237196765477,181.0
2015,1275,lung disease,-0.29289223714379237,526.0
2016,1500,endoscopic retrograde,-0.2941176470588224,300.0
2017,274,results reveal,-0.29563328264175587,252.0
2018,2310,med international,-0.2958889482114258,326.0
2019,1292,resonance energy,-0.2961116650049848,198.0
2020,2105,cognitive processes,-0.2962583290620185,170.0
2021,3329,american society,-0.29672882526527294,278.0
2022,2606,patients asymptomatic,-0.29685362517099895,155.0
2023,2527,cell layer,-0.2980519480519482,153.0
2024,1213,still unknown,-0.2984343637093535,177.0
2025,829,novel technique,-0.30243902439024434,186.0
2026,2146,analysis included,-0.30249762883338605,208.0
2027,3209,controls respectively,-0.3030694668820684,134.0
2028,164,treatment groups,-0.30363951473137013,292.0
2029,1218,balloon angioplasty,-0.3054180121994971,224.0
2030,874,anisotropy fa,-0.3061913696060042,612.0
2031,1164,retinal nerve,-0.3065217391304359,564.0
2032,1747,western blot,-0.3084249084249078,421.0
2033,604,memory performance,-0.3113183766070077,247.0
2034,2020,using either,-0.31277258566978167,251.0
2035,3206,doppler echocardiography,-0.31318681318681335,228.0
2036,3619,found higher,-0.3133413461538459,237.0
2037,2878,provide valuable,-0.3145665773011621,160.0
2038,2579,stay days,-0.31521739130434767,145.0
2039,1942,studies suggest,-0.3159251304080981,396.0
2040,707,well known,-0.31604938271605093,256.0
2041,2788,bifurcation lesions,-0.31628197130380603,169.0
2042,2916,fluorescein angiography,-0.3163018284831308,267.0
2043,3465,grade grade,-0.3172661870503598,196.0
2044,3376,could identified,-0.3179142136248944,162.0
2045,2876,similar results,-0.317987152034261,330.0
2046,1413,principal component,-0.318903036238982,296.0
2047,3358,herein present,-0.3190812720848054,129.0
2048,3391,parietal regions,-0.3216482878699941,163.0
2049,3400,improve quality,-0.32183908045977017,140.0
2050,206,foreign body,-0.32189349112425997,304.0
2051,1604,ventricular hypertrophy,-0.3233554616777307,282.0
2052,942,new bone,-0.3241168946177306,366.0
2053,1622,length hospital,-0.32549019607843566,166.0
2054,893,imaging provides,-0.3257918552036198,144.0
2055,449,serum creatinine,-0.3259141494435611,246.0
2056,2670,remains controversial,-0.3281399046104937,258.0
2057,3440,patients met,-0.3281437125748494,274.0
2058,3137,layer thickness,-0.3291621327529923,275.0
2059,711,reson med,-0.329283473584624,389.0
2060,2512,artery ica,-0.3298245614035094,188.0
2061,1723,bypass surgery,-0.3300518134715028,182.0
2062,3002,femoral component,-0.3339070567986235,194.0
2063,2821,patients abnormal,-0.3344423906346277,236.0
2064,751,high diagnostic,-0.3361654968599926,182.0
2065,21,fourier transform,-0.3364438411944348,661.0
2066,1343,groups difference,-0.3366533864541825,169.0
2067,1196,develop new,-0.3371446822101557,182.0
2068,1610,genetic testing,-0.33739295908658323,197.0
2069,3012,rat model,-0.3378591189614809,294.0
2070,3086,patients aortic,-0.33786407766990445,174.0
2071,3005,present investigated,-0.3394366197183085,241.0
2072,2127,could serve,-0.3396782841823045,181.0
2073,890,commonly performed,-0.3412322274881495,120.0
2074,2570,pulmonary fibrosis,-0.3433048433048427,241.0
2075,1575,data provide,-0.3434167573449398,263.0
2076,1008,cardiovascular magnetic,-0.34348069390039104,279.0
2077,3560,visceral fat,-0.34454713493530503,233.0
2078,1897,type iii,-0.3460171165240286,292.0
2079,2209,cardiomyopathy hcm,-0.346673336668334,165.0
2080,561,hip joint,-0.3467475192943771,255.0
2081,1914,second trimester,-0.34697535474234575,202.0
2082,3315,task performance,-0.347181008902079,234.0
2083,2305,higher accuracy,-0.3478260869565208,144.0
2084,1239,intraclass coefficient,-0.34837688044338955,550.0
2085,2767,cognitive control,-0.3487728363166633,450.0
2086,3179,events occurred,-0.34927452118398233,177.0
2087,3083,treatment plans,-0.3500000000000021,154.0
2088,1814,knee arthroplasty,-0.350969942442977,392.0
2089,2942,treatment time,-0.351592356687897,138.0
2090,2802,molecular weight,-0.3516430171769974,219.0
2091,3204,ligament acl,-0.3520782396088015,240.0
2092,1550,limited data,-0.3528037383177546,302.0
2093,3439,examined whether,-0.3538396978598395,248.0
2094,3104,aortic regurgitation,-0.35580912863070513,245.0
2095,2691,patients brain,-0.35629820051413963,189.0
2096,3100,magnetic susceptibility,-0.35731830078518245,174.0
2097,1497,showed lower,-0.35982532751092183,412.0
2098,3175,enhanced depth,-0.3612826603325411,169.0
2099,2039,endothelial dysfunction,-0.3652777777777807,263.0
2100,698,patients unilateral,-0.3658247829518548,309.0
2101,3408,imaging system,-0.3673139158576052,454.0
2102,1063,previous research,-0.3678160919540226,160.0
2103,3064,period years,-0.3707592891760901,255.0
2104,2215,human body,-0.3739495798319317,178.0
2105,824,quantitative imaging,-0.3750000000000005,195.0
2106,2739,elastic modulus,-0.3750716332378225,238.0
2107,2261,thickness measured,-0.3752415458937188,239.0
2108,819,understanding mechanisms,-0.37595190380761473,134.0
2109,1718,epithelial cells,-0.37747956193120635,532.0
2110,898,brain region,-0.37769625825385206,198.0
2111,1225,facial nerve,-0.37946611909650885,168.0
2112,235,sclerosis ms,-0.38150782361308727,447.0
2113,2553,brain tissue,-0.3833935018050525,472.0
2114,3301,treatment options,-0.38396546407647253,566.0
2115,2993,used calculate,-0.3840258168616372,280.0
2116,624,therapeutic option,-0.38409090909090937,169.0
2117,2332,score improved,-0.38448275862069,223.0
2118,1790,recurrence rate,-0.3845099383139127,255.0
2119,3144,early late,-0.38455918977253783,313.0
2120,1193,years range,-0.3849439775910357,1434.0
2121,961,could used,-0.3879907621247056,840.0
2122,1919,score range,-0.38832116788321164,152.0
2123,488,abdominal pain,-0.38857279846571846,593.0
2124,43,whereas patients,-0.3895252080274112,173.0
2125,229,reviewed medical,-0.39240506329113917,155.0
2126,379,surgical removal,-0.3945368171021382,151.0
2127,1096,sons ltd,-0.3948538754764941,565.0
2128,977,values patients,-0.3954832881662165,199.0
2129,2408,present man,-0.39611650485436706,136.0
2130,932,spin labeling,-0.3964387464387471,242.0
2131,1818,aortic dissection,-0.3987708352733035,404.0
2132,2781,feasible safe,-0.398777506112471,233.0
2133,1222,processing speed,-0.3992888186487555,163.0
2134,1638,immune response,-0.40006930006930036,251.0
2135,2904,patients confirmed,-0.40043823609969825,170.0
2136,1150,fifteen patients,-0.4016563146997912,194.0
2137,473,using method,-0.4022346368715092,360.0
2138,1007,factors associated,-0.40310600945307407,995.0
2139,2264,univariate analysis,-0.40426908150064633,625.0
2140,1440,per cent,-0.4044429057757773,347.0
2141,3099,results revealed,-0.4053356282271933,471.0
2142,2748,investigate influence,-0.40722891566264974,156.0
2143,3382,minor complications,-0.40752532561505017,128.0
2144,328,aimed assess,-0.41091570648877884,484.0
2145,1443,early diastolic,-0.4113475177304956,190.0
2146,2520,oxygen species,-0.41164144353899756,442.0
2147,2896,radiation oncology,-0.41176470588235314,315.0
2148,2195,valve replacement,-0.4131336764935275,779.0
2149,3238,associated functional,-0.41410184667039707,148.0
2150,2542,electrical stimulation,-0.4152501214181642,225.0
2151,2200,characteristic analysis,-0.4166316098419996,398.0
2152,3251,liver lesions,-0.41689750692520766,215.0
2153,2047,virus infection,-0.4170575692963759,163.0
2154,2306,patients benefit,-0.41754385964912316,136.0
2155,1173,vector machine,-0.417973040439341,182.0
2156,8,data acquired,-0.4194915254237288,374.0
2157,3324,readily available,-0.4202898550724638,174.0
2158,4,microscopy revealed,-0.4203821656050942,220.0
2159,249,days range,-0.4207468879668046,234.0
2160,3566,patients total,-0.42113702623906646,321.0
2161,2360,thickness μm,-0.4228206945428773,157.0
2162,855,resonance imaging,-0.42282095605340164,11563.0
2163,1612,sickle cell,-0.42355250245338644,166.0
2164,2018,cm cm,-0.423575188830396,487.0
2165,270,five cases,-0.42374616171954865,230.0
2166,1766,accuracy sensitivity,-0.42407407407407355,229.0
2167,3575,overall results,-0.42490272373540877,234.0
2168,1948,stereotactic body,-0.4275590551181105,181.0
2169,1048,ionizing radiation,-0.42839632277834505,466.0
2170,882,system used,-0.4285714285714286,285.0
2171,1016,improve outcomes,-0.4286576168929119,203.0
2172,2695,results present,-0.42963776070252424,206.0
2173,2879,present findings,-0.430311820159535,129.0
2174,1111,posterior fossa,-0.43061536891519514,274.0
2175,3541,using techniques,-0.43267108167770435,140.0
2176,2271,humeral head,-0.433798145775232,264.0
2177,1358,long axis,-0.43448275862068914,168.0
2178,177,investigated effects,-0.43492296404989095,228.0
2179,1863,contrast enhancement,-0.43497884344146703,514.0
2180,833,interventional procedures,-0.4354482194023738,197.0
2181,3490,artery calcification,-0.43606557377049227,133.0
2182,3201,versus respectively,-0.436178247734139,275.0
2183,948,important prognostic,-0.43638726445743975,146.0
2184,408,insular cortex,-0.43661895760194486,188.0
2185,2494,samples obtained,-0.4368463395012066,181.0
2186,635,symptoms patients,-0.437837837837837,216.0
2187,1920,distal femur,-0.4383561643835617,160.0
2188,3188,intraocular pressure,-0.4384615384615364,323.0
2189,2414,remained stable,-0.4391420911528154,273.0
2190,2705,referral center,-0.44097410127560893,184.0
2191,3524,patients however,-0.44206383909051344,337.0
2192,1597,using combination,-0.4425606753429487,233.0
2193,1888,dose index,-0.4427787934186468,173.0
2194,159,improve diagnostic,-0.4441767068273097,237.0
2195,2733,cardiopulmonary bypass,-0.4444444444444453,240.0
2196,1930,animal studies,-0.4450704225352052,158.0
2197,3425,mouse brain,-0.4454935622317603,173.0
2198,2503,mechanism action,-0.4458598726114643,150.0
2199,3247,investigate effect,-0.4458999484270253,393.0
2200,3090,microscope sem,-0.4467153284671532,153.0
2201,2533,many years,-0.4476190476190489,141.0
2202,1934,factor vegf,-0.4488372093023247,193.0
2203,2400,multidisciplinary team,-0.45128205128205207,132.0
2204,513,showed improvement,-0.4517713083128735,280.0
2205,1012,recently introduced,-0.4518518518518515,122.0
2206,3478,cell count,-0.45382436260623144,267.0
2207,3471,systemic lupus,-0.4542113773335298,206.0
2208,233,coronary flow,-0.45605218651848395,286.0
2209,1333,data analyzed,-0.45631829644158073,479.0
2210,1047,imaging performed,-0.4568345323741173,635.0
2211,1711,weight gain,-0.4573863636363647,161.0
2212,3398,hepatocellular carcinoma,-0.45759814831300627,659.0
2213,627,coronary heart,-0.45849056603773564,162.0
2214,1590,imaging dwi,-0.45942396097194854,415.0
2215,1018,treatment strategies,-0.4598404255319164,247.0
2216,2850,board approval,-0.4613003095975226,149.0
2217,2387,approach used,-0.46327835745540147,222.0
2218,589,patients small,-0.4636176349402547,194.0
2219,2434,malignant benign,-0.4639154504277818,419.0
2220,1015,aims investigate,-0.46393562545720596,151.0
2221,1996,respectively differences,-0.4641909814323619,250.0
2222,540,published data,-0.46451612903225864,168.0
2223,2316,blood samples,-0.46529763452040457,358.0
2224,88,patients good,-0.4661921708185043,131.0
2225,3307,abnormalities patients,-0.4670658682634725,130.0
2226,2426,objective present,-0.46720835751596035,161.0
2227,3551,reson imaging,-0.467337164750958,697.0
2228,2136,total knee,-0.46735024284943266,433.0
2229,2158,younger years,-0.4680883185506703,234.0
2230,2706,neuroimaging data,-0.4689265536723183,166.0
2231,1390,based upon,-0.46985446985447005,226.0
2232,1696,bone quality,-0.46999860002799915,218.0
2233,1576,cutoff value,-0.4702878282053599,357.0
2234,1565,surgical techniques,-0.4703832752613227,225.0
2235,372,examinations patients,-0.47486631016042813,148.0
2236,3615,closely related,-0.47530562347188116,324.0
2237,1386,admitted hospital,-0.4762122598353153,347.0
2238,3330,acute chronic,-0.4778969395762479,261.0
2239,1607,patients performed,-0.47985212569316094,236.0
2240,162,amino acid,-0.48054730863559986,454.0
2241,3460,uterine artery,-0.48148591971240196,246.0
2242,2775,university hospital,-0.48164368748310404,524.0
2243,3080,scanning microscopy,-0.48256227758007136,226.0
2244,146,tumor cells,-0.4826833073322941,714.0
2245,329,determine association,-0.48351648351648296,180.0
2246,1156,surgical intervention,-0.48415181278040303,644.0
2247,700,analyses conducted,-0.4888888888888884,154.0
2248,3397,pituitary gland,-0.48958333333333387,235.0
2249,1582,however patients,-0.489637812893302,287.0
2250,2139,national institute,-0.4896656534954405,179.0
2251,1134,dose distributions,-0.49056603773584934,130.0
2252,2356,conventional imaging,-0.49082684091480244,315.0
2253,2391,objective determine,-0.4910485933503821,288.0
2254,3613,copyright john,-0.4931705110809585,376.0
2255,1539,prostate biopsy,-0.4939929328621892,233.0
2256,922,pulsatility index,-0.49443207126948907,222.0
2257,2510,subcortical structures,-0.4949868073878644,134.0
2258,3492,provides information,-0.4949868073878644,134.0
2259,3419,internal carotid,-0.49654032208682863,765.0
2260,2628,used reference,-0.4966392830470489,175.0
2261,714,flow rate,-0.49742976688583346,219.0
2262,2511,preoperatively postoperatively,-0.49795918367347164,183.0
2263,3538,however whether,-0.5000000000000004,170.0
2264,3033,osteogenic differentiation,-0.500755287009064,195.0
2265,3359,mortality patients,-0.5029411764705877,342.0
2266,3413,left upper,-0.5032258064516129,156.0
2267,676,neck pain,-0.5033436358527676,169.0
2268,2710,resonance cmr,-0.5033727551467321,442.0
2269,2933,left middle,-0.5038667459845338,231.0
2270,325,patients less,-0.5049707602339168,157.0
2271,2141,treatment however,-0.5058655221745358,136.0
2272,772,fracture healing,-0.5059907834101387,183.0
2273,675,based analysis,-0.506849315068493,135.0
2274,469,small intestine,-0.5070422535211258,160.0
2275,1707,conducted using,-0.5073390733907334,269.0
2276,1678,cases respectively,-0.5083910700538854,254.0
2277,3112,conducted retrospective,-0.5106874638937019,260.0
2278,510,cancer therapy,-0.5111000744971442,251.0
2279,527,ssc patients,-0.5128856624319396,157.0
2280,976,tumor cell,-0.513978494623656,239.0
2281,1116,last years,-0.5157639450282949,290.0
2282,1416,examination performed,-0.5174876847290636,191.0
2283,1020,images acquired,-0.5189189189189192,612.0
2284,1148,renal function,-0.5204185933317111,648.0
2285,1735,underlying mechanism,-0.5213282247765011,157.0
2286,1605,success achieved,-0.5243862520458245,178.0
2287,872,pivotal role,-0.5280528052805271,160.0
2288,1885,brain connectivity,-0.5280770112308045,256.0
2289,475,operative time,-0.5294605809128633,348.0
2290,614,thyroid cancer,-0.5305207495114392,325.0
2291,2019,cortical surface,-0.5308940022632964,227.0
2292,1503,developed novel,-0.531407942238267,224.0
2293,768,mean value,-0.5336538461538463,185.0
2294,2932,left temporal,-0.5343283582089563,179.0
2295,2385,ventral striatum,-0.5361141602634466,222.0
2296,3113,data sets,-0.5369441079771593,535.0
2297,266,fully understood,-0.5371994342291393,211.0
2298,564,tissue engineering,-0.5381961557417447,455.0
2299,776,functional brain,-0.5384615384615337,385.0
2300,2179,exhibited higher,-0.5386401326699735,232.0
2301,1446,scanning calorimetry,-0.5390070921985817,190.0
2302,2230,detection rate,-0.5390443791557118,498.0
2303,2492,medial prefrontal,-0.5394714407502131,452.0
2304,37,symptomatic patients,-0.541850220264318,369.0
2305,1769,contrast enhanced,-0.5424501424501428,204.0
2306,3339,treatment response,-0.5428660630658764,621.0
2307,2012,provide evidence,-0.5431309904153352,425.0
2308,1966,af patients,-0.5433962264150979,144.0
2309,58,imaging data,-0.5438811937740973,828.0
2310,496,healthy participants,-0.5476613838422894,322.0
2311,55,treatment modality,-0.5482758620689643,159.0
2312,1835,long term,-0.5493621955933491,374.0
2313,1686,review board,-0.5504885993485346,533.0
2314,3508,defined presence,-0.5512195121951193,113.0
2315,2578,beneficial effects,-0.5523809523809446,174.0
2316,3186,image features,-0.5526717557251933,181.0
2317,2074,soft tissues,-0.5537535126455213,363.0
2318,1681,plaque rupture,-0.5550660792951547,140.0
2319,3367,maximum standardized,-0.5560652113843616,234.0
2320,1387,examined effect,-0.5568345323740946,129.0
2321,1223,cardiac structure,-0.5571913929784811,164.0
2322,2388,staphylococcus aureus,-0.5580057526366247,388.0
2323,340,magn reson,-0.5582087774668022,1090.0
2324,505,recurrence rates,-0.5586109807602065,192.0
2325,1890,arterial phase,-0.5605640896499617,210.0
2326,622,temporal resolution,-0.563305372122078,367.0
2327,2951,option patients,-0.5641344956413434,151.0
2328,3448,among subjects,-0.5641677255400244,148.0
2329,1081,parameters patients,-0.5641711229946541,211.0
2330,10,success rates,-0.5647429171038815,414.0
2331,1383,total body,-0.5649421789409622,221.0
2332,712,chronic pain,-0.5670165616981566,206.0
2333,2546,neural networks,-0.5677908937605399,273.0
2334,763,postoperative complications,-0.570512820512822,445.0
2335,2151,resonance angiography,-0.5706654991243422,343.0
2336,3110,fatty liver,-0.5708612898808727,379.0
2337,1166,early phase,-0.571394517282479,141.0
2338,2439,visual impairment,-0.5739130434782598,132.0
2339,2417,paper presents,-0.57435897435897,224.0
2340,1560,patients breast,-0.5746143057503494,241.0
2341,3486,see text,-0.5750047437511849,1292.0
2342,145,predictors mortality,-0.575609756097562,118.0
2343,2596,using approach,-0.5756718528995761,185.0
2344,1001,angular gyrus,-0.5782270606531873,143.0
2345,381,formula see,-0.5794255538818253,1287.0
2346,1595,replacement therapy,-0.5849169152109079,176.0
2347,495,plane systolic,-0.5850746268656586,196.0
2348,1142,showed difference,-0.5850746268656735,392.0
2349,972,new species,-0.5853519791419772,196.0
2350,762,data support,-0.5854897218863383,269.0
2351,2644,quality assessment,-0.5856100104275272,216.0
2352,2067,photon emission,-0.5866642242168887,239.0
2353,2726,muscle thickness,-0.5868421052631588,223.0
2354,1858,various types,-0.5873015873015864,185.0
2355,3147,right middle,-0.5873505182035615,257.0
2356,3290,cm respectively,-0.5879194630872484,146.0
2357,3230,brain responses,-0.5880341880341906,172.0
2358,1665,pathological changes,-0.5893567553603719,187.0
2359,1163,birth weight,-0.5893781411747067,405.0
2360,3554,prognostic information,-0.5897435897435908,230.0
2361,3483,optic nerve,-0.5900582790538218,662.0
2362,1986,specificity respectively,-0.5920556107249275,271.0
2363,1714,lv ejection,-0.5944739045492601,426.0
2364,1782,internal capsule,-0.5948002536461632,210.0
2365,2373,required patients,-0.5953125000000022,127.0
2366,284,associated better,-0.5962117532782905,186.0
2367,1989,changes associated,-0.5970086468801127,241.0
2368,832,tetralogy fallot,-0.5980133880371424,227.0
2369,3200,radial diffusivity,-0.5990220048899757,294.0
2370,1037,anterior wall,-0.599999999999993,139.0
2371,596,chest radiographs,-0.5999999999999996,141.0
2372,1129,diagnostic yield,-0.6068637444784223,470.0
2373,3190,subclavian artery,-0.6069536423841038,282.0
2374,1594,myocardial perfusion,-0.607265933153414,618.0
2375,1743,basal cell,-0.608588957055215,124.0
2376,3207,diffusion weighted,-0.6097305780800433,259.0
2377,2440,previously described,-0.6108723789800687,437.0
2378,359,volume ml,-0.6111803913136965,233.0
2379,2445,vital capacity,-0.6142180094786734,144.0
2380,2094,stent thrombosis,-0.6197935640558595,176.0
2381,771,fluid csf,-0.6206050695012273,345.0
2382,2827,cells within,-0.6219490781387172,154.0
2383,2259,dose reduction,-0.6232327092090193,466.0
2384,2646,potentially used,-0.627551020408161,123.0
2385,2956,patients could,-0.6281690140845083,223.0
2386,3552,time required,-0.6289855072463761,217.0
2387,1375,lupus erythematosus,-0.6291467938526762,212.0
2388,83,core biopsy,-0.6294642857142853,235.0
2389,3636,breast imaging,-0.6295585412667939,328.0
2390,1486,high specificity,-0.6298850574712634,274.0
2391,2592,transient ischemic,-0.6302250803858533,196.0
2392,1050,single photon,-0.6304804804804798,247.0
2393,1185,doppler sonography,-0.6313358988455198,174.0
2394,2828,circumferential strain,-0.6324708269913751,271.0
2395,2089,developed new,-0.6329670329670325,160.0
2396,2320,cancer imaging,-0.6362722091853835,146.0
2397,3452,metabolic syndrome,-0.6371991247264773,336.0
2398,2941,brain tumors,-0.637323943661969,362.0
2399,2109,connectivity within,-0.6381578947368423,194.0
2400,2334,assess association,-0.6469282013323464,190.0
2401,1271,mitral annular,-0.6483660130718958,186.0
2402,2052,scanned using,-0.6492215965551508,200.0
2403,524,seven cases,-0.6499999999999991,143.0
2404,3336,rectal cancer,-0.6513339466421348,354.0
2405,2963,disease severity,-0.6524357838795403,381.0
2406,390,hypertensive patients,-0.6525347975992838,350.0
2407,1676,macular thickness,-0.6565606551133115,338.0
2408,2923,catheter ablation,-0.6588075880758794,187.0
2409,2448,growth restriction,-0.6604182804027869,203.0
2410,3081,replacement tavr,-0.6663519892110598,183.0
2411,2350,arthroplasty tka,-0.6666666666666659,180.0
2412,1493,μm μm,-0.6688785666887861,360.0
2413,420,serum albumin,-0.6691867124856814,254.0
2414,2174,substantia nigra,-0.672489082969433,140.0
2415,201,imaging features,-0.6739762810472149,753.0
2416,3126,similar patients,-0.6747179827471812,164.0
2417,1494,spinal cord,-0.6750853242320827,2116.0
2418,1617,algorithm based,-0.67758620689655,131.0
2419,3262,inferior vena,-0.6791411042944852,369.0
2420,2595,assigned groups,-0.6791443850267348,127.0
2421,935,tertiary referral,-0.6794918330308515,234.0
2422,895,patients women,-0.6810810810810871,294.0
2423,213,psychiatric disorders,-0.6821529745042495,258.0
2424,321,spearman rank,-0.6837642192347446,174.0
2425,887,longitudinal changes,-0.6842105263157883,130.0
2426,3537,levels measured,-0.6848602988953875,170.0
2427,3149,myocardial fibrosis,-0.6856199559794564,267.0
2428,2281,patients low,-0.6862264714669819,396.0
2429,1642,macular hole,-0.6862745098039214,182.0
2430,3354,potential improve,-0.6875000000000008,154.0
2431,2829,patients associated,-0.68804347826087,211.0
2432,2495,rate complications,-0.6885245901639353,140.0
2433,1162,provide first,-0.6905569007263933,186.0
2434,3212,therapeutic strategy,-0.6926829268292671,142.0
2435,3026,successfully treated,-0.6939384322437325,377.0
2436,1985,fluorescence lifetime,-0.6952986022871668,144.0
2437,378,mortality rates,-0.6967687074829919,241.0
2438,434,every months,-0.6969432314410478,228.0
2439,661,genetic analysis,-0.697719869706839,119.0
2440,198,retinal vein,-0.6991233985165215,192.0
2441,3143,analyses revealed,-0.7001023541453429,380.0
2442,2311,bone marrow,-0.7015784887844224,1342.0
2443,418,control eyes,-0.7018867924528289,186.0
2444,1055,samples collected,-0.702290076335879,230.0
2445,3117,purpose article,-0.7028192371475938,163.0
2446,1972,patients referred,-0.706430155210644,531.0
2447,2165,force microscopy,-0.7066238913002385,814.0
2448,3534,surface roughness,-0.7098344693281373,243.0
2449,2307,stem cells,-0.7099281134641545,1044.0
2450,2435,included patients,-0.709937029642139,1926.0
2451,2891,bone density,-0.7109286523216284,465.0
2452,1939,metastatic disease,-0.7122781065088759,321.0
2453,2277,reported cases,-0.7136431784107944,280.0
2454,1384,showed better,-0.7148659626320045,275.0
2455,1542,injury patients,-0.7163475699558172,152.0
2456,880,currently used,-0.7186372745490971,163.0
2457,2769,total cholesterol,-0.7195281782437751,183.0
2458,1691,across different,-0.7228915662650586,200.0
2459,1935,lung function,-0.7249283667621778,330.0
2460,72,proportional hazards,-0.7260834014717872,296.0
2461,1348,evaluation performed,-0.7272727272727294,180.0
2462,2496,using novel,-0.7278225806451625,285.0
2463,1639,fluorescent imaging,-0.7279543602281983,154.0
2464,3263,cell imaging,-0.7301587301587279,230.0
2465,981,model based,-0.7330595482546199,255.0
2466,220,retinal detachment,-0.7333923826395047,230.0
2467,756,cellular level,-0.7339285714285726,137.0
2468,1107,cells using,-0.7346153846153843,191.0
2469,1345,type iv,-0.7346863468634695,181.0
2470,99,determine whether,-0.7358922691305892,1826.0
2471,1114,characteristic curves,-0.7361779391738561,477.0
2472,1645,filtration rate,-0.7376608841634028,338.0
2473,2117,imaging probes,-0.73879781420765,169.0
2474,1311,using test,-0.7432584269662919,189.0
2475,2309,cumulative incidence,-0.7433652530779749,143.0
2476,1013,prior surgery,-0.744658261446583,181.0
2477,1041,treated patients,-0.7447002507408261,297.0
2478,2206,brain mapp,-0.745319232275754,536.0
2479,2002,hum brain,-0.745319232275754,536.0
2480,2241,depth imaging,-0.7457212713936437,183.0
2481,1467,criteria patients,-0.7479944674965411,208.0
2482,2497,silver nanoparticles,-0.7488986784140952,306.0
2483,2173,emission tomography,-0.7498711531056531,2482.0
2484,23,patients undergoing,-0.7504539035707072,2480.0
2485,1851,score patients,-0.7504601226993883,233.0
2486,927,mapp periodicals,-0.7512591498220409,495.0
2487,1704,coronary syndrome,-0.7514376996805114,392.0
2488,2985,coefficient adc,-0.7533039647577117,570.0
2489,765,improved patients,-0.754929577464787,134.0
2490,1912,immediate postoperative,-0.7561119293078025,151.0
2491,3475,preterm infants,-0.7594202898550723,438.0
2492,209,brain changes,-0.759694762400278,233.0
2493,2070,left superior,-0.7603393425238617,239.0
2494,1355,collected data,-0.7623651618058329,203.0
2495,3529,good agreement,-0.7668639053254449,468.0
2496,1431,differences among,-0.7677607585703874,277.0
2497,881,right ventricular,-0.7704174388844743,1408.0
2498,3384,lv systolic,-0.771351594072744,409.0
2499,1997,months median,-0.772641509433962,182.0
2500,2774,neurological deficits,-0.7737773152965656,338.0
2501,2618,therapeutic effect,-0.7768867924528319,183.0
2502,2649,nitric oxide,-0.7770152955766838,254.0
2503,2303,however studies,-0.7774617067833696,323.0
2504,512,positively associated,-0.7775571002979148,435.0
2505,1585,heart rate,-0.7777777777777775,915.0
2506,3379,therapeutic options,-0.7794871794871802,152.0
2507,1505,procedure time,-0.7800845122175268,386.0
2508,3422,associated changes,-0.7808724832214778,179.0
2509,1886,weighted imaging,-0.7816720257234735,187.0
2510,746,several studies,-0.7844135802469143,299.0
2511,96,could improve,-0.7848101265822798,320.0
2512,1221,iterative reconstruction,-0.7871985971065321,402.0
2513,2297,living cells,-0.790142311697328,542.0
2514,2666,knee joint,-0.7929832992911214,264.0
2515,154,surgery years,-0.7962616822429935,142.0
2516,3461,york heart,-0.7969849246231148,183.0
2517,1947,determine effect,-0.7984189723320188,202.0
2518,3392,tomography scanning,-0.7990117356392814,196.0
2519,2479,clinically useful,-0.7994082840236659,193.0
2520,2950,levels patients,-0.799556213017751,235.0
2521,2729,thickness imt,-0.8010899182561301,210.0
2522,1655,tomography performed,-0.8011799410029464,194.0
2523,2148,alone combination,-0.8062387522495489,192.0
2524,65,acute kidney,-0.8067265256429755,285.0
2525,1776,whole body,-0.8088026138766097,397.0
2526,459,valve disease,-0.8108626198083062,141.0
2527,334,ventricular diastolic,-0.8115983026874106,151.0
2528,2735,myocardial strain,-0.8117647058823522,138.0
2529,1712,ventricular systolic,-0.8121693121693088,307.0
2530,3216,independent factor,-0.8125984251968492,348.0
2531,2585,among groups,-0.8126037228077975,671.0
2532,2823,recommended patients,-0.8131147540983603,124.0
2533,980,prepared using,-0.8132882882882875,157.0
2534,914,laser scanning,-0.817436250861475,409.0
2535,14,healthy controls,-0.8191294601158223,3132.0
2536,310,tests performed,-0.8201133144475935,193.0
2537,2543,signal changes,-0.8210526315789483,182.0
2538,3430,bone graft,-0.8220770738079661,217.0
2539,455,valve implantation,-0.8240437158469894,348.0
2540,2522,estimated glomerular,-0.8245614035087717,235.0
2541,2232,ovarian cancer,-0.8248608534322837,247.0
2542,2532,respiratory motion,-0.8261369315342332,271.0
2543,1682,cord injury,-0.8265683983462153,277.0
2544,729,sd years,-0.8267548321464887,301.0
2545,3517,used investigate,-0.8271604938271601,335.0
2546,3226,brain injury,-0.8275054864667127,808.0
2547,2853,approach based,-0.8276643990929703,219.0
2548,725,learning memory,-0.828635851183766,147.0
2549,1369,potential role,-0.8296977660972392,287.0
2550,302,neurological examination,-0.8334975369458136,141.0
2551,1767,routine practice,-0.8355658198614333,201.0
2552,1621,malignant tumors,-0.8356374807987718,170.0
2553,2390,high resolution,-0.8365130613442909,750.0
2554,3542,functional neuroimaging,-0.8368421052631577,159.0
2555,1759,much higher,-0.8374558303886926,237.0
2556,654,room temperature,-0.8380069524913096,226.0
2557,3381,participants performed,-0.8388714733542308,223.0
2558,1324,values respectively,-0.8391857506361314,291.0
2559,1295,plays key,-0.8392124692370807,165.0
2560,2131,time minutes,-0.8394366197183105,298.0
2561,888,septal defect,-0.839777518614873,407.0
2562,3518,blood cells,-0.8410214835832981,266.0
2563,2465,mass spectrometry,-0.8416835096896919,437.0
2564,2720,subjects underwent,-0.8417061611374455,444.0
2565,392,remains poorly,-0.8425324675324688,173.0
2566,1722,muscle cells,-0.8429223744292221,213.0
2567,2467,fibrillation af,-0.8433510638297875,302.0
2568,2213,aortic root,-0.84677419354839,336.0
2569,780,progenitor cells,-0.8475079533404035,148.0
2570,1566,class ii,-0.848741188318228,294.0
2571,1806,among women,-0.8490814696485605,373.0
2572,850,right atrium,-0.850187265917598,227.0
2573,815,diastolic dysfunction,-0.8514364281062293,530.0
2574,1265,complications related,-0.8520408163265311,167.0
2575,632,patients high,-0.854557207498382,661.0
2576,2526,preoperative postoperative,-0.857731958762888,416.0
2577,1180,volume measured,-0.858761987794247,197.0
2578,450,remains challenge,-0.860294117647059,156.0
2579,1315,subset patients,-0.8671875000000004,296.0
2580,2794,comprised patients,-0.8673837879369953,213.0
2581,311,executive function,-0.871240947588066,338.0
2582,572,provide information,-0.8714843749999999,291.0
2583,2716,tomography used,-0.8714859437750997,155.0
2584,291,cutoff values,-0.8733620561580747,247.0
2585,1031,experimental conditions,-0.8738317757009333,170.0
2586,2621,following treatment,-0.8749229821318553,284.0
2587,2201,post hoc,-0.8759856630824391,282.0
2588,1777,groups patients,-0.8795731707317016,577.0
2589,1641,upper airway,-0.8803869832893588,195.0
2590,3355,healthy control,-0.8819161127664386,583.0
2591,203,database patients,-0.8823529411764709,150.0
2592,1242,family history,-0.8838709677419405,411.0
2593,3605,women mean,-0.885074626865678,593.0
2594,2265,examination revealed,-0.8858540403052255,462.0
2595,859,axial diffusivity,-0.8868360277136265,192.0
2596,267,body surface,-0.8896663078579106,285.0
2597,1724,investigate potential,-0.889768483943241,161.0
2598,2007,energy dispersive,-0.8925143953934698,279.0
2599,3377,descending artery,-0.8984641638225251,195.0
2600,621,inversely associated,-0.8999999999999988,198.0
2601,2861,treatment decisions,-0.9003533568904624,182.0
2602,841,live cell,-0.9006657789613864,178.0
2603,3633,images obtained,-0.900783289817232,690.0
2604,869,carotid thickness,-0.9008356545961002,462.0
2605,1350,majority patients,-0.9011209895632011,376.0
2606,570,joint space,-0.9017019082001001,186.0
2607,511,expression levels,-0.9030546623794233,411.0
2608,417,months respectively,-0.9047098620869115,328.0
2609,3146,matter tracts,-0.9088334457181388,293.0
2610,324,student test,-0.9090909090909084,150.0
2611,3497,materials methods,-0.9098559855985611,293.0
2612,2322,new york,-0.9104895104895121,217.0
2613,2967,pooled sensitivity,-0.911320754716981,161.0
2614,1450,present aimed,-0.9138840070298728,312.0
2615,108,absorptiometry dxa,-0.915665902037513,390.0
2616,3304,lung diseases,-0.9173076923076926,159.0
2617,2699,mrna expression,-0.9177387914230043,214.0
2618,1544,available data,-0.9193548387096768,190.0
2619,2279,periodicals clin,-0.9205479452054807,168.0
2620,875,clin ultrasound,-0.9205479452054807,168.0
2621,20,chronic hepatitis,-0.9206008583690994,143.0
2622,738,bile duct,-0.9208669354838716,522.0
2623,3368,disease progression,-0.9232283020993725,814.0
2624,350,drug release,-0.9255859104146451,412.0
2625,2076,recently developed,-0.9286516853932572,348.0
2626,3469,contrast agents,-0.930649038461539,957.0
2627,820,results patients,-0.9308045018757835,385.0
2628,1534,lymph node,-0.9324784459238253,1499.0
2629,2545,underwent coronary,-0.9333333333333383,224.0
2630,36,added value,-0.9343715239154587,200.0
2631,851,mechanisms involved,-0.9367327667610971,160.0
2632,2056,uptake values,-0.937922556853101,218.0
2633,889,contralateral side,-0.9480093676815002,184.0
2634,2466,small bowel,-0.948876568427195,458.0
2635,864,investigated relationship,-0.950631458094144,180.0
2636,1581,weeks gestation,-0.9558446527644916,757.0
2637,3108,symptom onset,-0.957220412595006,232.0
2638,2905,atomic force,-0.9603546548448401,892.0
2639,2920,effective connectivity,-0.9611770289511156,166.0
2640,1647,shed light,-0.9636363636363605,212.0
2641,1184,wilcoxon test,-0.9641398093508864,236.0
2642,1260,cavernous sinus,-0.9642857142857142,180.0
2643,1530,h e,-0.9671497584541072,182.0
2644,1936,patients pulmonary,-0.9686888454011751,225.0
2645,1281,past decade,-0.9689507494646697,181.0
2646,1061,ductus arteriosus,-0.9701042873696414,182.0
2647,1872,epidermal growth,-0.9705528188286775,286.0
2648,3512,cardiac function,-0.9714765100671141,579.0
2649,947,tomography magnetic,-0.9726768829475069,678.0
2650,27,limited number,-0.9746835443037989,140.0
2651,2046,available article,-0.9757127771911324,308.0
2652,616,demonstrated high,-0.9764453961456124,152.0
2653,2164,cognitively normal,-0.9767660910518062,183.0
2654,1352,vertebral body,-0.9768637532133675,380.0
2655,441,transgenic mice,-0.9775641025641029,183.0
2656,2026,glomerular filtration,-0.9776766143989228,367.0
2657,2587,connectivity left,-0.9782837127845885,147.0
2658,2432,cervical length,-0.9787365813377367,431.0
2659,2472,stromal cells,-0.9802970597150629,330.0
2660,537,brain structures,-0.9813829787234073,205.0
2661,544,showed good,-0.9825503355704696,488.0
2662,689,findings patients,-0.9826902331756687,452.0
2663,1823,anterior insula,-0.9835164835164834,179.0
2664,331,lesions identified,-0.9841521394611753,135.0
2665,1698,small number,-0.9852034525277417,235.0
2666,3407,individual differences,-0.9862646206674538,455.0
2667,1513,older adults,-0.9892497888351347,991.0
2668,3105,rates respectively,-0.9904659882163909,402.0
2669,612,well established,-0.9906250000000135,317.0
2670,184,mouse models,-0.9926793557833041,226.0
2671,690,white matter,-0.9934424100766166,4173.0
2672,672,clinically important,-0.9948009748172231,157.0
2673,866,pathological findings,-0.999999999999997,193.0
2674,2626,associated reduction,-1.0000000000000018,135.0
2675,620,limiting membrane,-1.000000000000002,170.0
2676,1470,prospective observational,-1.0033222591362077,453.0
2677,2900,hepatitis c,-1.0044642857142851,225.0
2678,1277,patients months,-1.0048387096774176,178.0
2679,75,bypass grafting,-1.0048919496556632,298.0
2680,950,patients assessed,-1.0056189640035107,249.0
2681,2564,pulmonary valve,-1.0065146579804598,206.0
2682,1437,paediatric patients,-1.0087759815242499,156.0
2683,3586,image quality,-1.0094175612882563,3294.0
2684,1658,transforming growth,-1.013888888888889,146.0
2685,3274,magnetic stimulation,-1.0144732628882493,217.0
2686,1377,medical students,-1.01516731124937,234.0
2687,2931,active surveillance,-1.0166666666666702,122.0
2688,788,wide variety,-1.0170634920634918,233.0
2689,2380,diffusivity md,-1.0179775280898833,151.0
2690,255,showed highest,-1.0182661434177667,213.0
2691,3491,mechanism underlying,-1.0188055908513376,211.0
2692,3297,vitro studies,-1.0193050193050188,120.0
2693,3544,different imaging,-1.0197384066587403,192.0
2694,2036,results suggested,-1.0206896551724154,296.0
2695,1780,assess impact,-1.0221038615179732,202.0
2696,1276,time point,-1.0267515923566868,372.0
2697,1097,family members,-1.0296296296296252,139.0
2698,2588,plays critical,-1.0303236797274269,144.0
2699,2238,range months,-1.0314243759177697,878.0
2700,1115,fraction lvef,-1.0327354260089676,329.0
2701,2768,cell migration,-1.0354148845166833,356.0
2702,969,central venous,-1.0364417705199835,389.0
2703,966,proposed approach,-1.0377358490566044,264.0
2704,501,retrospective analysis,-1.0396508728179528,758.0
2705,122,first evidence,-1.0438908659549266,176.0
2706,3095,side branch,-1.0446854663774414,168.0
2707,3044,diagnostic criteria,-1.0463667820069193,378.0
2708,3213,knee flexion,-1.0465447637140828,195.0
2709,2352,screw fixation,-1.0471243042671607,332.0
2710,766,main pulmonary,-1.0489945155393041,151.0
2711,916,imaging imaging,-1.0504413619167734,245.0
2712,3322,nerve palsy,-1.0517184942716882,153.0
2713,3457,connectivity analysis,-1.051744885679902,190.0
2714,3132,alzheimer disease,-1.0546780959328828,1464.0
2715,929,liver metastases,-1.0553217077570616,351.0
2716,2528,value accuracy,-1.0564417177914125,123.0
2717,2948,understanding role,-1.0580912863070546,150.0
2718,2016,sagittal plane,-1.05810084463783,318.0
2719,3128,doppler imaging,-1.0583534187492072,309.0
2720,509,brain development,-1.0583808437856308,273.0
2721,3038,tissue samples,-1.0588235294117643,240.0
2722,1703,developed method,-1.0593293207222683,176.0
2723,3013,heart failure,-1.0602272727272744,2177.0
2724,1663,analysis used,-1.0652063168619486,697.0
2725,2013,evaluated whether,-1.0687499999999812,171.0
2726,3472,sleep apnea,-1.0714285714285694,207.0
2727,2599,early stages,-1.0716751918158576,453.0
2728,2233,evaluation treatment,-1.0749414519906337,153.0
2729,3294,used image,-1.0779560308972072,193.0
2730,1984,medline embase,-1.079543292102757,183.0
2731,214,groups however,-1.086486486486484,201.0
2732,2170,well described,-1.1021555763823778,168.0
2733,312,clinically relevant,-1.1136563876651917,711.0
2734,1346,exact test,-1.1141732283464578,283.0
2735,3467,cm range,-1.114285714285715,174.0
2736,1751,resonance images,-1.114285714285715,390.0
2737,2406,diabetes mellitus,-1.1163734776725251,1125.0
2738,2872,neurological deficit,-1.1164179104477627,187.0
2739,1889,complete resolution,-1.1173366063209564,289.0
2740,2753,arteriovenous malformations,-1.1194184839044632,154.0
2741,1082,blood loss,-1.1200607243548033,527.0
2742,377,tumor response,-1.1250000000000022,210.0
2743,1191,physicochemical properties,-1.128228228228229,221.0
2744,2045,acquisition time,-1.1305122494432085,282.0
2745,1562,kidney disease,-1.1315079524864096,551.0
2746,2468,artery pressure,-1.1317073170731657,174.0
2747,3427,scanning electron,-1.1334738321039632,2305.0
2748,593,studies including,-1.1335102853351045,219.0
2749,3096,ventricular function,-1.134057533695436,397.0
2750,2071,middle temporal,-1.1369318181818207,348.0
2751,1538,congenital heart,-1.1397723956813546,558.0
2752,1054,performed within,-1.1425583266291268,263.0
2753,2838,cystic fibrosis,-1.1431079894644431,210.0
2754,2285,randomized trial,-1.1442447790189407,380.0
2755,2172,optic neuritis,-1.144654088050313,182.0
2756,3062,promising results,-1.1447761194029873,236.0
2757,1151,multiple regression,-1.1448763250883396,405.0
2758,2182,assessment patients,-1.145352464129754,204.0
2759,344,fluorescence microscopy,-1.147058823529407,780.0
2760,737,patients heart,-1.1475409836065595,210.0
2761,1297,american college,-1.150129421915446,215.0
2762,2304,neural correlates,-1.15046948356808,377.0
2763,207,images used,-1.1517536355859725,204.0
2764,1511,low cytotoxicity,-1.1525704809286932,139.0
2765,3498,development novel,-1.1528815706143147,246.0
2766,2698,microscopic examination,-1.1555555555555583,172.0
2767,2717,images showed,-1.158098591549298,286.0
2768,1248,regression used,-1.1596768270290128,277.0
2769,3546,brain function,-1.1637279596977326,330.0
2770,794,morphological characteristics,-1.1664473684210535,197.0
2771,1460,frontal cortex,-1.1668653158522064,445.0
2772,2541,transcranial magnetic,-1.1763643502159413,211.0
2773,471,atrial septal,-1.1785714285714264,297.0
2774,2538,proposed method,-1.1790627944829943,1564.0
2775,1477,demographic data,-1.1797833935018038,266.0
2776,2066,intracranial aneurysms,-1.180967829143012,326.0
2777,258,cancer treatment,-1.183038869257952,279.0
2778,472,unstable angina,-1.1833333333333425,142.0
2779,3588,tube current,-1.1842105263157883,150.0
2780,828,controls patients,-1.1869158878504584,381.0
2781,1294,feasibility safety,-1.1883201153568843,201.0
2782,3299,mean preoperative,-1.1909090909090922,131.0
2783,3607,survival pfs,-1.1935251798561126,237.0
2784,678,imaging characteristics,-1.1946554149085793,274.0
2785,2679,examinations performed,-1.19674758425642,403.0
2786,493,resting state,-1.198888730588409,825.0
2787,2650,lesion glycolysis,-1.2088235294117597,137.0
2788,3311,present novel,-1.2110091743119231,220.0
2789,2216,medical imaging,-1.214565387627249,385.0
2790,1238,frontal regions,-1.2153846153846195,158.0
2791,1555,treatment planning,-1.2157544602358676,731.0
2792,2128,lymph nodes,-1.2161511145916326,1313.0
2793,607,first trimester,-1.2166123778501623,249.0
2794,3055,patients randomized,-1.2181818181818196,268.0
2795,2061,mean arterial,-1.2187500000000004,195.0
2796,3528,parietal cortex,-1.2190939339646745,433.0
2797,2357,superior vena,-1.2209223847019135,201.0
2798,3421,mice showed,-1.2245874587458752,181.0
2799,1009,times higher,-1.226107501476668,291.0
2800,557,biomedical applications,-1.2303142329020342,256.0
2801,295,five different,-1.2315789473684204,156.0
2802,1793,areas curve,-1.233333333333334,148.0
2803,6,intravenous injection,-1.2370535714285706,163.0
2804,2058,cbct scans,-1.2409090909090945,189.0
2805,843,limits agreement,-1.2416988416988402,268.0
2806,3350,interest roi,-1.2438133874239348,219.0
2807,990,according presence,-1.2446808510638316,130.0
2808,3581,oxidative stress,-1.2461011791555723,840.0
2809,1419,however difference,-1.2477744807121676,290.0
2810,1894,knee oa,-1.248351648351653,284.0
2811,2935,nerve sheath,-1.2493150684931533,152.0
2812,2584,imaging modality,-1.250099088386844,830.0
2813,1159,demographic characteristics,-1.2510638297872354,182.0
2814,1412,time course,-1.2521739130434804,256.0
2815,2744,type diabetes,-1.255160568045888,1106.0
2816,3102,used analysis,-1.2563981042654,241.0
2817,2741,type ii,-1.2577437858508669,759.0
2818,1029,neurological disorders,-1.261507128309565,163.0
2819,3287,bone grafting,-1.262068965517241,183.0
2820,2544,temporal gyrus,-1.2629939428901102,534.0
2821,985,bone loss,-1.2634664093595471,663.0
2822,1296,validated using,-1.2701030927835124,168.0
2823,2836,results demonstrated,-1.2717948717948702,496.0
2824,416,months surgery,-1.273336524652945,532.0
2825,3630,years mean,-1.2762508338892575,911.0
2826,854,cystic lesions,-1.2766954377311945,167.0
2827,2424,physical activity,-1.2797212230215815,537.0
2828,1588,total lesion,-1.2857142857142825,180.0
2829,685,left ventricle,-1.2922317314022365,727.0
2830,752,prospective studies,-1.2942598187311103,408.0
2831,3520,cancer cell,-1.2960945381178859,584.0
2832,778,total hip,-1.2968490878938634,690.0
2833,3135,analysis revealed,-1.2970644659210173,1558.0
2834,3001,randomized controlled,-1.2978359335681806,614.0
2835,963,compare performance,-1.2996742671009767,133.0
2836,2425,tested whether,-1.3065637065637066,188.0
2837,827,left anterior,-1.308510638297873,615.0
2838,3253,due lack,-1.3129464285714303,173.0
2839,333,taking account,-1.3130044843049342,244.0
2840,1717,might useful,-1.3177914110429445,179.0
2841,1487,low high,-1.3195876288659878,256.0
2842,915,transmission electron,-1.319656786271444,1538.0
2843,1842,functional imaging,-1.323334247326564,409.0
2844,1207,experimental results,-1.324722991689752,517.0
2845,1687,screening mammography,-1.3333333333333308,240.0
2846,19,gastric cancer,-1.3476908723371128,405.0
2847,2313,macular edema,-1.3571428571428603,360.0
2848,269,within hours,-1.3584991472427503,412.0
2849,2218,investigated whether,-1.361018996376416,626.0
2850,388,matter gm,-1.3615894039735126,257.0
2851,78,interventional radiology,-1.362197603436584,241.0
2852,1856,alternative method,-1.36230661040788,167.0
2853,2481,mechanical properties,-1.3714738981706385,1040.0
2854,1364,levels associated,-1.379032258064517,285.0
2855,680,dorsal anterior,-1.37958115183246,155.0
2856,2742,used detect,-1.3836257309941515,338.0
2857,3571,medical record,-1.3873417721519,137.0
2858,1868,vivo using,-1.3898305084745717,164.0
2859,2072,disease cvd,-1.3902439024390212,171.0
2860,110,lean mass,-1.3963983829474482,322.0
2861,3158,atrial fibrillation,-1.398741966361274,965.0
2862,1030,imaging computed,-1.405063291139243,185.0
2863,2719,patients eyes,-1.4074074074074043,190.0
2864,906,using confocal,-1.4074074074074068,190.0
2865,728,showed excellent,-1.4095127610208824,225.0
2866,2442,spatial temporal,-1.4100697134004672,222.0
2867,807,found cases,-1.4173697270471481,168.0
2868,796,cell adhesion,-1.418993538280788,366.0
2869,3375,thickness cimt,-1.4192439862543003,295.0
2870,840,cingulate cortex,-1.4195663397005656,887.0
2871,1673,head trauma,-1.4195953141640079,215.0
2872,2438,analysis data,-1.4200260078023377,252.0
2873,1273,ten patients,-1.4224598930481247,406.0
2874,34,even though,-1.4239159001314021,378.0
2875,3103,cancer underwent,-1.4259740259740226,183.0
2876,2188,showed differences,-1.4280448717948755,469.0
2877,3004,right inferior,-1.4293801504837036,327.0
2878,1088,network connectivity,-1.4357515960533982,217.0
2879,30,linear mixed,-1.4380165289256226,174.0
2880,200,cell membrane,-1.4384390955506943,481.0
2881,805,multivariate logistic,-1.439429928741104,606.0
2882,1615,using imaging,-1.442168674698798,342.0
2883,1812,endoplasmic reticulum,-1.443211488250654,335.0
2884,615,adjusted odds,-1.4492022645393732,247.0
2885,1322,better results,-1.4499999999999997,145.0
2886,335,preliminary results,-1.4505180069067578,241.0
2887,439,obese patients,-1.4545680033071517,241.0
2888,3496,purpose present,-1.4603491271820483,244.0
2889,2312,chronic kidney,-1.466337041615162,434.0
2890,2715,differ groups,-1.4762527233115466,308.0
2891,1600,cells results,-1.481858407079649,197.0
2892,2269,hepatic artery,-1.4860872144764197,248.0
2893,1095,pulmonary arteries,-1.4893617021276573,200.0
2894,1472,antibacterial activity,-1.4922330097087382,212.0
2895,1476,brain damage,-1.4984374999999992,137.0
2896,2075,mr images,-1.512888301387976,1090.0
2897,2217,patients hips,-1.5130434782608702,174.0
2898,3557,high low,-1.513550267119961,294.0
2899,127,echocardiography performed,-1.5137055837563484,213.0
2900,1756,superparamagnetic iron,-1.51583011583011,151.0
2901,2149,thyroid nodules,-1.518905526230747,564.0
2902,1801,address issue,-1.5212598425196866,138.0
2903,3022,connectivity patterns,-1.5218855218855252,226.0
2904,736,test performed,-1.5237804878048786,147.0
2905,2370,assessed patients,-1.529032258064442,237.0
2906,1177,range patients,-1.530261969286353,242.0
2907,3590,results provide,-1.5328703703703712,616.0
2908,2471,rsna online,-1.5419107057129184,303.0
2909,2712,analyzed retrospectively,-1.5424731182795681,151.0
2910,2478,wound healing,-1.5445544554455453,260.0
2911,2100,unknown whether,-1.5448818897637744,218.0
2912,1706,surgical technique,-1.5478827361563476,297.0
2913,2381,patients surgical,-1.549367088607596,153.0
2914,498,target lesion,-1.5506172839506203,314.0
2915,2834,jugular vein,-1.5528384279475966,254.0
2916,1952,stenosis patients,-1.5531249999999963,142.0
2917,2222,well understood,-1.5542119565217396,369.0
2918,723,patients assigned,-1.5553512803676954,188.0
2919,3166,benign malignant,-1.5610942249239883,856.0
2920,2207,medical management,-1.5640624999999952,143.0
2921,1956,remains challenging,-1.564120370370372,233.0
2922,3054,subjects using,-1.5673819742489292,166.0
2923,2525,interbody fusion,-1.5714285714285725,165.0
2924,3066,positron emission,-1.5756775917543742,2428.0
2925,1844,overall accuracy,-1.5785714285714265,221.0
2926,470,general population,-1.5822916666666682,496.0
2927,2751,connectivity fc,-1.584664536741216,240.0
2928,1306,subgroup analyses,-1.5868421052631574,134.0
2929,25,kappa statistics,-1.5875000000000028,127.0
2930,740,none patients,-1.589573459715639,312.0
2931,3401,patients normal,-1.5909090909090948,700.0
2932,1903,vast majority,-1.59212962962963,181.0
2933,3177,patients diagnosed,-1.597703261368864,1023.0
2934,294,body fat,-1.5987349778621138,568.0
2935,3445,cardiogenic shock,-1.5999999999999837,120.0
2936,1896,density bmd,-1.6019119828580821,534.0
2937,3221,aortic stenosis,-1.6033650329188045,562.0
2938,1099,evaluation patients,-1.6083475880944254,322.0
2939,3248,studies using,-1.6088546679499485,398.0
2940,2681,range cm,-1.6129870129870125,161.0
2941,3164,matter volume,-1.6140141227593714,537.0
2942,489,artery bypass,-1.6228963938179717,443.0
2943,2416,within h,-1.625224416517059,355.0
2944,3565,operating characteristic,-1.6355077785938383,1775.0
2945,814,brain activity,-1.6359681317697559,923.0
2946,1650,different techniques,-1.6394088669950786,128.0
2947,297,access site,-1.641819515774028,167.0
2948,939,high dose,-1.6441860465116231,202.0
2949,282,patients multiple,-1.6448979591836579,341.0
2950,2087,bipolar disorder,-1.645436105476673,312.0
2951,178,noninvasive imaging,-1.6473343298455427,271.0
2952,3288,mean period,-1.6502283105022864,278.0
2953,597,method evaluated,-1.6516853932584268,147.0
2954,2997,mean diffusivity,-1.6564202334630416,387.0
2955,1023,visual cortex,-1.6606221547799618,509.0
2956,1429,radiation exposure,-1.6614173228346443,1055.0
2957,1314,high level,-1.6617100371747255,298.0
2958,3172,female patients,-1.6641221374045787,545.0
2959,3208,exhibited high,-1.66415094339622,126.0
2960,1471,provide useful,-1.6643678160919553,181.0
2961,2970,tensor imaging,-1.6655845683368398,1142.0
2962,2287,central macular,-1.6666666666666698,175.0
2963,1535,proposed algorithm,-1.6674405107370869,221.0
2964,1049,molecular mechanism,-1.6697368421052619,141.0
2965,1105,multiple sclerosis,-1.6710706150341679,917.0
2966,611,treatment results,-1.6721728081321485,188.0
2967,920,supplemental material,-1.6733017377567192,331.0
2968,319,online supplemental,-1.6733017377567192,331.0
2969,3161,brain magnetic,-1.6795909671921632,438.0
2970,2728,time series,-1.680220537560303,230.0
2971,2487,functional connectivity,-1.683375116711639,2855.0
2972,2140,development new,-1.686614173228346,357.0
2973,1999,sensitivity specificity,-1.6897733908921275,4952.0
2974,709,resonance spectroscopy,-1.6974203338391471,329.0
2975,2273,digital subtraction,-1.6989499192245598,369.0
2976,2488,strongly associated,-1.7018216682646228,355.0
2977,2822,resistive index,-1.7059147180192582,159.0
2978,2897,middle frontal,-1.709602986087549,311.0
2979,3494,time points,-1.7098570353649394,988.0
2980,585,using system,-1.7166448230668365,177.0
2981,1878,angiography mra,-1.7176470588235315,146.0
2982,1960,microscopy afm,-1.7205146533237934,415.0
2983,2033,histological findings,-1.7210749646393224,156.0
2984,899,however limited,-1.724508519003936,153.0
2985,1044,mtt assay,-1.727586206896553,167.0
2986,653,appropriate treatment,-1.7325966850828756,196.0
2987,1243,thirteen patients,-1.733638863428051,193.0
2988,371,using various,-1.7345132743362879,140.0
2989,2998,atrial appendage,-1.7354497354497347,205.0
2990,2024,treatment modalities,-1.737931034482758,168.0
2991,3390,data patients,-1.738660907127427,805.0
2992,3232,method based,-1.7398607128226151,411.0
2993,2795,children years,-1.7467615125421236,288.0
2994,946,superior frontal,-1.7480647431386314,324.0
2995,1246,studies found,-1.7499999999999973,140.0
2996,141,neuroimaging studies,-1.7530507685142067,459.0
2997,2960,rrna gene,-1.7574803149606315,124.0
2998,2634,conventional methods,-1.7578947368421034,167.0
2999,3181,great potential,-1.7639575971731445,416.0
3000,2126,different regions,-1.7658536585365845,181.0
3001,3482,apparent diffusion,-1.7785066896849377,808.0
3002,1080,matter wm,-1.7812530354541056,346.0
3003,2355,improve accuracy,-1.7819123881300085,291.0
3004,409,high accuracy,-1.7878787878788032,295.0
3005,1753,cerebral arteries,-1.7888888888888892,161.0
3006,2961,fractional anisotropy,-1.7954298844705494,1223.0
3007,1586,method used,-1.7963927855711488,498.0
3008,1727,using technique,-1.8011173184357576,248.0
3009,215,across groups,-1.8028962188254183,249.0
3010,2103,classification system,-1.8093174431202566,334.0
3011,933,years women,-1.8127659574467978,284.0
3012,2413,analysis variance,-1.8137432188065095,510.0
3013,739,used patients,-1.8155087404751247,332.0
3014,1208,images patients,-1.815738963531673,430.0
3015,3042,combination therapy,-1.8169884169884305,181.0
3016,3598,correlations found,-1.817859577368781,226.0
3017,3455,vs respectively,-1.8182586644125065,478.0
3018,2894,amino acids,-1.8189067863744388,341.0
3019,158,echocardiographic parameters,-1.8205231388329992,348.0
3020,2835,optic disc,-1.8213660245183836,400.0
3021,147,cortex dlpfc,-1.8214285714285678,210.0
3022,769,imaging scans,-1.8231006794317501,314.0
3023,2852,mean change,-1.8243119266055035,194.0
3024,3094,coefficient variation,-1.8304021813224294,274.0
3025,556,aimed investigate,-1.8410333584148406,749.0
3026,54,factor receptor,-1.8453046112420082,308.0
3027,3183,less invasive,-1.8503082614056696,183.0
3028,1807,internal jugular,-1.855535390199638,284.0
3029,818,showed high,-1.856306999881559,548.0
3030,3281,characteristic curve,-1.85927109974424,1077.0
3031,767,nuclear medicine,-1.861450864614085,455.0
3032,2825,body composition,-1.8709239488598919,793.0
3033,1867,poorly understood,-1.8709726213885964,665.0
3034,2952,records reviewed,-1.8721973094170437,167.0
3035,3125,cardiac cycle,-1.8750000000000044,180.0
3036,1132,showed strong,-1.87622149837133,192.0
3037,2250,speckle tracking,-1.8817023322914224,430.0
3038,3593,patients moderate,-1.8878504672897447,202.0
3039,1274,right left,-1.8925057567510977,861.0
3040,2927,potential application,-1.893670886075944,187.0
3041,2470,children hospital,-1.8945848375451215,192.0
3042,2830,male subjects,-1.897196261682246,145.0
3043,1178,carcinoma hcc,-1.9177264363115911,358.0
3044,2257,mean difference,-1.921786753380108,591.0
3045,3276,cells cultured,-1.921978021978025,159.0
3046,2807,high performance,-1.9230769230769176,125.0
3047,2407,lower extremities,-1.9246390312063375,291.0
3048,3610,per day,-1.9270072992700689,220.0
3049,2645,material properties,-1.9275590551181097,272.0
3050,1019,left right,-1.9281868566904214,994.0
3051,423,years average,-1.9294117647058822,164.0
3052,3395,default mode,-1.9311377245508956,645.0
3053,2288,approved institutional,-1.9348946135831397,243.0
3054,281,body weight,-1.9365603644646967,694.0
3055,1287,women underwent,-1.9426124197002206,252.0
3056,2242,cell culture,-1.943532783948408,382.0
3057,426,fisher exact,-1.947730398899587,354.0
3058,2858,inflammatory response,-1.9495166487647662,275.0
3059,2181,institutional review,-1.9502979991485756,733.0
3060,487,carotid stenosis,-1.955236139630393,207.0
3061,862,weeks weeks,-1.9557080474111077,209.0
3062,1040,patients advanced,-1.9561643835616436,374.0
3063,648,fluorescent probe,-1.9572501444251884,220.0
3064,2225,heart association,-1.958333333333328,235.0
3065,2582,used treatment,-1.9615819209039493,217.0
3066,1710,often associated,-1.9624999999999848,157.0
3067,2190,cardiac death,-1.967088607594933,444.0
3068,3349,months later,-1.968580060422953,362.0
3069,3567,mean differences,-1.9740259740259776,152.0
3070,2133,contrast medium,-1.9775248933143688,331.0
3071,601,surgical approach,-1.9783691572842037,367.0
3072,647,emission computed,-1.9823713160396617,477.0
3073,1918,invasive procedures,-1.997001499250375,148.0
3074,1278,time peak,-1.9981481481481511,166.0
3075,825,using different,-1.999691358024691,589.0
3076,3331,min min,-1.9999999999999765,240.0
3077,1692,studies showed,-2.0017857142857154,413.0
3078,3635,needle aspiration,-2.0036697247706483,336.0
3079,3060,image reconstruction,-2.005172282650036,538.0
3080,1258,closely associated,-2.005277044854882,200.0
3081,2185,bone resorption,-2.0068027210884303,295.0
3082,2114,measured using,-2.0133637548891796,1420.0
3083,2330,used analyze,-2.0153846153846113,262.0
3084,2189,outcomes evaluated,-2.023326959847039,143.0
3085,3122,test whether,-2.024944974321355,184.0
3086,3351,patients symptoms,-2.0250000000000097,126.0
3087,499,node metastasis,-2.031150573436918,283.0
3088,2262,used model,-2.0312944523470757,204.0
3089,3577,liver cirrhosis,-2.0329787234042533,273.0
3090,3053,analyses showed,-2.0336793540945743,304.0
3091,57,showed low,-2.049079754601227,167.0
3092,1715,patients died,-2.049257425742571,487.0
3093,3333,therapeutic agents,-2.0526315789473735,143.0
3094,1549,cells treated,-2.0543828264758495,174.0
3095,2431,mean values,-2.056338028169011,365.0
3096,1488,material available,-2.0695652173913093,340.0
3097,1829,analyses using,-2.0741573033707867,142.0
3098,112,mineral density,-2.0811649464203557,1227.0
3099,227,cortical bone,-2.0842607313195445,690.0
3100,271,mr imaging,-2.0865581569499865,2480.0
3101,2098,findings support,-2.0892293826047776,380.0
3102,3352,reviewed patients,-2.0958052822371833,355.0
3103,290,years surgery,-2.102150537634412,170.0
3104,1108,propose novel,-2.1085124677558063,183.0
3105,107,correlated negatively,-2.1092511013215893,126.0
3106,2502,skeletal muscle,-2.112875779920585,745.0
3107,2563,head injury,-2.1215041128084606,153.0
3108,3561,ventricular outflow,-2.122611744084137,351.0
3109,3059,cell proliferation,-2.1276096129150637,532.0
3110,3250,disorder mdd,-2.1325581395348894,262.0
3111,2318,detected patients,-2.1403548941041803,456.0
3112,669,severe aortic,-2.1456896551724136,262.0
3113,1479,results obtained,-2.1512481644640244,586.0
3114,1827,prostate cancer,-2.1574246694125314,1746.0
3115,998,showed similar,-2.1641418983700875,342.0
3116,440,surface area,-2.176253819881361,1153.0
3117,566,adjuvant therapy,-2.181818181818171,120.0
3118,1521,visual acuity,-2.1873065015479893,1570.0
3119,3106,supramarginal gyrus,-2.196388261851011,139.0
3120,2059,cancer cells,-2.2076578332034265,1273.0
3121,1357,domain optical,-2.209694793536801,362.0
3122,2420,histopathological examination,-2.2105263157894743,240.0
3123,208,vitro vivo,-2.2153462258265666,772.0
3124,997,tricuspid valve,-2.2166666666666592,285.0
3125,3582,fmri data,-2.2271196816651315,428.0
3126,3231,control groups,-2.2328600405679517,688.0
3127,2394,imaging sequences,-2.233333333333334,134.0
3128,2684,spectrum disorder,-2.2365489130434835,279.0
3129,3246,pregnant women,-2.2405711472181205,373.0
3130,169,groups different,-2.2678571428571397,127.0
3131,64,first step,-2.2682170542635784,231.0
3132,795,patients average,-2.2693693693693655,229.0
3133,3570,benign lesions,-2.2713607594936707,319.0
3134,1646,tomography spect,-2.277639046538028,237.0
3135,907,pediatric patients,-2.285513737549302,895.0
3136,12,met inclusion,-2.2932536293766064,463.0
3137,569,insulin resistance,-2.294223826714801,410.0
3138,2459,future research,-2.2963893249607494,318.0
3139,437,daily practice,-2.3027027027026863,142.0
3140,425,ra patients,-2.3095558546433352,440.0
3141,910,region interest,-2.3121153508000707,487.0
3142,2282,used imaging,-2.315384615384618,215.0
3143,327,image registration,-2.316256748650279,394.0
3144,3195,men mean,-2.317544587308177,458.0
3145,3077,using new,-2.318501170960192,198.0
3146,2258,kidney injury,-2.3200207468879626,315.0
3147,1342,acquired using,-2.3207248018119957,218.0
3148,3189,doppler ultrasound,-2.332149603324513,506.0
3149,1822,future studies,-2.3387521465369145,659.0
3150,2964,values measured,-2.3404600811908027,184.0
3151,2423,patients severe,-2.3475650433622475,897.0
3152,1125,using data,-2.349311294765825,328.0
3153,33,evaluated using,-2.351213282247788,1315.0
3154,2415,based results,-2.352717391304343,234.0
3155,2577,annular plane,-2.3674796747967513,208.0
3156,1869,strain rate,-2.3762523982093318,355.0
3157,2457,imaging methods,-2.3809523809523854,375.0
3158,1280,outflow tract,-2.3952837522674297,409.0
3159,1840,successfully applied,-2.3959731543624145,170.0
3160,2040,neural mechanisms,-2.4089132134479976,395.0
3161,1168,western blotting,-2.413590033975086,288.0
3162,1372,hip score,-2.4305975049244966,223.0
3163,949,plasma levels,-2.438709677419351,216.0
3164,750,used functional,-2.4447204968944174,246.0
3165,176,receiver operating,-2.447007223942193,2018.0
3166,3624,patients major,-2.457142857142853,172.0
3167,741,tracking echocardiography,-2.459060402684569,229.0
3168,3495,assess whether,-2.462951807228919,442.0
3169,1071,single molecule,-2.471541501976288,169.0
3170,1469,surface morphology,-2.478947368421059,157.0
3171,1649,patients results,-2.482352941176466,211.0
3172,2663,endothelial growth,-2.4894062863795097,396.0
3173,90,muscle mass,-2.492971246006391,561.0
3174,61,prospective patients,-2.494949494949491,247.0
3175,1499,mean sd,-2.4971462310568766,976.0
3176,563,spectral domain,-2.5028387787895143,396.0
3177,744,sought determine,-2.5090909090909066,414.0
3178,747,microscopy sem,-2.512578616352209,765.0
3179,3418,analyses performed,-2.52962233756936,673.0
3180,580,anterior temporal,-2.529940119760467,169.0
3181,1644,novel approach,-2.5363636363636264,279.0
3182,2983,however still,-2.5487179487179463,142.0
3183,1664,surrogate marker,-2.55172413793103,148.0
3184,1427,cardiac magnetic,-2.5531249999999943,817.0
3185,987,medical records,-2.5591364687740876,922.0
3186,1864,method measuring,-2.566265060240969,142.0
3187,2171,patients female,-2.575830815709973,294.0
3188,588,function assessed,-2.5830058417419037,293.0
3189,1458,tomography cbct,-2.586046511627894,417.0
3190,3219,radical prostatectomy,-2.587500000000011,184.0
3191,2294,spatial statistics,-2.591978609625675,262.0
3192,817,neuronal activity,-2.594577846630521,212.0
3193,157,ventromedial prefrontal,-2.599999999999987,163.0
3194,2980,without evidence,-2.608534850640117,173.0
3195,1557,reactive oxygen,-2.6237467018469713,452.0
3196,2104,carried using,-2.6295358649789082,228.0
3197,2683,commonly used,-2.634567901234563,1067.0
3198,1991,neuroendocrine tumors,-2.6351966873705908,172.0
3199,2567,electroencephalography eeg,-2.639751552795032,250.0
3200,1908,months years,-2.641420118343199,248.0
3201,351,signaling pathway,-2.676056338028165,228.0
3202,82,cell wall,-2.6764705882352997,413.0
3203,971,novel method,-2.693135563987581,379.0
3204,633,left inferior,-2.6936238902340666,451.0
3205,3522,newly developed,-2.7301642178046706,318.0
3206,2178,investigate relationship,-2.7336683417085506,340.0
3207,1433,adipose tissue,-2.742404621974291,805.0
3208,1892,deviation sd,-2.7471004243281505,249.0
3209,53,children adolescents,-2.7523025469513813,359.0
3210,3535,intravascular ultrasound,-2.7957831325301186,357.0
3211,1000,results demonstrate,-2.8056112224448895,1000.0
3212,3211,bone mineral,-2.806802439780833,1419.0
3213,2229,relaxation times,-2.836737400530507,293.0
3214,1637,signal intensity,-2.8396361136087074,1013.0
3215,117,surgery patients,-2.8418930762489114,523.0
3216,2603,wall thickness,-2.8514386059705634,718.0
3217,1846,nanoparticles nps,-2.8571428571428674,200.0
3218,3603,valuable information,-2.857340241796202,176.0
3219,85,white blood,-2.8684813753581726,213.0
3220,3275,dose gy,-2.872727272727276,158.0
3221,830,imaged using,-2.8875667429443173,208.0
3222,3003,field view,-2.887671232876711,272.0
3223,3173,parameters measured,-2.8892617449664426,205.0
3224,1371,could provide,-2.8929292929293142,358.0
3225,902,reporting data,-2.894736842105256,275.0
3226,2820,complications patients,-2.894736842105258,225.0
3227,967,results indicate,-2.904162812210877,1427.0
3228,2557,males mean,-2.9076923076923054,189.0
3229,2550,structure function,-2.9108910891089153,630.0
3230,516,past years,-2.925842696629208,336.0
3231,701,performed assess,-2.9277210884353693,313.0
3232,606,similar groups,-2.929169728141058,643.0
3233,2826,antibiotic therapy,-2.9333333333333327,136.0
3234,1525,cell growth,-2.9358840112766824,287.0
3235,248,segmentation method,-2.9369565217391256,193.0
3236,1734,cortical subcortical,-2.9504132231404965,210.0
3237,2223,used identify,-2.954423592493295,580.0
3238,3009,seven patients,-2.955726074996381,604.0
3239,189,showed association,-2.977836411609499,171.0
3240,3098,survival os,-2.9880823401950196,394.0
3241,1190,treatment choice,-2.992592592592583,202.0
3242,3530,tumor location,-2.9934210526315828,175.0
3243,3155,auditory cortex,-2.999999999999997,185.0
3244,975,cell death,-3.0028737220226525,811.0
3245,2107,grade ii,-3.0082840236686565,246.0
3246,797,aortic valve,-3.0194630872483215,1636.0
3247,2971,posterior wall,-3.0489510489510554,218.0
3248,2275,resonance mr,-3.055954452000643,938.0
3249,1170,images images,-3.0607287449392766,189.0
3250,322,liver disease,-3.0770925110132215,635.0
3251,1482,patients examined,-3.1020746887966806,178.0
3252,1042,gray matter,-3.102160837603032,1352.0
3253,239,ultrasound imaging,-3.1076719576719634,691.0
3254,758,system patients,-3.119187358916478,147.0
3255,2243,groups according,-3.121546961325968,565.0
3256,276,rheumatoid arthritis,-3.124326970141939,491.0
3257,877,tissue doppler,-3.1276374956762467,330.0
3258,87,specificity accuracy,-3.140493287542916,479.0
3259,3405,performed patients,-3.1512134411947668,1688.0
3260,1491,past decades,-3.162886597938138,236.0
3261,3134,carbon nanotubes,-3.166666666666664,171.0
3262,63,using images,-3.170552147239258,152.0
3263,1651,poor outcomes,-3.1919463087248205,174.0
3264,2214,inversion recovery,-3.2102941176470696,531.0
3265,1094,pulmonary artery,-3.211192468619249,1137.0
3266,2613,scan time,-3.2198275862068986,249.0
3267,3006,nine patients,-3.2200864375385887,616.0
3268,792,arthritis ra,-3.2253968253968184,254.0
3269,2299,peripheral blood,-3.2357615894039866,349.0
3270,2643,seen patients,-3.2461470717745424,380.0
3271,2228,high rate,-3.24999999999999,325.0
3272,461,patients stable,-3.2506887052341504,236.0
3273,2974,investigate whether,-3.2519888991674595,837.0
3274,3194,central role,-3.2558139534883774,224.0
3275,3050,values lower,-3.26666666666668,147.0
3276,1237,single center,-3.2809523809523773,212.0
3277,1174,cerebrovascular disease,-3.2919896640827035,182.0
3278,289,confocal laser,-3.3140625000000115,404.0
3279,2908,eight patients,-3.3240667196187474,675.0
3280,2548,growth factor,-3.3368153585544986,1115.0
3281,202,blood oxygen,-3.3388960205391536,255.0
3282,1146,value suvmax,-3.344168260038246,159.0
3283,2749,detection limit,-3.3450127877237747,319.0
3284,320,attenuation correction,-3.350372208436725,157.0
3285,1816,cells showed,-3.3524429967426785,166.0
3286,2017,stress testing,-3.356756756756752,161.0
3287,272,specificity sensitivity,-3.3661971830986057,239.0
3288,2501,controls mean,-3.3664783427495246,218.0
3289,1002,ventricular volume,-3.3817351598173553,161.0
3290,2031,drug administration,-3.4094339622641514,139.0
3291,1820,power doppler,-3.410404624277448,300.0
3292,909,newly diagnosed,-3.4214843750000035,461.0
3293,1902,patients findings,-3.4338762214983785,251.0
3294,979,eligible patients,-3.444098573281453,187.0
3295,1171,cancer pca,-3.44593639575972,212.0
3296,1006,infants born,-3.4476821192053078,137.0
3297,1593,contrast agent,-3.4635386366510765,919.0
3298,1909,previously demonstrated,-3.4671052631578987,155.0
3299,3383,arterial pressure,-3.4766087844739504,254.0
3300,421,assessed using,-3.485875267145916,1759.0
3301,2746,whether patients,-3.5034482758620746,127.0
3302,251,imaging reporting,-3.525925925925923,238.0
3303,937,remaining patients,-3.5323383084577396,426.0
3304,3479,image acquisition,-3.5364811691961773,379.0
3305,1124,review patients,-3.5461988304093586,379.0
3306,3157,likert scale,-3.54820936639118,184.0
3307,3131,widely used,-3.572131462617716,1273.0
3308,574,recent advances,-3.579719188767547,447.0
3309,1175,imaging studies,-3.584886649874066,1186.0
3310,2589,autism spectrum,-3.588994864269999,263.0
3311,2727,high rates,-3.5972752043596734,161.0
3312,1130,excellent agreement,-3.5999999999999925,174.0
3313,2575,patients females,-3.6178861788617964,178.0
3314,2506,assess feasibility,-3.632464929859724,171.0
3315,212,different stages,-3.664596273291928,236.0
3316,3394,inferior frontal,-3.6680161943319662,755.0
3317,1603,number studies,-3.690452261306536,136.0
3318,3543,revision surgery,-3.701000434971726,261.0
3319,2111,relatively common,-3.712500000000004,132.0
3320,3068,technique used,-3.7523364485981383,365.0
3321,124,fluorescent protein,-3.7613722998729244,361.0
3322,3451,computational fluid,-3.7640117994100235,220.0
3323,363,gleason score,-3.7741496598639546,292.0
3324,2371,systolic blood,-3.7793594306049854,354.0
3325,1073,differences found,-3.7806122448979496,741.0
3326,2096,showed complete,-3.783177570093462,184.0
3327,242,without need,-3.8031558185404224,311.0
3328,131,chain reaction,-3.808080808080787,377.0
3329,518,tomography revealed,-3.812600969305344,200.0
3330,151,findings reveal,-3.8167539267015744,135.0
3331,3594,general anesthesia,-3.826562499999997,316.0
3332,2480,left hemisphere,-3.839678284182304,231.0
3333,3018,higher values,-3.846191051995157,224.0
3334,706,previously reported,-3.8498973907944998,980.0
3335,1679,metabolic tumor,-3.8531249999999804,137.0
3336,2798,control subjects,-3.895823955989009,1277.0
3337,1474,left posterior,-3.914410480349352,166.0
3338,3121,included consecutive,-3.914960629921291,226.0
3339,594,identify patients,-3.9158878504672683,419.0
3340,3621,serum levels,-3.927210884353732,502.0
3341,1528,anterior posterior,-3.935156249999989,657.0
3342,262,anterior cingulate,-3.941463414634147,808.0
3343,3129,texture features,-3.9499462943072015,227.0
3344,2659,obstructive sleep,-3.9541984732824518,185.0
3345,1075,play important,-3.9728986245542726,582.0
3346,2153,information regarding,-3.9769230769230606,329.0
3347,1800,total consecutive,-3.977881257275891,335.0
3348,1792,aneurysm sac,-3.9873239436619716,149.0
3349,1628,analysis indicated,-3.9925925925926,308.0
3350,2396,brain regions,-3.9950066270073785,1994.0
3351,2968,using image,-3.9999999999999862,184.0
3352,2191,patients prostate,-4.00305343511448,138.0
3353,3556,healthy children,-4.006299212598432,212.0
3354,2864,cell lines,-4.007883817427383,743.0
3355,283,used evaluation,-4.009638554216856,128.0
3356,1192,left ventricular,-4.015465421651569,4587.0
3357,59,fluoroscopy time,-4.016460396039605,391.0
3358,1978,medial frontal,-4.06341463414633,147.0
3359,1360,matter integrity,-4.076987447698738,203.0
3360,1485,tumors patients,-4.114285714285709,144.0
3361,1541,diffusion coefficient,-4.127388535031846,864.0
3362,1512,beneficial effect,-4.146835443037952,126.0
3363,2895,aimed determine,-4.1477606024573905,508.0
3364,2519,years total,-4.162500000000021,111.0
3365,2685,head neck,-4.1634813142714036,1169.0
3366,3574,weeks postoperatively,-4.164102564102564,116.0
3367,982,patients first,-4.165624999999979,258.0
3368,2915,fluoroscopic guidance,-4.176687116564428,148.0
3369,2137,overall survival,-4.188524590163931,1460.0
3370,435,mode network,-4.188776305533906,507.0
3371,2799,differences groups,-4.193083573487031,485.0
3372,2772,quantitative computed,-4.209523809523795,221.0
3373,2887,eleven patients,-4.223693379790941,209.0
3374,919,biomechanical properties,-4.239130434782605,150.0
3375,474,tube voltage,-4.285714285714292,150.0
3376,2379,mean years,-4.300053821313247,4205.0
3377,1906,pattern analysis,-4.314049586776864,174.0
3378,873,brain networks,-4.330161750713606,615.0
3379,1464,twelve patients,-4.346365105008062,236.0
3380,2813,years patients,-4.347656250000007,742.0
3381,917,differences observed,-4.355056179775312,456.0
3382,2797,positively correlated,-4.407286673058492,936.0
3383,1884,bone formation,-4.407719799857025,752.0
3384,2276,qualitative quantitative,-4.430944963655242,251.0
3385,3568,total cases,-4.433333333333336,209.0
3386,224,curve auc,-4.441602465331276,609.0
3387,821,previous studies,-4.4786374981647405,1240.0
3388,1269,radiation dose,-4.491341842014454,1514.0
3389,93,remains unclear,-4.49227498228205,773.0
3390,2237,potential use,-4.4927536231884035,248.0
3391,2234,patients atrial,-4.500917431192674,223.0
3392,2868,studies needed,-4.514446002805071,619.0
3393,1754,criteria included,-4.518110236220472,151.0
3394,3072,new technique,-4.5249999999999915,181.0
3395,777,portal vein,-4.53213213213211,539.0
3396,3087,mammalian cells,-4.543209876543216,160.0
3397,3596,species ros,-4.5690376569037605,260.0
3398,3010,method using,-4.573244147157166,318.0
3399,658,real time,-4.58634868421052,507.0
3400,3309,state examination,-4.599999999999986,143.0
3401,1329,reach significance,-4.636144578313223,148.0
3402,463,literature review,-4.674846625766849,508.0
3403,3625,systolic diastolic,-4.683201058201084,485.0
3404,3618,right anterior,-4.728828828828834,181.0
3405,236,diffraction xrd,-4.741121495327103,267.0
3406,3076,independent factors,-4.745008756567394,437.0
3407,1423,article reviews,-4.768020969855849,214.0
3408,1133,subjects without,-4.7873350923482825,336.0
3409,1926,models used,-4.791597958382429,439.0
3410,2458,monoclonal antibody,-4.820512820512809,188.0
3411,1832,subtraction angiography,-4.820749279538928,328.0
3412,2327,revealed presence,-4.822222222222203,217.0
3413,413,bone health,-4.887931034482756,210.0
3414,582,brain imaging,-4.942648845686515,473.0
3415,163,patients grade,-4.9436619718309815,195.0
3416,3549,used predict,-4.956521739130424,266.0
3417,1483,ultrasound used,-4.971428571428569,174.0
3418,732,patients acute,-4.980310880828997,1068.0
3419,3438,important role,-5.009707548614343,1352.0
3420,2069,test used,-5.021549421193194,532.0
3421,1285,six patients,-5.0370757180156716,689.0
3422,343,mass index,-5.054821204953374,2137.0
3423,395,image noise,-5.055101339745801,457.0
3424,3245,disease associated,-5.08591065292098,200.0
3425,1172,disorder characterized,-5.097041420118349,219.0
3426,1608,data indicate,-5.115566625155676,437.0
3427,2063,oxide nanoparticles,-5.139473684210525,279.0
3428,2845,ventricle lv,-5.144736842105242,170.0
3429,1524,hundred patients,-5.149999999999988,412.0
3430,2881,objective assess,-5.155555555555575,174.0
3431,456,molecular imaging,-5.159666975023126,581.0
3432,1498,new insights,-5.210126582278504,294.0
3433,2328,imaging contrast,-5.225000000000002,209.0
3434,3579,crohn disease,-5.244925575101496,340.0
3435,2999,groups mean,-5.246153846153868,231.0
3436,1995,imaging using,-5.24745762711864,432.0
3437,879,tomography imaging,-5.269406867845988,641.0
3438,3622,imaging brain,-5.271844660194228,181.0
3439,2014,mean dose,-5.2828125000000075,147.0
3440,638,diagnostic therapeutic,-5.337738246505715,236.0
3441,71,pedicle screws,-5.342995169082125,158.0
3442,3623,lv diastolic,-5.3587939698492315,248.0
3443,3453,elevation myocardial,-5.412720848056527,333.0
3444,2622,scan performed,-5.415165876777253,197.0
3445,3506,techniques used,-5.466176470588217,413.0
3446,1339,compare accuracy,-5.4736842105263035,156.0
3447,3154,controlled trial,-5.558823529411768,420.0
3448,1388,hypertrophic cardiomyopathy,-5.575757575757571,320.0
3449,3085,least squares,-5.577676537585402,231.0
3450,565,gyrus right,-5.596590909090909,197.0
3451,3559,subjects mean,-5.603773584905674,165.0
3452,2212,diastolic function,-5.652501238236744,554.0
3453,185,large number,-5.692682926829297,389.0
3454,452,hip arthroplasty,-5.716901408450705,451.0
3455,618,relatively low,-5.733509234828523,265.0
3456,2648,complications associated,-5.7538461538461565,132.0
3457,3317,present new,-5.783574879227085,146.0
3458,2771,underwent surgical,-5.795297191378218,407.0
3459,1402,diastolic blood,-5.882828282828288,208.0
3460,3136,weight loss,-5.903614457831351,525.0
3461,1877,left atrial,-5.926279374925464,1104.0
3462,526,ultrasound ivus,-6.024710424710438,166.0
3463,2984,forty patients,-6.075376884422117,195.0
3464,3441,healthy volunteers,-6.078225867699527,1312.0
3465,2254,metabolic activity,-6.117056856187325,295.0
3466,3067,fat mass,-6.129210890632239,458.0
3467,1186,enhancement lge,-6.150000000000011,164.0
3468,2220,better performance,-6.222516556291424,162.0
3469,3215,sensitive specific,-6.252298850574704,253.0
3470,3152,aim investigate,-6.3083861874559455,973.0
3471,2656,high frequency,-6.352066115702464,183.0
3472,637,subjective image,-6.360722347629802,193.0
3473,1414,ventricular tachycardia,-6.472289156626586,158.0
3474,3210,estimated using,-6.482758620689724,376.0
3475,2244,aim assess,-6.503039513677807,778.0
3476,1771,corpus callosum,-6.619622093023254,799.0
3477,552,studied using,-6.658064516129008,312.0
3478,2610,ventricular lv,-6.699633699633675,930.0
3479,2000,negatively associated,-6.731313131313161,196.0
3480,76,patients suffering,-6.791304347826071,284.0
3481,686,female mean,-6.892857142857153,193.0
3482,216,polymerase chain,-6.939568345323747,371.0
3483,3434,patients classified,-6.982733812949621,422.0
3484,1837,correlated positively,-7.0104234527687215,211.0
3485,1813,brain structure,-7.0792079207920855,429.0
3486,1653,spatial distribution,-7.090909090909109,280.0
3487,3284,adult male,-7.173006134969295,158.0
3488,3114,pigment epithelium,-7.204166666666702,266.0
3489,547,using scanning,-7.275526024363257,307.0
3490,666,respiratory failure,-7.288524590163919,171.0
3491,2010,imaging technology,-7.294736842105228,231.0
3492,2910,cerebral venous,-7.333333333333328,160.0
3493,847,mean square,-7.352380952380949,193.0
3494,2090,findings suggest,-7.389396067415739,1725.0
3495,357,cortical thickness,-7.4285714285713915,1112.0
3496,3545,level iii,-7.517647058823574,213.0
3497,538,harris hip,-7.574137931034487,191.0
3498,1821,live cells,-7.613683223992536,269.0
3499,930,physiological conditions,-7.6322580645161135,169.0
3500,1964,perfusion imaging,-7.77832167832171,454.0
3501,1614,results show,-7.778564206268916,1570.0
3502,2962,data system,-7.780487804878042,319.0
3503,809,fluorescence imaging,-7.809324452901994,578.0
3504,844,cardiovascular mortality,-7.844827586206922,182.0
3505,2787,median months,-7.917139924734851,737.0
3506,3627,groups using,-7.929274004683859,209.0
3507,863,linear model,-7.955555555555561,179.0
3508,3218,provide insight,-8.021800947867273,217.0
3509,481,patients operated,-8.043478260869547,185.0
3510,558,pressure bp,-8.08421052631577,192.0
3511,277,wide range,-8.100321248279018,781.0
3512,759,patients achieved,-8.307692307692355,180.0
3513,45,stent implantation,-8.30897832817341,213.0
3514,15,four patients,-8.390625000000004,895.0
3515,349,degeneration amd,-8.392682926829295,222.0
3516,1021,adverse events,-8.394883941260154,1248.0
3517,2921,arthroplasty tha,-8.41893004115226,193.0
3518,575,january june,-8.437499999999917,225.0
3519,3499,morbidity mortality,-8.569172932330824,786.0
3520,373,used examine,-8.626533166458085,241.0
3521,2436,delivery system,-8.638286479250313,296.0
3522,3020,ultrasound scan,-8.659259259259256,167.0
3523,86,nsclc patients,-8.838805970149291,141.0
3524,1905,near infrared,-8.841176470588207,334.0
3525,3553,reference values,-8.8565217391305,291.0
3526,2594,frontal gyrus,-8.947157843376417,1036.0
3527,3502,ultrasound findings,-8.98812785388129,266.0
3528,2348,human brain,-9.009710391822779,867.0
3529,1227,radiological findings,-9.089425981873077,307.0
3530,3595,repeated measures,-9.099999999999993,133.0
3531,360,computerized tomography,-9.129528535980112,292.0
3532,468,infarction stemi,-9.1772357723577,332.0
3533,1473,high quality,-9.276762402088805,209.0
3534,2043,performed consecutive,-9.340298507462636,149.0
3535,2398,effective safe,-9.369230769230864,203.0
3536,2210,imaging modalities,-9.4350328947369,1043.0
3537,1053,early detection,-9.484611316763603,557.0
3538,2053,connective tissue,-9.622149837133541,422.0
3539,1854,controls differences,-9.682608695652188,131.0
3540,1408,results showed,-9.783297847172904,1798.0
3541,2581,liver biopsy,-9.791566265060286,301.0
3542,2365,early treatment,-9.829752066115745,313.0
3543,3073,model used,-9.835831809872051,441.0
3544,2077,maxillary sinus,-9.885714285714243,346.0
3545,1229,crucial role,-9.906613226452821,321.0
3546,204,used test,-9.957446808510662,180.0
3547,599,area receiver,-10.001250977326052,566.0
3548,1211,signaling pathways,-10.032850241545864,176.0
3549,2266,brain areas,-10.043478260869529,539.0
3550,2429,patients analyzed,-10.062962962962969,247.0
3551,172,upper lower,-10.082843137254832,307.0
3552,410,fluid dynamics,-10.160869565217418,246.0
3553,484,years ago,-10.22222222222219,184.0
3554,3521,ml ml,-10.222222222222214,160.0
3555,994,adult patients,-10.27100271002717,758.0
3556,1319,first time,-10.361595273264456,1482.0
3557,2554,imaging findings,-10.521011831905335,1205.0
3558,1420,monte carlo,-10.52375886524824,503.0
3559,2839,right superior,-10.600000000000053,219.0
3560,2917,underwent successful,-10.72614555256066,197.0
3561,3258,cholangiopancreatography ercp,-10.732824427480969,190.0
3562,3035,subjects patients,-10.733333333333313,182.0
3563,1293,tuberculosis tb,-10.844444444444381,122.0
3564,2857,green fluorescent,-10.918725099601643,193.0
3565,1153,echocardiography tee,-11.04938271604937,179.0
3566,3008,determined using,-11.100000000000096,603.0
3567,560,radiation doses,-11.152173913043493,285.0
3568,490,demonstrate feasibility,-11.241758241758253,155.0
3569,3480,patients underwent,-11.302243558342187,6409.0
3570,1312,surgical repair,-11.620858895705572,287.0
3571,1236,quality assurance,-11.656756756756785,227.0
3572,338,groups respectively,-11.665105386416853,586.0
3573,1683,imaging techniques,-11.74760448521925,1226.0
3574,904,obtained using,-11.910117145899896,766.0
3575,3312,activity score,-12.077419354838755,156.0
3576,3028,lower patients,-12.164705882352953,376.0
3577,2701,years males,-12.294117647058833,220.0
3578,2531,cases controls,-12.516279069767492,207.0
3579,1518,left atrium,-12.809893992932826,342.0
3580,2752,response treatment,-13.12631578947371,258.0
3581,3459,cell types,-13.144715447154448,376.0
3582,826,performed without,-13.421582733812892,176.0
3583,664,finite element,-13.51046452271569,665.0
3584,871,femoral neck,-13.64903474903473,667.0
3585,2832,provide novel,-13.705263157894775,217.0
3586,1226,vena cava,-13.751162790697816,657.0
3587,2939,spatial resolution,-13.924731182795709,1050.0
3588,2221,analysis showed,-13.961727101236635,1657.0
3589,1144,used characterize,-14.075609756097558,199.0
3590,2605,mineral content,-14.37014925373126,166.0
3591,697,data acquisition,-14.37500000000003,230.0
3592,1417,image guidance,-14.399999999999855,268.0
3593,1249,previous work,-14.409771986970648,219.0
3594,2113,purpose assess,-14.675528700906417,352.0
3595,3040,right posterior,-14.82276422764224,172.0
3596,2756,antimicrobial activity,-15.111111111111116,170.0
3597,1424,great promise,-15.399999999999967,154.0
3598,1740,using fmri,-15.467213114754038,255.0
3599,2115,total number,-15.6618510158013,307.0
3600,2776,retrograde cholangiopancreatography,-15.746153846153845,267.0
3601,250,underlying mechanisms,-15.842105263157713,315.0
3602,2784,commercially available,-15.968908489525967,521.0
3603,155,published periodicals,-16.33333333333338,245.0
3604,2274,aim work,-16.399999999999952,246.0
3605,2112,imaging fmri,-16.500473933649292,1024.0
3606,68,plays important,-16.66753812636175,524.0
3607,800,lumbar puncture,-17.249999999999968,138.0
3608,1154,et al,-17.558823529411857,597.0
3609,2598,retrospective review,-17.655395683453083,1067.0
3610,719,new method,-17.903030303030235,422.0
3611,2308,iron oxide,-18.42857142857145,344.0
3612,2842,quantum dots,-18.71155778894475,214.0
3613,89,transcatheter aortic,-18.737931034482994,494.0
3614,1415,functional groups,-20.40000000000004,168.0
3615,3197,radiation therapy,-21.311225238444514,1092.0
3616,2617,retinal pigment,-21.362068965517437,295.0
3617,536,used assess,-21.419525065963132,1230.0
3618,856,percent patients,-21.63404255319155,164.0
3619,600,matched controls,-21.826771653543176,252.0
3620,3372,locally advanced,-22.42042253521129,403.0
3621,2333,cervical spine,-23.620858895705492,621.0
3622,2559,higher incidence,-25.041221374045637,278.0
3623,1773,using single,-25.666666666666647,154.0
3624,731,blood pressure,-26.889959698615602,1993.0
3625,959,imaging protocol,-27.310344827586338,220.0
3626,3120,multivariate analyses,-30.620689655172445,370.0
3627,546,cell line,-30.786885245901427,626.0
3628,1726,performed determine,-31.573426573426655,301.0
3629,2806,retrospectively reviewed,-31.788217522658936,1299.0
3630,1631,macular degeneration,-32.307407407407595,429.0
3631,958,imaging systems,-38.171428571428564,167.0
3632,2199,executive control,-39.085106382978545,167.0
3633,2523,endothelial function,-43.225000000000094,247.0
3634,1558,cell membranes,-46.00000000000053,161.0
3635,2034,cancer nsclc,-51.399999999999345,257.0
3636,1883,lv mass,-52.12987012987047,446.0
3637,2597,consecutive series,-57.81428571428548,213.0
3638,542,present first,-74.28571428571334,200.0
3639,718,ultrasound images,-75.02564102564104,385.0
3640,1492,nucleic acids,-83.29629629629747,173.0
3641,341,strongly correlated,-126.30697674418597,292.0
